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1 Introduction 
1.1 Epigenetic regulations of cell 
1.1.1 The importance of chromatin structure 
Chromatin is a highly regulated nucleoprotein complex through which genetic 
material is structured and interfered to elicit cellular processes, including gene transcription, 
DNA replication, differentiation and DNA repair. Most of the epigenetic changes take place 
at the chromatin level, the higher order of DNA. Chromatin structure is built up by 
nucleosomes, which contain ± 146 bp of DNA wrapped around an octamer of four core 
histones (H2A, H2B, H3 and H4) (Figure	   1.1). The chromatin structure is controlled by 
epigenetic mechanisms including DNA methylation, post-translational modifications of 
histones and nucleosome positioning. The dynamics of their modifications can define the 
accessibility of chromatin regions to the transcriptional machinery and thus alter gene 
expression (Maes et al., 2013). Moreover, chromatin structure and dynamics are supposed to 
be involved in the regulation and facilitation of DNA repair. 
	  
Figure 1.1: Nucleosome structure. A 2.8 Å model of a nucleosome (left). A schematic representation of histone 
organization within the octamer core around which the DNA (black line) is wrapped (right). Nucleosome 
formation occurs first through the disposition of an H3/H4 tetramer on the DNA, followed by two sets of 
H2A/H2B dimers. Unstructured amino terminal histone tails extrude from the nucleosome core, which consists 
of structured globular domains of the eight histone proteins. Picture from www.genesandsignals.org (Allis et al., 
2006). 
Historically, chromatin structure was divided into two main types: euchromatin, which 
is an open, gene-rich and transcriptionally active region of chromatin and heterochromatin, 
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which constitutes 15-30% of mammalian chromatin and represents condensed regions with 
low gene density but high level of repetitive sequences (Figure	  1.2).  
	  
Figure 1.2: Distinction between euchromatin and heterochromatin. Summary of common differences 
between euchromatin and constitutive heterochromatin. This includes differences in the type of transcripts 
produced, recruitment of DNA-binding proteins, chromatin-associated proteins and complexes, covalent histone 
modifications, and histone variant composition. Picture from www.genesandsignals.org (Allis et al., 2006). 	  
Histones within heterochromatin have low levels of acetylation, but high levels of 
histone H3 methylation on lysine 9 and 27 (Figure	   1.3). In contrast, histones within 
euchromatin are highly acetylated and are methylated on lysine 4 and 36 of histone H3 
(Barski et al., 2007; Rice et al., 2003; Xu and Price, 2011). Heterochromatin mostly contains 
silent genes and compacted regions such as centromeres and telomeres. Typical marks include 
low levels of acetylation and methylation on H4K9, H3K27 and H4K20. In contrast, 
euchromatin is a less compacted region containing active genes, which contain high levels of 
acetylation, H3K4me3 and H3K36me3 (Maes et al., 2013). 
	  
Figure 1.3: Characterization of histone H3. The first 30 amino acids of histone H3 are shown. Human H3 
lysine residues known to be posttranslational modified are depicted: red for methylation, green for acetylation, 
and yellow for both. Red lollipops indicate that H3 Lys9 can be mono-, di-, or trimethylated. The purple line 
from residues 5–16 denotes the branched synthetic peptide used for immunization. The shaded box reflects the 
epitope similarity between Lys9 and Lys27 (picture from Rice et al., 2003). 
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 1.1.1.1 Chromatin and genome stability  
Heterochromatin is important for maintaining genomic stability. It can be subdivided 
into facultative and constitutive heterochromatin. Facultative heterochromatin is composed of 
silent DNA, which can be transcriptionally activated under certain conditions, such as during 
cell development and differentiation. Constitutive heterochromatin contains repetitive DNA, 
which is not transcriptionally active, and is particularly prevalent at the centromeric, 
pericentric and telomeric regions. The difference in chromatin compaction between 
euchromatin and heterochromatin is determined by interaction of DNA with histones and 
other non-histone proteins. 
Epigenetically heritable domains of heterochromatin control the structure and 
transcriptionally active domains and are required for proper chromosome segregation (Grewal 
and Moazed, 2003). The chromatin compaction of heterochromatin helps to protect DNA 
from damage. Interestingly, DNA damage in heterochromatin was shown to be refractory to 
repair and requires the surrounding chromatin structure to be decondensed (Cann and 
Dellaire, 2011; Cowell et al., 2007; Falk et al., 2008; Karagiannis at al., 2007) . Thus, cells 
must maintain a delicate balance between allowing repair factors to access these regions and 
ensuring that these regions retain their organization to prevent increased DNA damage and 
chromosomal mutations (Cann and Dellaire, 2011). 
1.1.1.2 Chromatin modification and the epigenetic control of gene expression 
Epigenetics is defined as the sum of heritable and non-heritable changes in chromatin 
structure, which control gene expression, and is independent of changes in the primary DNA 
sequence. Histone modifications have the potential to affect many fundamental biological 
processes. Modification of chromatin structure and subsequent regulation of gene expression 
is controlled by direct DNA methylation by DNA methyltransferases (DNMTs) and/or 
structural modification of amino acid residues on the N-terminal tail of histone proteins by 
nuclear enzymes, including histone acetyltrasferases (HATs), histone deacetylases (HDACs), 
arginine methyltransferases (HRMTs), lysine methyltrasferases (HKMTs) and lysine 
demethylases (HKDMs). Alteration of the methylation, acetylation or phosphorylation state 
of the nucleosome unit influences chromatin condensation (Decarlo and Hadden, 2012). 
Histones are modified at many sites with over 60 different residues where 
modification can be detected by specific antibodies. However, not all the modifications 
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appear on the same histone at the same time. Histone modifications are the result of complex 
interplay between different molecules referred to as chromatin remodelling proteins. 
Methylation of histone residues represents an important modification that is involved 
in both activation and repression of transcription with three different forms: mono-, di-, or 
trimethyl (Kouzarides, 2007). 
Histone phosphorylation is another major modification, which is highly dynamic. It 
may have important consequences for chromatin compaction via charge changes. 
Phosphorylation takes place mostly on serine or threonine residues on histone tails. The 
balance of phosphorylation is established by phosphatases and kinases, which remove and add 
phosphate groups, respectively. Histone phosphorylation regulates cell function including 
transcription, apoptosis, cell cycle, DNA repair and chromatin condensation (Maes et al., 
2013). Phosphorylation of the H2A variant H2AX for example plays an important role in 
DNA damage response of the cells. 
1.1.2 The role of methylation in cancer: methyltrasferases 
DNA methylation is an oldest epigenetic mechanism known to correlate with gene 
repression and thus plays a critical role in human carcinogenesis. There are at least two major 
processes by which methylation can contribute to the oncogenic phenotype: focal 
hypomethylation of promoter regions of oncogenes and hypermethylation of the promoters of 
tumour suppressor genes. Thus the indicated alterations in homeostasis of epigenetic 
mechanism are central regulations, which contribute to cancer initiation and progression 
(Baylin and Jones, 2006). 
In addition, histone methylation is a key posttranscriptional modification known to 
play an important role in cell cycle regulation, development, DNA damage response. As 
shown in Figure	  1.4 an abnormal histone methylation pattern can lead to cancer initiation or 
progression (Kouzarides and Berger, 2006). In contrast to acetylation, histone methylation 
does not alter the charge of arginine and lysine residues. Thus, methylation does not directly 
modulate the nucleosomal interactions required for chromatin restructuring (Hunt et al., 
2013). Two general classes of methylating enzymes have been described: the histone arginine 
methyltransferases (HRMTs) and histone lysine methyltransferases (HKMTs) (Allis et al., 
2006; Lachner et al., 2003). Methylated lysine residues appear to be chemically more stable. 
All histone HKMTs and HRMTs require S-adenosylmethionine as a methyl group donor 
(Pachaiyappan and Woster, 2014).  
1 Introduction 	  
	   5	  
	  
Figure 1.4: Sites of histone lysine methylation, their protein binders and functional role in genomic 
processes. Methylation of histones occurs at lysine residues in histone H3 and H4. Certain methylated lysine 
residues are associated with activating transcription (green Me flag), whereas other are involved in repressive 
processes (red Me flag). Proteins that bond particular methylated lysine residues are indicated. Source 
www.genesandsignals.org (Kouzarides and Berger, 2006).  	  
HKMTs regulate transcriptional activity by writing epigenetic marks. The most widely 
studied HKMTs are G9a, SUV39H, EZH2 and DOT1L. Methylation of histone H3K9, a 
hallmark of silent chromatin, is regulated by two subgroups of HKMTs, G9a/G9a-like 
proteins that mainly induce mono- and di-methylation of histone H3K9 (H3K9me1, 
H3K9me2), whereas SUV39h1 contributes to tri-methylation of histone H3K9 (H3K9me3). 
Su(var)3-9 was initially identified as a suppressor of variegation and involves the spreading of 
heterochromatin into adjacent euchromatic regions (Elgin and Reuter, 2006). Methylation at 
histone H3K9 also increases DNA methylation and reduces the level of activating chromatin 
modifications at promoter regions of aberrantly silenced tumour suppressor, which can be 
often found in cancer cells (M. Takahashi et al., 2012).  
1.1.2.1. Chemical modulators of chromatin 
Histone modifications play an important role in chromatin environment and their 
alterations can lead to tumorigenesis. The HMT SUV39h1 was described as the first SET 
domain-containing histone lysine methyltransferase (HKMT), which generates di- and 
trimethylation marks on H3K9 (Rea et al., 2000). Tachibana et al. (2001) reported HMT G9a 
as the second HKMT, which is primarily responsible for the dimethylation of lysine 9 on 
histone H3 (H3K9me2). The overexpression of G9a has been linked to several tumour types, 
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including the progression potential of metastatic lung cancer (Chen et al., 2010). The first 
reported G9a inhibitor BIX-01294, a diazepin-quinazolin-amine derivative, (Figure	   1.5) 
showed good selectivity against other HMTs (Decarlo and Hadden, 2012). 
	  
Figure 1.5: The chemical structure of small molecules inhibiting HMTs. A: Generic structure of an 
epidithiodioxopiperazine, the most common form of ETP. In some circumstances the sulphur bridge contains 
one, three or four sulphur atoms; these compounds are usually co-produced with those containing the disulphide. 
R=any atom or group; B: Structure based-design of Chaetocin; C: Structure-based design of gliotoxin; D: 
Quinazoline-based design of BIX-01294; E: Quinazoline-based design of UNC0638. (Modified picture from 
Decarlo and Hadden, 2012 and Gardiner et al., 2005). 
Chaetocin, Gliotoxin, UNC0638 and BIX01294 are small molecules described to 
inhibit histone H3K9 HMTs (Maleszewska et al., 2014; M. Takahashi et al., 2012; Vedadi et 
al., 2012). Chaetocin and Gliotoxin, which possess more selective inhibiting activity against 
G9a and SUV39H1 belong to epipolythiodioxopiperazines (ETPs). ETPs, a class of fungal 
metabolites, are characterized by the presence of an internal disulphide bridge, which interact 
with thiol groups leading to the generation of reactive oxygen species by redox cycling and 
thereby can inactivate proteins. The diketopiperazine ring is derived from a cyclic dipeptide 
and its sulphur bridge imparts all known toxicity of these molecules. The toxicity of ETPs has 
made them the attractive potential therapeutic agents for cancer (Gardiner et al., 2005). 
Gliotoxin, another HKTs inhibitor, is one of the structurally simplest ETPs (M. Takahashi et 
al., 2012). It exerts an immunosuppressive effect and causes apoptotic and necrotic cell death 
in vitro (Vigushin et al., 2004). Chaetocin and Gliotoxin are conserved SAM-dependent-
enzymes, which functions as a coactivator for HMTs to methylate proteins.  
In contrast BIX01294 and UNC0638 inhibit G9a and GLP but not SUV39h1 (M. 
Takahashi et al., 2012). Both reduce the global H3K9me2 level in several cell lines (Vedadi et 
al., 2012). 
! !
[82]. It has been hypothesized that 1 competes with SAM for
binding to three C-terminal cysteine residues essential for activity
on H3K9-specific KMTs and although structural analysis has not
verified this hypothesis, it is thought that the lack of the cysteine
residues on E(z), PRSET7 or SET7/9 is responsible for its limited
activity against these targets [83]. D velopment of a fully synthetic
pathway and subsequent exploratory SAR for 1 identified key
structural motifs requisite for G9a inhibitory activity [84]. There
was no difference in G9a inhibition between the natural product 1
and its antipode (IC50 values ¼ 2.4 mM vs. 1.7 mM, respectively) [84].
The sulfur moieties of 1 and other fungal epidithiodiketopiper-
azines (ETPs) are critical for activity against other targets as it
imparts torsional strain that locks the molecule into a rigid
configuration [85,86]. An S-deficient (þ)-chaetocin (2) analog was
inactive against G9a, demonstrating that tetra-sulfation was
essential for anti-KMT activity as well [84]. Treatment with 1
(0.5 mM) reduced H3K9me3 levels in U937 human lymphoma cells
and induced apoptosis in a dose-dependent manner (0.05e1 mM)
[83]. In vivo studies for 1 have been reported; however, these
results have not demonstrated in vivo inhibition of KMTs [83].
Other (ETP) have recently been shown to exhibit anti-KMT-ase
activity in vitro; particularly against G9a and SUV39H1 [87].
These results confirmed that the disulfide moiety is essential for
KMT inhibition (Fig. 2). Gliotoxin (3), chetomin (4), and 11,110-
dideoxyverticillin A (5) contain at least one disulfide bridge and
demonstrated potent inhibition of KMT activity; by contrast, the
loss of the disulfide bridge in the structurally related
bisdethiobis(methylthio)-acetylgliotoxin (6) significantly reduces
potency of the ETP scaffold as evidenced by a nearly 20 fold loss in
activity at G9a and SUV39H1. It has been postulated that the
disulfide moiety present in 4 of the 5 ETP compounds may grant
selectivity through interaction with the pre- and post-SET cysteine
containing domains of G9a and SUV39H1 [87]. In vitro results for
these ETPs have not been reported.
2.2.2. Small molecule inhibitors
2.2.2.1. Quinazoline-based inhibitors. Chaetocin and other epige-
netic inhibitors are known to compete for the conserved SAM
binding region on several HMT families. This explains the observed
cross-reactivity of GLP and G9a with Chaetocin and other struc-
urally conserved SAM-dependent-enzymes. With this in mind,
discovery efforts have begun to include competitive SAM binding of
hits as exclusion criteria for lead selection, as is the case in the
discovery of BIX-01294 (7, Fig. 3) [88]. Results from a virtual screen
identified a 125K compound subset with probabilistic activity
against KMTs that was subsequently screened for anti-KMT activity
against G9a. It is important to note that the screening assay was
conducted in the presence of excess SAM to limit the number of
non-specific false positives [88].
While BIX-01294 was not the most active inhibitor identified in
the screen, it was the sole compound to exhibit significantly greater
selectivit t ward G9a/GLP (IC50s ¼ 1.9 and 0.7 mM, respectively)
compared to SUV39H1 and PRMT1 (an arginine methyltransferase).
BIX-01294 reduced H3K9me2 levels at multiple G9a target genes in
mouse embryonic stem cells and fibroblasts in a transient fashion,
suggesting its potential as a valuable probe for reversible modula-
tion of H3K9me2 [88]. Co-crystallographic data identified BIX-
01294 as a non-competitive inhibitor of GLP that binds a region
separate from the SAM binding domain [89]. The dimethoxy of the
quinazoline and the diazepane ring are responsible for the majority
of interaction with GLP. The benzyl moiety does not appear
essential for high affinity GLP binding; however, it may enhance cell
permeability. The selectivity for GLP and G9a is due to the favorable
interactions and structural arrangement adopted by BIX-01294
upon binding; specifically, the inhibitor occupies the region
reserved for the histone (H3) peptide, Lys4 to Arg8. While, overlay
analysis revealed striking structural overlap with the histone
peptide and the inhibitor, BIX-01294 does not occupy the Lys9
binding channel [89]. A singular report demonstrates dose-
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residues on E(z), PRSET7 or SET7/9 is responsible f r its limited
activity against these targets [83]. Development of a fully synthetic
pathway and subsequent exploratory SAR for 1 identified key
structural motifs requisi e f r G9a inhibitory activity [84]. Th e
was no difference in G9a inhibition between the natural product 1
and its antipode (IC50 values ¼ 2.4 mM vs. 1.7 mM, respectively) [84].
The sulfur moieties of 1 and other fungal epidithiodiketopiper-
azines (ETPs) are critical for activity against other targets as it
imparts torsional strain that locks the molecule into a rigid
configuration [85,86]. An S-deficient (þ)-chaetocin (2) analog was
inactive against G9a, demonstrating that tetra-sulfation was
essential for anti-KMT activity as well [84]. Treatme t with 1
(0.5 mM) reduced H3K9me3 levels in U937 human lymphoma cells
and induced apoptosis in a dose-dependent manner (0.05e1 mM)
[83]. In vivo studies for 1 have been reported; however, these
results have not demonstrated in vivo inhibition of KMTs [83].
Other (ETP) have recently been shown to exh bit anti-KMT-ase
activity in vitro; particularly against G9a and SUV39H1 [87].
These results confirmed that the disulfide moiety is essential for
KMT inhibition (Fig. 2). Gliotoxin (3), chetomin (4), and 11,110-
dideoxyverticillin A (5) conta n at least one disulfide bridge and
demonstrated potent inhibition of KMT activity; by contrast, the
loss of the disulfide bridge in the structurally related
bisdethiobis(methylthio)-acetylgliotoxin (6) significantly reduces
potency of the ETP scaffold as evidenced by a nearly 20 fold loss in
activity at G9a and SUV39H1. It has been postulated that the
disulfide moiety present in 4 of the 5 ETP compounds may grant
selectivity through interaction with the pre- and post-SET cysteine
containing domains of G9a and SUV39H1 [87]. In vitro results for
these ETPs have not been reported.
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While BIX-01294 was not the most active inhibitor identified in
the screen, it was the sole compound to exhibit significantly greater
selectivity toward G9a/GLP (IC50s ¼ 1.9 and 0.7 mM, respectively)
compared to SUV39H1 and PRMT1 (an arginine methyltransferase).
BIX-01294 reduced H3K9me2 levels at multiple G9a target genes in
mouse embryonic stem cells n fibroblasts in a transient fashion,
sug esting its potential as a valuable p obe for rev rsible modula-
tion of H3K9me2 [88]. Co-crystallographic data identified BIX-
01294 as a non-competitive inhibitor of GLP that binds a region
separate from the SAM binding domain [89]. The dimethoxy of the
quinazoline and th diazepan ring are responsible for the majority
of interaction with GLP. The benzyl moiety does not appear
essential for high affinity GLP binding; however, it may enhance cell
permeability. The selectivity for GLP and G9a is due to the favorable
interactions and structural arrangement adopted by BIX-01294
upon binding; specifically, the inhibitor occupies the region
reserved for the histone (H3) peptide, Lys4 to Arg8. While, overlay
analysis revealed striking structural overlap with the histone
peptide and the inhibitor, BIX-01294 does not occupy the Lys9
binding channel [89]. A singular report demonstrates dose-
H
N
N
N
O
O
HO
S
S
N
H
N
N
O
O
OH
S
S N N
O
O OH
OHH
SS
N
H
N
N
O
O
CH3S
S
H
N
N
N
O
O
S
S H
N
N
N
O
O
S
S
N
H
N
N
O
O
S
S
H
H
1, (+)-Chaetocin
SUV39H1, IC50 = 0.8 µM
G9a, IC50 = 3 µM
3, Gliotoxin
G9a, IC50 = 0.53 µM
SUV39H1, IC50 = 0.26 µM
4, Chetomin
G9a, IC50 = 0.17 µM
SUV39H1, IC50 = 0.0.066 µM
5, 11,11'-dideoxyverticillin A
G9a, IC50 = 0.63 µM
SUV39H1, IC50 = 0.53 µM
OH
OH
H
H
H
N
N
N
O
O
HO
N
H
N
N
O
O
OH
H
H
2, S-deficient (+)-Chaetocin
G9a, IC50 > 50 µM
N N
O
O OH
AcO
6, Bisdet iobis(methylthio)-
acetylgliotoxin
G9a, IC50 > 10 µM
SUV39H1, IC50 > 10 µM
S
S
H
Fig. 2. Natural product inhibitors of KMTs.
D. DeCarlo, M.K. Hadden / European Journal of Medicinal Chemistry 56 (2012) 179e194182
dependent BIX-01294-mediated reduction in cancer growth after
48 hr incubation (2e6 mM) in a panel of human cancers (urothelium
carcinoma, lung, and bladder) [90].
Informedmodifications from the structural data on the GLP/BIX-
01294 complex led to the synthesis and characterization of E72 (8)
[91]. While BIX-01294 binds the GLP H3 peptide region, it lacks the
depth necessary to serve as a structural mimic of the K9 residue.
Replacing the C-7 meth xy of BIX-01294 with a 5-aminopentyloxy
moiety provided an extended aliphatic chai with a terminal amine
that could reach within the K9 binding region of GLP. A further
modification included replacing the 3-diazepine ring with a dime-
thylaminopropyl group designed to improve electrostatic interac-
tions between the inhibitor an Asp1131 within the bindi g site of
GLP. Co-crystallization of the E72/GLP complex demonstrated that
it binds in a similar fashion to BIX-01294, i cludingmaintai ing key
hydrogen bonds between the core quin zoline and piperidine rings
and aspartate residues within the binding site. In addition, the
dimethylamino functionality formed a salt bridge with Asp1131 as
predicted. A min al SAR study on aliphatic chain-length for this
moiety determined that the three-carbon linkage was optimal for
activity [91]. Finally, the 5-aminopentyl substituent replacing the
benzyl moiety of BIX-01294 fits in an acidic surface groove of the
GLP binding site and the amine may improve electrostatic inter-
action with the carbonyl of adjacent Val1136 [91]. Isothermal
titration calorimetry demonstrated that E72 was a high affinity
binder to both G9a and GLP (Kd values ¼ 164 and 136 nM,
respectively) and a mass spectrometry-based inhibitory assay
generated an IC50 of 1.3 mM for GLP, a 7-fold incre se in potency
compared with BIX-01294 [91]. It also was sh wn that treatment
with 2.5 mM rescues the pro-apoptosis gene for fatty acid synthase
(Fas) from epigenetic silencing in NIH 3T3 cells, a functional
observation of G9a inhibition. At present, no published reports of
in vitro or in vivo tumor-specific activity have surfaced, however at
equal 10 mM doses E72 exhibits significantly reduced cytotoxicity
compared to BIX-01294 in three mouse embryonic stem c ll
models [91].
A second series of quinazoline-based inhibitors (designated
UNC0) designed to improve on the limitations of BIX-01294
through structure-based drug design has also been reported.
Initially, thirteen analogs were synthesized and evaluated in two
separate assays as potential G9a inhibitors [92]. SAR from these
studies confirmed that removing or replacing the benzyl moiety
fails to affect potency; however, the methyl piperidine is essential
for G9a inhibition and remains present on all UNC compounds to
date [92e94]. Chlorination at the 2-amino region res lted in severe
potency reduction in both assays, whilst tolerable potency loss was
achieved with various heterocyclic and alkylamino substitutions at
this region. Side-chain functionalization at the C-7 methoxy was
predicted to incorporate activity at the GLP ysin binding pocket
si ilarly to the E72 study [92]. The results from these initial SAR
studies yielded UNC0224 (9) as a high affinity binder (Ki ¼ 2.6 nM)
and inhibitor of G9a (IC50 ¼ 15 nM) [92].
Building upon the success of UNC0224, a updated report o the
previously mentioned SAR studies was published with a more
extensive focus on the 7-aminoalkoxy moiety [93]. Extension of the
alkyl chain identified that the G9a lysine binding pocket was able to
accommodate up to a 5-carbon aminoalkoxy tether. Capping the
chain with various methylamino or cyclicamino functional groups
maintained or slightly improved G9a inhibition. Si ilar to the
piperidine substituent, replacing the terminal nitrogen resulted in
drastic loss of potency. The most potent analog, UNC0321 (10) was
generated upon replacing the 5 ca bon alkylamino with an ethox-
yethyl moiety. Subsequent SAR on a constrained ring system and
increased amino capping groups produced potency loss, verifying
that the dimethylaminoethoxyethyl moiety was optimal for inter-
actions at the lysine binding pocket. Binding studies indicate that in
contrast to the equipotent inhibition of G9a and GLP by UNC0224,
UNC0321 is more selective for G9a (Ki¼ 63 pM). Both UNC0224 a d
UNC0321 demonstrated >1000-fold selectivity for G9a over SET7/
9, SET8 and PRMT3 and the histone demethylase JMJDE2 (IC50
values > 40 mM) [93].
Despite the superior potency of UNC0321 in biochemical assays,
BIX-01294 maintains enhanced activity in cellular assays,
presumably due to poor membrane permeability. UNC0638 was
designed to increase lipophilicity while maintaining potent in vitro
activity against G9a and this discovery effort was successful [94].
UNC0638 (11) inhibited both G9a and GLP (IC50s < 15 nM and
19 nM, respectively) and was identified as a competitive inhibitor
with respect to the peptide substrate, but non-competitive with
respect to SAM. UNC0638 exhibited >500-fold selectivity for G9a/
N
N
NH
HN
N
H3CO
O
N
H2N
NH2
N
N
HN
N
H3CO
OO N
N
N N
N
HN
N
H3CO
ON
N
N
HN
N
H3CO
H3CO N
N
7, BIX-01294
G9a, IC50 = 1.9 µM
GLP, IC50 = 0.7 µM
8, E72
G9a, Kd = 164 nM
GLP, Kd = 136 nM
G9a, IC50 = 1.3 µM
N
N
HN
N
H3CO
O N
N
9, UNC0224
G9a, Ki = 2.6 nM
G9a, IC50 = 15 nM
N
10, UNC0321
G9a, Ki = 63 pM
G9a, IC50 = 6.0 nM
11, UNC0638
G9a, Ki = 3.7 nM
G9a, IC50 < 15 nM
Fig. 3. Quinazoline-based inhibitors of KMTs.
D. DeCarlo, M.K. Hadden / European Journal of Medicinal Chemistry 56 (2012) 179e194 183
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Informedmodifications from the structural data on the GLP/BIX-
01294 complex led to the synthesis and characterization of E72 (8)
[91]. While BIX-01294 binds the GLP H3 peptide region, it lacks the
depth necessary to serve as a structural mimic of the K9 residue.
Replacing the C-7 methoxy of BIX-01294 with a 5-aminopentyloxy
moiety provided an extended aliphatic chainwith a terminal amine
that could reach within the K9 binding region of GLP. A further
modification includ d replacing the 3-diazepine ring with a dime-
thylaminopropyl group designed to improve electrostatic interac-
tions between the inhibitor and Asp1131 within the binding site of
GLP. Co-crystallization of the E72/GLP complex demonstrated that
it binds in a similar fashion to BIX-01294, includingmaintaining key
hydrogen bonds between the core quinazoline and piperidine rings
and spartate residues within the bind ng site. In additi , th
dimethylamino functionality formed a salt bridge with Asp1131 as
predicted. A minimal SAR study on aliphatic chain-length for this
moiety determined that the three-carbon linkage was optimal for
activity [91]. Finally, the 5-aminopentyl substituent replacing the
benzyl moiety of BIX-01294 fits in an acidic surface groove of the
GLP binding site and the amine may improve electrostatic inter-
action with the carbonyl of adjacent Val1136 [91]. Isothermal
titration calorimetry demonstrated that E72 was a high affinity
binder to bo h G9a and GLP (Kd values ¼ 164 and 136 M,
respectively) and a mass spectrometry-based inhibitory assay
generated an IC50 of 1.3 mM for GLP, a 7-fold increase in potency
compared with BIX-01294 [91]. It also was shown that treatment
with 2.5 mM resc es the pro-apoptosis gene for fatty acid synthase
(Fas) from epigenetic silencing in NIH 3T3 cells, a functi nal
observation of G9a inhibition. At present, no published reports of
in vitro or in vivo tumor-specific activity have surfaced, however at
equal 10 mM doses E72 exhibits significantly reduced cytotoxicity
compared to BIX-01294 in three mouse embryonic stem cell
models [91].
A second series of quinazoli e-based inhibitors (de ignated
UNC0) designed to improve on the limitations of BIX-01294
through structure-based drug design has also been reported.
Initially, thirteen analogs were synthesized and evaluated in two
separate assays as potential G9a inhibitors [92]. SAR from these
studies confirmed that removing or replacing the benzyl moiety
fails to affect potency; however, the methyl piperidine is essential
for G9a inhibition and remains present on all UNC compounds to
date [92e94]. Chlorination at the 2-amino region resulted in severe
potency reduction in both assays, whilst tolerable potency loss was
achieved with various heterocyclic and alkylamino substitutions at
this region. Side-chain functionalization at the C-7 methoxy was
predicted to incorporate activity at the GLP lysine binding pocket
similarly to the E72 study [92]. The results from these initial SAR
studies y elded UNC0224 (9) as a high affinity binder (Ki ¼ 2.6 nM)
and inhibitor of G9a (IC50 ¼ 15 nM) [92].
Building upon the success of UNC0224, an updated report on the
previously mentioned SAR studies was published with a more
extensive focus on the 7-amino lkoxy moiety [93]. Extension of the
alkyl chain identified that the G9a lysine binding pocket was able to
accommodate up to a 5-carbon aminoalkoxy tether. Capping the
chain with various methylamino or cyclicamino functional groups
maintained or slightly improved G9a inhibition. Similar to the
piperidine substituent, replacing the terminal nitrogen resulted in
drastic loss of potency. The most potent analog, UNC0321 (10) was
generated upon replacing the 5 carbon alkylamino with an ethox-
yethyl moiety. Subsequ nt SAR n constrained ring system and
increased amino capping group produced potency loss, verifying
that the dimethylaminoethoxyethyl moiety was optimal for inter-
actions at the lysine binding pocket. Binding studies indicate that in
contrast to the equipotent inhibition of G9a and GLP by UNC0224,
UNC0321 is more selective for G9a (Ki¼ 63 pM). Both UNC0224 and
UNC0321 demonstrated >1000-fold selectivity for G9a over SET7/
9, SET8 and PRMT3 and the histone demethylase JMJDE2 (IC50
values > 40 mM) [93].
Despite the superior potency of UNC0321 in biochemical assays,
BIX-01294 maintains enhanced activity in cellular assays,
presumably due to poor membrane permeability. UNC0638 was
designed to incr ase lipophilicity while maintaining potent in vitro
activity against G9a and this discovery ffort was successful [94].
UNC0638 (11) inhibited both G9a and GLP (IC50s < 15 nM and
19 nM, respectively) and was identified as a competitive inhibitor
with respect to the peptide substrate, but non-competitive with
respect to SAM. UNC0638 exhibited >500-fold selectivity for G9a/
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Epipolythiodioxopiperazines (ETPs) are toxic secondary metabolites made only by fungi. The
best-known ETP is gliotoxin, which appears to be a virulence factor associated with invasive
aspergillosis of immunocompromised patients. The toxicity of ETPs is due to the presence of a
disulphide bridge, which can inactivate proteins via reaction with thiol groups, and to the generation
of reactive oxygen species by redox cycling. With the availability of complete fungal genome
sequences and efficient gene-disruption techniques for fungi, approaches are now feasible to
delineate biosynthetic pathways for ETPs and to gain insights into the evolution of such gene
clusters.
Introduction
Most fungal toxins are secondary metabolites – low-
molecular-mass compounds that are dispensable, but may
provide selective advantage under particular conditions.
Well-characterized classes of toxins include polyketides
(e.g. aflatoxins), cyclic peptides, alkaloids and sesquiter-
penoids (e.g. trichothecenes). Another class, the epipoly-
thiodioxopiperazines (ETPs), is characterized by the
presence of an internal disulphide bridge (Fig. 1). The
diketopiperazine ring is derived from a cyclic dipeptide
and its sulphur bridge imparts all known toxicity of these
molecules (Mullbacher et al., 1986).
Gliotoxin was the first ETP reported and is the best-
characterized. Its name is derived from its identification
as a metabolite of Gliocladium fimbriatum (possibly a
Trichoderma sp.) (Weindling & Emerson, 1936; Weindling,
1941). Gliotoxin is implicated in animal mycoses. It is
immunosuppressive and causes apoptotic and necrotic cell
death in vitro. The toxicity of ETPs has made them attrac-
tive as potential therapeutic agents for diseases such as
cancer (Vigushi et al., 2004). In spite of their important
biological effects, little is known about their biosynthesis
or even their primary role in the biology of the organisms
that produce them. Furthermore these aspects, as well as
the discontinuous taxonomic distribution of ETPs amongst
fungi, and their structural relatedness, have never been
reviewed. Such a review is timely as tools are now available
to analyse their biosynthetic pathways and to determine
unequivocally their role in disease. These tools include com-
plete fungal genome sequences and efficient gene-disruption
techniques for fungi. Recently these approaches have been
applied to identify a biosynthetic gene cluster for an ETP,
sirodesmin PL, in Leptosphaeria maculans, and to predict
genes in the gliotoxin biosynthetic pathway in Aspergillus
fumigatus (Gardiner et al., 2004). In this review we describe
the range of fungi that produce ETPs, and the proposed
modes of ETP activity, biosynthesis and transport. We
also discuss current opinion about the evolution of such
biosynthetic gene clusters.
Diversity of ETP toxins and their discontinuous
distribution
At least 14 different ETPs (excluding those with minor
modifications) are known (Table 1). The diversity of struc-
tures stems from the amino acids of the core ETP moiety,
as well as the modifications of these amino acids. All
natural ETPs is lated to d te contain at least one arom tic
amino acid. A diverse range of filamentous ascomycetes
3Present address: Institute for Molecular Biosciences, University of
Queensland, 4072 QLD, Australia.
Fig. 1. Generic structure of an epidithiodioxopiperazine, the
most common form of ETP. In some circumstances the sulphur
bridge contains one, three or four sulphur atoms; these
compounds are usually co-produced with those containing the
disulphide. R=any atom or group.
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Table 1. ETP molecules from various fungal species
Compound Structure* Producing organism(s) Predicted amino
acidsD
References
Gliotoxin Aspergillus fumigatus,
Trichoderma virens,
Penicillium spp.,
Candida albicans
Phe, Ser Kirby & Robins (1980);
Shah & Larsen (1991)
Sirodesmin Leptosphaeria maculans,
Sirodesmium diversum
Tyr, Ser Curtis et al. (1977);
Ferezou et al. (1977)
Hyalodendrin Hyalodendron sp. Phe, Ser Stillwell et al. (1974)
Sporidesmin A Pithomyces chartarum Trp, Ala Kirby & Robins (1980)
Chaetomin Chaetomium globosum Trp, Ser Sekita et al. (1981)
Chaetocin Chaetomium spp. Trp, Ser Sekita et al. (1981)
Verticillins Verticillium spp. (A
and B), Penicillium
sp. (A), Gliocladium
catenulatum (D)
Trp and Byeng et al. (1999);
Joshi et al. (1999);
Kirby & Robins (1980);
Sekita et al. (1981)
A: R1=R2=CH3 (Ala)
B: R1=CH3 (Ala),
R2=CH2OH (Ser)
D: R1=R2=
CH2(OH)CH3 (Thr)
Leptosin Leptosphaeria sp.
OUPS-4
Trp, Ser, Val Takahashi et al. (1994)
Emestrin Aspergillus spp. Phe, Tyr Refs in Seya et al. (1986)
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Cha tomin Chaetomium globosum Trp, Ser Sekita et al. (1981)
C a tocin Chaetomium spp. Trp, Ser Sekita et al. (1981)
Verticillins Verticillium spp. (A
and B), Penicillium
sp. (A), Gliocladium
catenulatum (D)
Trp and Byeng et al. (1999);
Joshi et al. (1999);
Kirby & Robins (1980);
Sekita et al. (1981)
A: R1=R2=CH3 (Ala)
B: R1=CH3 (Ala),
R2=CH2OH (Ser)
D: R1=R2=
CH2(OH)CH3 (Thr)
Leptosin Leptosphaeria sp.
OUPS-4
Trp, Ser, Val Takahashi et al. (1994)
Emestrin Aspergillus spp. Phe, Tyr Refs in Seya et al. (1986)
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1.2 Radiation and DNA repair 
Tumour cells can be killed by radiation or chemotherapy via induction of damage in 
DNA. Ionizing radiation (IR) induces different biological effects, which depend on the type of 
radiation. Radiation effects are mostly classified by direct and indirect ionizing events to the 
target. The ionization events after exposure to IR cause DNA damage, either directly by 
occurring in the DNA molecule itself or indirectly through radicals produced by ionization of 
atoms or molecules in the vicinity of the DNA, which are not evenly distributed in space but 
localized along the tracks of the ionizing particles (Hall et al., 1993). 
IR produces many hundreds of different simple chemical damages in DNA as well as 
their clustered combinations. The simple damage, including single-strand breaks (SSBs), 
tends to correlate poorly with biological effectiveness. In addition, DNA base damage, 
crosslinks of DNA-DNA as well as of DNA-protein and can also lead to significant biological 
effects (Tichý et al., 2010). However double-strand breaks (DSBs) are the most deleterious 
type of DNA damage with severe consequences for cell survival and maintenance of genomic 
stability (Ariyoshi et al., 2007; Kinner at el., 2008; Mills et al., 2003). About 70% of the 
deposited energy from low LET induced isolated lesions and less complex DNA damage on 
short DNA sequences and only 30% of the energy causes clustered damage sites on DNA. In 
contrast, 90% of the deposited energy from high LET results in clustered damage sites on 
longer DNA sequences (Lavelle and Foray, 2014; Leatherbarrow et al., 2006; Qiu, 2015). 
Thus, both the direct and indirect effects may damage genomic DNA after IR. DNA damage 
effects by IR are dependent on the local architecture of the DNA sequence, such as naked 
DNA, chromosomal territory, open euchromatin and densely compacted chromatin. In this 
respect, it was shown that genomic DNA in central euchromatin regions is affected with less 
energy and radicals than that of peripheral heterochtomatin, and most of energy and radicals 
are partially and/or completely lost in peripheral heterochromatin (Qiu, 2015).  
The DNA DSBs are considered to be the most relevant damage for the deleterious 
effects of IR. Thus, the DNA damage response (DDR) pathway, especially of DSBs, is 
essential for the maintenance of genomic stability. DDR is a network of signalling pathways, 
which responds to DNA damage and activates cell cycle checkpoints, DNA repair and cell 
death pathways, e.g. apoptosis (Lou et al., 2006). 
1.2.1 Double strand breaks and its repair 
Double strand breaks (DSBs) can be formed by a single ionizing event by the 
coincidence of SSB on the complementary strands. DNA DSBs are the main cause of 
1 Introduction 	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genotoxic effects, such as chromosomal breaks and exchanges and can thus lead to cell death 
(Christmann at al., 2003; Iliakis et al., 2007; Lips and Kaina, 2001). Posttranslational 
modifications (PTMs) including phosphorylation, acetylation, methylation and ubiquitylation 
play an important role in the signalling of DNA repair processes. It has been shown that 
histone modifications play a primary role in DNA damage repair by facilitating the access of 
repair proteins to DNA breaks (Hunt et al., 2013). 
There are two main repair pathways for DSBs: nonhomologous end joining (NHEJ) 
and homologous recombination (HR). The NHEJ is active in all cell cycle phases, but appears 
to play a major role during the G1 phase of the cell cycle. NHEJ is characterized as “quick 
and dirty” process and thus is a highly error prone process, because of the generation of new 
sequence combinations in the genome via deletions or additions of nucleotides, which can 
lead to mutations.  
NHEJ directly re-joins two broken ends and it generally leads to deletions of DNA 
sequence (Figure	   1.6). It mainly requires DNA-PK, which is composed of Ku70, Ku80 and 
DNA-PKcs, the catalytic subunit. DNA-PKcs is activated by interaction with a single-strand 
DNA at the site of DSB (Christmann et al., 2003). DNA-PK-dependent non-homologous end 
joining is also termed as D-NHEJ. This active kinase complex causes the phosphorylation of 
other proteins, which are involved in DSB repair mechanisms, such as PRA2, WRN (Werner 
syndrome protein), XLF/Cernunnos, XRCC4 and DNA ligase IV. The latter then joins DSB 
ends together by ligation (Jackson, 2002; Mladenov and Iliakis, 2011). Inactivation of the 
genes involved in NHEJ repair in cells leads to radiation sensitivity of the cells.  
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Figure 1.6: Mechanism of classical nonhomologous end joining (D-NHEJ) pathway. See text for details. 
(The picture from Mladenov and Iliakis, 2011). 	  
Recruitment of DNA repair factors and spreading of signalling around the damage 
initiate the DDR and result in the formation of discrete repair foci (Bekker-Jensen et al., 
2006; Ziv et al., 2006). One of the first histone modification events linked with the DDR is 
phosphorylation of H2AX variant on residue serine 139 in cells, when DNA DSBs are 
induced by ionizing radiation. The γ-component is a form of H2AX phosphorylated in the C-
terminal region (Figure	  1.7) (Fernandez-Capetillo et al., 2004; Kinner et al., 2008; Paull et al., 
2000; Rothkamm and Löbrich, 2003). DSBs cause chromatin remodelling and formation of 
so-called ionizing radiation-induced foci, where during the first minutes after irradiation 
proteins involved in DNA repair are attracted to the DSB (Tichý et al., 2010). Foci formation 
of γH2AX, which is an important signalling molecule of DSBs and that of 53BP1 (p53-
bilding protein1), are widely used for visualization of DSBs (Nagy and Soutoglou, 2009; 
Panier and Durocher, 2013). Both of them are markers for DSBs and a hallmark for the 
activation of NHEJ repair pathway.  
 
64 E. Mladenov, G. Iliakis / Mutation Research 711 (2011) 61–72
Table 1
Summary of the DSB repair protein toolkit. The key proteins involved in HRR, D-NHEJ and B-NHEJ are shown separated in seven categories, based on protein function.
Function HRR D-NHEJ B-NHEJ
DSB sensor molecules Mre11/Rad50/Nbs1 (MRN) Ku70/Ku80 PARP-1
DSB end processing enzymes MRN, CtIP, Exo1, Dna 2 Artemis, Polynucleotide Kinase (PNK),
Terminal Deoxynucleotidyl Transferase
(TDT)
MRN, CtIP
Recombinases Rad51 – –
DSB repair mediators Rad52, BRCA2, Rad51 paralogs DNA-PKcs Histone H1, WRN
Polymerases Pol !, Pol " Pol #, Pol $ Pol %
Ligases Ligase I Ligase IV Ligase III
Ligase promoting factors PCNA? XRCC4, XLF/Cernunnos XRCC1
ically the ends of the original DNAmolecules. The apparent shift in
higher eukaryotes from a high fidelity HRR to a low fidelity NHEJ
poses a conundrum that is discussed later.
At the biochemical level, it is well documented that one of the
most abundant (about 300,000 molecules per cell in humans) cel-
lular proteins, Ku, which exhibits an impressively high affinity for
DNA ends, initiates NHEJ by binding to the ends of a DSB (Fig. 2 and
Table 1) [3,37]. Ku is a heterodimer consisting of the Ku70 andKu80
subunits, and once bound to DNA ends it attracts the catalytic sub-
unit of the DNA-dependent protein kinase (DNA-PKcs) to form the
active DNA-PK holoenzyme [38,39]. Formation of this active kinase
complex causes the phosphorylation of other proteins involved in
Fig. 2. Outlineof themainplayers andof thekey stepsofDNA-PKcs-dependentNHEJ
(D-NHEJ). D-NHEJ efficiently restores genomic integrity without ensuring sequence
restoration. Association of Ku to DNA ends facilitates the recruitment of DNA-PKcs,
a major kinase activated by DNA ends and contributing to the efficiency of this
repair pathway. DNA-PKcs promotes end-proces ing by the Artemis nuclease and
subsequent rejoining of broken DNA ends by the LigIV/XRCC4/XLF complex.
this repair pathway, such as RPA2, WRN, XLF/Cernunnos, DNA Lig-
ase IV (LigIV) and XRCC4, as well as the autophosphorylation of
DNA-PKcs [40–44]. DNA-PKcs also binds to and regulates the activ-
ityofArtemis, anendonucleasepossibly involved in thepre-ligation
processing of DNA ends, particularly if they contain complex DNA
damage [32,39,45–47].
DNA-PKcsautophosphorylation is thought toprovide theenergy
required to mediate a structural shift between opened and closed
holoenzyme conformations, which allows DNA end processing (by
polynucleotide kinase, PNK, and terminal deoxynucleotidyl trans-
ferase, TDT), polymerization (by DNA polymerases $ and #) and
ultimately ligation (by the LigIV/XRCC4/XLF complex). Through the
coordinated action of the LigIV/XRCC4/XLF and the DNA-PK com-
plexes, two locally available DNA ends are joined; and if the two
sealed DNA ends originate from one DSB, integrity is restored in
the DNA molecule (Fig. 2) [48–50].
To facilitate the discrimination between NHEJ pathways (see
below), we will refer to the pathway described above and now fre-
quently called “classical” or “canonical” asD-NHEJ.Our terminology
emphasizes its dependence on DNA-PKcs. While other terminolo-
gies such as classical, Ku-dependent, LigIV-dependent, etc. are also
justified, our preference for the former term is based on the argu-
ment that DNA-PKcs, as an evolutionary new component of this
pathway (DNA-PKcs is absent in lower eukaryotes and prokary-
otes), is likely to play a key role in the altered coordination of DSB
repair inhigher eukaryotes and theobserveddominanceofD-NHEJ.
It is unknownwhetherasof yetuncharacterized functions incor-
porated into the NHEJ machinery ensure rejoining of the original
DNA ends. We have speculated that D-NHEJ somehow exploits the
“topological privilege”, i.e. the immediate proximity, of the DNA
ends at the moment of DSB induction to restore with high proba-
bility, through build-in speed, the structural integrity in the broken
DNA molecule [51,52]. While the speed with which this pathway
completes a rather complex set of sequential reactions (typical half
times of the order of 15–30min) certainly contributes to this end,
the imposition of topological confines to the DNA ends through
structural determinants of the participating factors and the chro-
matin organization are likely to also play an important role and
require further investigation.
It is well documented that DNA-PKcs activation at the DSBs,
mediated byKu-DNA interactions [53], increases at least 10 fold the
kinase activity suggesting a central role in D-NHEJ. In line with this
expectation, several reports show that D-NHEJ is greatly compro-
mised in the absence of DNA-PKcs and that under such conditions
HRR is enhanced [54,55]. Notably, when HRR is measured in cells
in which DNA-PKcs is physically present but functionally compro-
mised a reduction in HRR is observed [56,57]. Similar results are
obtained when DNA-PKcs is irreversibly inhibited by wortman-
nin [58–60]. Thus, functionally compromised DNA-PKcs has more
severe consequences for the cell than the complete absence of the
enzyme. This is presumably because the non-functional enzyme
exerts a dominant negative effect and suppresses through the
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Figure 1.7: A model of the nucleosome core particle showing DNA interactions with core histone. The 
DNA entry and exit points are localized at the H2A/H2B dimer. The H2AX C-terminus, which is 14 amino acids 
longer than that of H2A, is drawn here in black with a red arrow marking the phosphorylation site within the 
SQEY motif (Kinner et al., 2008). 	  
An important regulator of DSB signalling is 53BP1, which was described two decades 
ago. It is a large protein of 1972 amino acids, that has no apparent enzymatic activity but 
contains interaction surface for numerous DSB-responsive proteins (Panier and Boulton, 
2014). The current model of 53BP1 recruitment to DSB sites proposes that H4K20 
methylation is also induced and becomes available for 53BP1 after DNA damage (Figure	  1.8). 
Therefore, 53BP1 is a bivalent histone modification reader that can recognize a histone code 
produced by DSB signalling (Fradet-Turcotte et al., 2013). However these histone 
modifications are normally present on chromatin and do not change after IR-induced DNA 
damage. 53BP1 also promotes ATM-dependent checkpoint signalling, especially at low levels 
of DNA damage. It is a key protein for DSB repair pathway choice and promotes the synapsis 
of distal DNA ends during NHEJ (Panier and Boulton, 2014). 
 
Figure 1.8: Summarize of 53BP1 functions in the DNA damage response. (Panier and Boulton, 2014). 
! 19!
  
Figure 9. A model of the nucleosome core particle showing DNA interactions with core histones. 
The DNA entry and exit points are localized at the H2A/H2B dimer. The H2AX C-terminus, which is 14 
amino acids longer than that of H2A, s drawn here in black with a red arrow marking the phos orylation 
site within the SQEY motif (Kinner, 2008). 
 
Initial DNA damage signals induce ATM activation (Fig.10) and recruitment, 
which is probably mediated by the M/R/N complex. This initial recruitment of ATM 
results in early H2AX phosphorylat on immediately adjacent t  DSBs. Phosphor lated 
H2AX then binds to MDC1 and accumulates additional MDC1- ATM near the sites of 
DNA breaks, resulting in the expansion of H2AX phosphorylation to the megabase 
chromosomal regions surrounding the sites of DNA breaks. This extended H2AX 
phosphorylation causes changes in chromatin structure and directly or indirectly 
facilitates the accumulation of down-stream ATM substrates at the sites of DNA breaks. 
ATM then phosphorylates its substrates, resulting in checkpoint activation and DNA 
repair (Lou, 2006). 
 
sequence (1). To ensure accessibility and chromatin struc-
ture facilitating the different functions of the DNA, inter-
actions with core histones are regulated by numerous
covalent modifications, many of which are localized at
the amino terminal histone tails protruding from the
nucleosome core (Figure 1B and C), as well as by specia-
lized variant core histones (10). These modifications reduce
the affinity of histone tails for adjacent nucleosomes,
thereby affecting chromatin structure. Howeve , he most
profound effect of histone modifications is their ability to
attract specific proteins to a stretch of chromatin that has
been appropriately modified (10,11). These recruited pro-
teins define and initia biological functions in a manner
intimately coordinated with local chromatin structure.
DNADSB repair in the context of chromatin
Modification of chromatin structure has been extensively
studied in the context of transcriptional regulation.
H2A
H2B
H3
H4
N-terminal tail histone fold
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Figu e 1. H2AX in the context of chromatin. (A) Organization of DNA in chromatin. One hu dr d and forty-seven base pairs of DNA (red) are
wrapped around a nucleosome (yellow) consisting of eight histone proteins (two H2A/H2B dimers and two H3/H4 dimers), thus forming the 11 nm
nucleosome. The histones dimerize via the histone fold motif and four histone dimers form the nucleosome core. Nucleosomes are separated by linker
DNA sections of 20–80 bp in length. The DN wraps in 1.7 turns around the nucle so e forming 142 hydrogen bonds at the DNA histone
interface. The histone tails protrude from the nucleosome core and can be modified, for instance by acetylation, phosphorylation or ubiquitinylation.
Further condensation of chromatin, as in the 30 nm fiber, allows a 100-fold compaction of DNA (schematic representation; the actual organization of
the nucleosomes in the 30 nm fiber is still under investigation). (B) All histone proteins share the highly conserved histone fold motif (displayed in
color) containing the three alpha helices involved in nucleosome core organization. Alpha helical domains outside the histone fold domain are shown
in gray. The structure on the right illustrates how two histone fold domains interact for dimer formation. (C) A model of the nucleosome core
particle showing DNA interactions with core histones (redrawn in a modified form from Ref. (148)).The DNA ntry and exit points are localized at
the H2A/H2B dimer. The H2AX C-terminus, which is 14 amino acids longer than that of H2A, is drawn here (there are no structural data available
and the schematic drawing is only for demonstration purposes) in black with a red arrow marking the phosphorylation site within the SQEY motif.
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Tudor domains
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domains that were first 
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melanogaster protein Tudor 
and bind to methylated Arg or 
Lys residues.
G2–M checkpoint
A type of DNA damage 
checkpoint that prevents cells 
with damaged genomes from 
entering into mitosis. It is 
predominantly mediated by 
the inhibition of CDC25 and 
cyclin-dependent kinase 1 
(CDK1) by the effector kinases 
checkpoint kinase 1 (CHK1) 
and CHK2, and by p53.
V(D)J recombination
A type of programmed genome 
rearrangement in maturing 
T and B lymphocytes during 
which variable (V), diversity (D) 
and joining (J) immunoglobulin 
gene segments are randomly 
combined by induction of DNA 
double-strand breaks, and 
repaired by non-homologous 
end-joining to generate 
antibodies with different 
antigen specificities.
Class switch recombination
(CSR). Genome rearrangements 
in activated B lymphocytes 
that promote the generation 
of different antibody isotypes 
with the same antigen 
specificity. It involves the 
programmed formation and 
repair of DNA double-strand 
breaks within the switch 
regions between different 
antibody heavy chain gene 
segments.
(directly or indirectly) with ATM-phosphorylated resi-
dues in 53BP1 (REF. 8). PTIP (PAX transactivation activa-
tion domain-interacting protein; also known as PAXIP1) 
is another 53BP1-interacting protein that is recruited to 
DSBs downstream of RNF8 (RING finger 8) and RNF168 
(REFS 9–11). Similar to RIF1, PTIP interacts with 53BP1 
in an ATM-dependent manner12. However, whether this 
interaction is required for the focal accumulation of PTIP 
is not clear. In human cells, the 53BP1–PTIP interaction 
has been shown to be dispensable for PTIP recruitment 
to DSB sites12. By contrast, in mouse cells, the inter-
action with phosphoryl ated 53BP1 is important for the 
accumulatio n of PTIP at damaged chromatin13.
Promoting checkpoint signalling. The second function 
of 53BP1 is to amplify ATM activity and to promote 
checkpoint signalling in response to low levels of DNA 
damage14–18. Under these conditions, loss of 53BP1 or 
its failure to localize to damaged chromatin signifi-
cantly reduces the phosphorylation of ATM targets 
such as p53, CHK2 and breast cancer 1 (BRCA1) and, as 
a consequence, leads to G2–M checkpoint defects and 
genomic instability14,15,17,18. ATM activity is stimulated 
by 53BP1 through a direct interaction between its 
C-terminal BRCT domains and the RAD50 component 
of the MRE11–RAD50–NBS1 (MRN) complex, which 
is responsible for the recruitment of ATM to the site 
of DNA damage19. The interaction with PTIP might 
also contribute to the effect of 53BP1 on ATM activity, 
but the underlying molecular mechanism of this is not 
known10,12.
Pathway choice. Several recent landmark studies have 
defined 53BP1 as a key determinant of DSB repair path-
way choice20–22. Eukaryotic cells have two main repair 
pathways to deal with DSBs: non-homologous end-
joinin g (NHEJ), which rejoins the broken ends of a 
severed DNA molecule (reviewed in REF. 23); and homol-
ogous recombination, which requires large stretches 
of identical or very similar DNA sequences elsewhere 
in the genome to serve as templates for DNA repair 
(reviewed in REF. 24) (BOX 1). The decision of which 
pathway to select for DSB repair is critical for the main-
tenance of genomic stability and is tightly controlled 
during different cell cycle phases25. A defining feature 
of the two pathways is whether they require DNA end-
resection. Homologous recombination depends entirely 
on the extensive resection of DNA surrounding the DSB 
to produce a 3ʹ single-strand overhang, whereas NHEJ 
efficiency greatly decreases upon DSB resection24,26. 
A major determinant of pathway choice, therefore, is 
the differential regulation of DNA end-resection during 
the cell cycle27. 53BP1 is an important positive regulator 
of NHEJ-mediated DSB repair that protects DSB ends 
from processing by the DNA end-resection machinery 
during the G1 phase of the cell cycle.
Long-range DNA end-joining. 53BP1 is also essential for 
the NHEJ of deprotected telomeres and of distal DNA 
ends generated during long-range V(D)J recombination 
and class switch recombination (CSR), which are impor-
tant for a functional adaptive immune response28–32. 
Notably, loss of 53BP1 results in the strongest CSR defect 
of all DSB-responsive proteins tested so far. CSR rates in 
B cells derived from 53bp1−/− (also known as Tp53bp1) 
mice are reduced to less than 10% relative to wild-type 
cells30,32. Exactly how 53BP1 prevents end-resection and 
promotes the synapsis of distal DNA ends is still uncer-
tain, although the latter process probably involves local 
changes in chromatin structure and mobility28,29. Given 
its numerous roles in DSB signalling, checkpoint activa-
tion and DSB repair, it is not surprising that 53BP1 has 
been proposed to be a tumour suppressor gene18.
Recruitment to damaged chromatin
When DSBs are detected, 53BP1 rapidly accumulates 
on the chromatin surrounding the break site33–35. This is 
driven by a signalling cascade that is initiated by the 
ATM-mediated phosphorylation of the histon e 2A 
(H2A) variant H2A.X (known as γH2A.X), followed 
by the recruitment of MDC1 (mediator of DNA 
Figure 1 | 53BP1 functions in the DNA damage response. 
p53-binding protein 1 (53BP1) bound to damaged 
chromatin carries out several functions. First, 53BP1 recruits 
additional DNA double-strand break (DSB) signalling and 
repair proteins to the site of DNA damage. Second, 53BP1 
promotes ataxia-telangiectasia mutated (ATM)-dependent 
checkpoint signalling, especially at low levels of DNA 
damage. Third, it is a key player in DSB repair pathway 
choice. Fourth, 53BP1 promotes the synapsis of distal DNA 
ends during non-homologous end-joining (NHEJ).
Figure 2 | Domain structure and interaction partners of 53BP1. p53-binding 
protein 1 (53BP1) contains 28 Ser/Thr-Gln (S/T-Q) sites in its amino terminus that match 
the consensus target sequence of the ataxia-telangiectasia mutated (ATM) kinase. 
ATM-mediated phosphorylation of the 53BP1 N terminus promotes the binding of its 
effectors RIF1 (RAP1-interacting factor 1) and PTIP (PAX transactivation activation 
domain-interacting protein). The 53BP1 carboxyl terminus contains tandem BRCT 
(BRCA1 carboxy-terminal) domains that bind to p53 and EXPAND1. The minimal 
focus-forming region in 53BP1 contains an oligomerization domain (OD), a Gly- and 
Arg-rich (GAR) motif, a tandem Tudor motif that binds to dimethylated Lys20 of histone 4 
(H4K20me2) and a ubiquitylation-dependent recruitment (UDR) motif that interacts with 
ubiquitylated H2AK15 (H2AK15ub). Amino acid positions are indicated.
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At present, immunostaining of γH2AX and also of 53BP1 is the most sensitive method 
for monitoring DSB induction (with IR doses in the order of mGy) and repair (Falk et al., 
2010). Loss of H2AX increases genomic instability, supporting the critical role of γH2AX in 
DDR (Fernandez-Capetillo et al., 2004).  
1.2.1.1. Backup pathways of nonhomologous end joining  
Several studies have shown that human tumour cells deficient in DNA-PKcs re-join 
DSBs with a similar fast and a slow component. Complete re-joining of DSBs was observed 
in cells deficient in Ku or DNA ligase IV. Results suggest that if D-NHEJ is genetically or 
chemically downregulated and at the same time HR somehow fails, then DNA DSBs could be 
repaired by backup NHEJ (Dibiase et al., 2000, Wang et al. 2001a, Wang et al., 2001b, Iliakis 
et al., 2007). The repair by the backup pathway (B-NHEJ) is slower, less efficient and more 
error prone than the DNA-PK dependent pathway (D-NHEJ) because of changing alterations 
in nucleotide sequence or the joining of unrelated ends. It can lead to a higher frequency of 
chromosomal translocations than other DNA repair pathways (Iliakis et al., 2007). B-NHEJ 
operates throughout the cell cycle (Iliakis, 2009), but its activity also shows cell cycle-
dependent fluctuations with an increased activity in G2 and a reduced one in G1 phase (Singh 
et al., 2011).  
Although the mechanism of B-NHEJ is still not fully understood, some of the putative 
components, which act in B-NHEJ, are already described. When essential components of D-
NHEJ are absent, PARP-1 is recruited for DSB repair. PARP-1 binds to the end of the DNA. 
Usually PARP-1 acts in SSB and base excision repair (BER), where it works as a sensor for 
DNA damage (Caldecott, 2001), but it is also involved in B-NHEJ (Figure	  1.9A). Moreover, 
the histone H1 has similar functions as Ku in D-NHEJ (Figure	  1.9B). The ligation during B-
NHEJ is carried out by DNA ligase III (Wang et al., 2005) or ligase I, which is regulated in 
complex with XRCC1 by PARP-1, instead of ligase IV in D-NHEJ (Wang et al., 2006). 
Evidence shows that histone H1, the MRN complex and Werner syndrome protein (Wrn) are 
involved in B-NHEJ (Mladenov and Iliakis, 2011). 
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Figure 1.9: Mechanism of B-NHEJ pathway. A: Outline of the main players in B-NHEJ pathway; B: Outline 
of possible interactions between D-NHEJ and B-NHEJ (Mladenov and Iliakis, 2011). 	  
1.2.1.2. Homologous recombination repair  
Homologous recombination repair (HRR) functions only in late S and G2 phases of 
the cell cycle when the DNA is replicated.  HRR is, in contrast to D-NHEJ and B-NHEJ, an 
error-free repair process. During HRR the damaged DNA enters into physical contact with 
undamaged DNA of the homologues chromosome and shares sequence homology, which is 
used as template for repair.  
HRR is initiated by a nucleolytic resection of DSB by the MRE11-RAD50-NBS1 
(MRN) complex. Resulting DNA tails are coated with replication protein A (RPA) forming a 
nucleoprotein (Takahashi et al., 2014). Rad52 protein, which protects against exonucleolytic 
activity, forms a heptameric ring complex with single-stranded DNA. Rad52 interacts with 
Rad51 and RPA, stimulating DNA strand exchange activity of Rad51. Thereafter, Rad51 
catalyses the strand-exchange events with a complementary strand in which the damaged 
DNA molecule invades the undamaged DNA duplex and displaces one strand as D-loop 
(Christmann et al., 2003). Assembly of the Rad51 is facilitated by different Rad51 paralogues 
(Rad51B, Rad51C, Rad51D and XRCC2 with XRCC3). After DSB recognition, DNA 
synthesis, ligation and branch migration, the resulting structure becomes resolved (Figure	  1.10). 
!
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Fig. 4. Outline of possible interactions between D-NHEJ and B-NHEJ and identifica-
tion of stepswhere suppression of B-NHEJ by D-NHEJ can occur (see text for details).
Proteins are presented with their ribbon shaped 3D structures. Since the 3D struc-
ture of LigIII is not available themodel for LigIII/XRCC1 proposed by Tomkinson and
Ellenberger was used [158].
by exerting similar alignment functions. In-vitro studies demon-
strate a dramatic enhancement by H1 of end joining by both LigIII
and LigIV, but the effect on the former ligase appears signifi-
cantly stronger [102]. Since this enhancement has been hitherto
characterized in biochemical studies, its physiological significance
remains unknown.
A number of reports point to the involvement of the MRN com-
plex in B-NHEJ (Fig. 3) [103–107]. Silencing of MRE11 in human
fibroblasts decreases the frequency of global end joining and impli-
cates MRE11 in NHEJ [108]. Also, inhibition of MRE11 by mirin in
XRCC4- and KU80-deficient hamster cells suppresses end joining.
Mirin treatment decreases end joining in other D-NHEJ mutants as
well, suggesting a role for MRE11 specifically in B-NHEJ [108].
The involvement of MRE11 in B-NHEJ suggests that processing
of DNA ends is a step in this repair pathway (Fig. 3). This assump-
tion is supported by experiments carried out in a mouse model
where the entire MRN complex was inactivated in the B-cell com-
partment and CSR was measured [109]. The MRN deficient mice
show strong defects in CSR, affecting both D-NHEJ and B-NHEJ.
Since experiments with mice expressing a non-functional MRE11
show a much milder phenotype a separation of function between
the MRN complex and MRE11 is suggested.
Other reports demonstrate a role for the BCR/Abl in DNA
end-joining and possibly also in B-NHEJ. This fusion protein has
deregulated tyrosine kinase activity and is generated by a chro-
mosomal translocation in chronic myeloid leukemia (CML). The
altered Abl activity stimulates cellular proliferation, inhibits apo-
ptosis and alters cell adhesion. It has been demonstrated that
up-regulation of BCR/Abl activity correlates with reduced D-NHEJ
and up-regulation of B-NHEJ repair pathway [110]. Indeed, CML
c lls show reduced levels for key D-NHEJ proteins like Artemis an
LigIV and up-regulation of LigIII and Werner syndrome proteins
(WRN), which under these conditions appear to form a complex
and to be recruited to DSBs (Fig. 3) [111]. These observations sug-
gest correlations between Abl activity and B-NHEJ and provide an
explanation for the increased genomic instability of these leukemic
cells.
DNA end resection that generates single stranded DNA regions
might facilitate B-NHEJ andmay explain the use ofmicrohomology
as a fortuitous stabilizing act prior to ligation. Since DNA end pro-
cessing is an important component of HRR, it will be important to
investigate to what extend aberrant HRR events allow, or even ini-
tiate the function of B-NHEJ. The observation that B-NHEJ activity
is significantly increased during the G2 phase of the cell cycle, that
it is reduced in G1 and significantly abrogated in resting cells [112],
hints to such interdependencies that require further investigation.
As discussed above, DSB processing is not only important for
genomic maintenance but also an important component of sev-
eral biologically relevantprocesses [113–118].Wereviewtherefore
next the known roles of B-NHEJ in such processes.
6. B-NHEJ and the formation of chromosomal
translocations
The discontinuity of genetic material and its organization
in distinct chromosomes is a prerequisite for the formation of
chromosome aberrations. Chromosome aberrations are structural
abnormalities in the chromosomes caused by large-scale rear-
rangements in the constituting DNA molecule of the same or
different chromosomes [119]. Fusions, deletions or insertions of
chromosomal arms, occurring as a result of chromosomal translo-
cations, are directly implicated in cell killing, genomic instability
and carcinogenesis [120]. Requirement for the generation of chro-
mosomal translocations is the induction of two DSBs in relative
proximity and the joining of the wrong ends by the repair system.
D-NHEJ is a candidate process for the generation of transloca-
tions and other exchange-type chromosomal aberrations due to its
capacity to join two DNA ends independently of molecular origin,
DNA sequence and secondary structure [52]. Indeed cell death in
repair proficient cells correlates well with the formation of visible
chromosome aberrations many of which are of exchange type and
thus the result of DSB misjoining [121,122].
If D-NHEJ had being the sole contributor of exchange type
chromosome aberration formation, one would have expected the
absence of such aberrations in D-NHEJ deficient cells and instead
the dominance of terminal deletions. Notably, an increase in
exchange type aberrations was observed in cells defective in com-
ponentsofD-NHEJ thatwasaccompaniedbyan increase in terminal
deletions [87]. This unexpected response can now be explained by
the function and the error-prone nature of B-NHEJ.
The error prone nature of B-NHEJ is shown not only for IR-
induced DSBs. It has also been found during CSR in B-cells deficient
for D-NHEJ, where translocations between IgH and c-Myc are sub-
stantially increased [123]. The role of B-NHEJ in translocations
involving the IgH locus was also demonstrated in peripheral B-
cells using a conditional knockout system to eliminate the XRCC4
gene product [124]. Similar resultswere obtained bymeasuring the
frequency of specific translocations in Ku80, LigIV and Ku80/LigIV
deficient B-cells [123,125,126]. The high frequency of specific
translocations in D-NHEJ deficient cells suggests that B-NHEJ is
more translocation prone than D-NHEJ. It has been suggested that
this may bemediated in part by the functions of Ku, which reduces
the mobility of DNA ends and thus the probability of exchange for-
mation [127,128]. Thus, B-NHEJ surfaces as a primary determinant
of chromosomal translocations and therefore as a major contribu-
tor to genomic instability and carcinogenesis [129,130]. It will be
relevant to investigate whether chromosome aberrations forming
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deficient in theKuheterodimer [73], the LigIV [86] andother factors
of D-NHEJ, aswell as for repair proficient cells exposed to inhibitors
chemically inactivating the DNA-PKcs kinase activity [86].
In the context of the above discussed pathway competition
model for DSB repair, the most immediate interpretation of the
results was that the slow repair component uncovered in D-NHEJ
deficient cells reflectsHRR. Therefore,we embarked in a large study
testingdifferentHRdeficientmutants available in theDT40 chicken
B-cells. These genetic studies systematically evaluated the role in
the repair of IR-induced DSBs of genes involved in HRR and tested
quantitatively repair of this lesion in thewild-type background that
showsa1000-foldupregulation inHRas compared toother chicken
cell types [73].
DT40 mutants with defects in genes encoding proteins of the
Rad52 epistasis group (Rad51B, Rad52, and Rad54) showed kinet-
ics of DSB rejoining identical to wild-type. Also, in wild type DT40
cells the upregulation of HR did not result in appreciably different
kinetics of DSB repair [73]. Finally, HRR defects in D-NHEJ mutants
did not cause a measurable additional defect in DSB repair.
These results in aggregate suggested that the repair observed in
D-NHEJmutants could not be attributed toHRR and led us to specu-
late that in higher eukaryotes an alternative pathway of end joining
is active operating with slower kinetics and mainly as backup to
D-NHEJ, which we therefore termed B-NHEJ. These observations
provided clear evidence for an important physiological contribu-
tion of alternative pathways of NHEJ. Since cells with defects in
DNA-PKcs and other components of D-NHEJ show dramatically
increased levels of chromosomal aberrations after exposure to IR,
it could be further inferred that B-NHEJ is error-prone [87]. Indeed
animals defective in components ofD-NHEJ arehighly cancer prone
on a p53 deficient background [88] (see below for amore extensive
discussion of this topic).
Despite the above outlined extensive contribution of B-NHEJ
to the repair of IR-induced DSBs, the function of alternative path-
ways continued to receiveonly limitedattention. This changedwith
the demonstration that alternative pathways of NHEJ can robustly
substitute for D-NHEJ in class switch recombination (CSR) in LIG4
deficient mice [89,90]. Alternative pathways were also found to
substitute for V(D)J recombination in D-NHEJ deficient cells when
mutations in RAG1 and RAG2 led to proteins able to generate but
unable to hold the DNA ends, which could thus be funneled to
alternativeprocessing [91–93].Other reports subsequently showed
nearwild typeCSRactivity inXRCC4and LIG4-deficientmiceassoci-
ated with chromosome abnormalities that included translocations
at the IgH locus. Thus, the error prone nature of alternative path-
ways of NHEJ demonstrated for IR-induced DSBs could also be
confirmed for other endpoints and the role of B-NHEJ in carcino-
genesis could be consolidated [89,90] (see below).
The above discoveries placed B-NHEJ not only at the forefront
of DSB repair research but also at the center of carcinogenesis
and led to an avalanche of studies describing its various char-
acteristics. The multitude of approaches used to document the
function of this “new” form of NHEJ has also led to a multitude
of terms used to describe it. These include alternative NHEJ (A-
NHEJ, or alt-NHEJ), microhomology-mediated end-joining (MMEJ),
KU-independent end-joining, LigIV-independent NHEJ, and our
proposed term backup NHEJ [91,94–97]. We prefer and will use
here the term B-NHEJ instead of alt-NHEJ because this form of end
joining only comes to the fore when D-NHEJ is defective. Thus, it
appears to operate as a “true” backup rather than an equal, alter-
native partner. We do not imply of course that D-NHEJ defects in
the form of mutations or treatments with inhibitors are the only
prerequisites for B-NHEJ function. We envision that even in repair
proficient cells, D-NHEJmay fail to engage at certainDSBs, or itmay
fail to complete allowing thus B-NHEJ to substitute. Also, the use
of microhomology, although frequent it is not a requirement—an
Fig. 3. Outline of themainplayers andof the key steps of an alternative formofNHEJ
functioning as a backup to D-NHEJ (B-NHEJ). The enzymatic activities implicated in
B-NHEJ are shown together with their possible contributions in the process.
issue has been discussed at some length [3,98]. Therefore, use of
this terminology to describe the pathway appears inaccurate at the
outset.
We anticipate that as the characterization of B-NHEJ proceeds
and mechanistic information becomes available, better terms will
develop reflecting important mechanistic properties of this repair
pathway rather than arbitrarily selected phenomenological mani-
festations of the same.
5. The enzymatic make-up of B-NHEJ
The chara terization of enzymatic activities contributing to B-
NHEJ, the coordination of their functions, and their interactions
with components of D-NHEJ and HRR has evolved as a prime area
of current research in the field. Since DNA ligation is the last step
of the end joining reaction and D-NHEJ is exclusively dependent
on LigIV, it was reasonable to inquire which ligase is involved in
B-NHEJ. Genetic and biochemical experiments point to the func-
tion of DNA ligase III (LigIII) in this pathway (Fig. 3 and Fig. 4) [86].
Interestingly, even low levels of LigIII are sufficient for effective end
joining, and this holds also tru for the function of LigIV in D-NHEJ
[99].
LigIII functions in a complex with XRCC1 and is regulated by
PARP1 [100]. Since LIG3 is only present in vertebrates, its involve-
ment in B-NHEJ hints to changes in the organization and possibly
also the regulation of DSB repair in the course of evolution. Also,
since the LigIII/XRCC1/PARP1 complex is involved in other DNA
repair activities, such as repair of SSBs and base damag s [100],
parsimony in the utilization of cellular repair factors is indicated.
The ide tification of PARP1 as a putative component of B-NHEJ
and the binding of this enzyme to DNA ends suggested a possible
competitionwithKu (Fig. 4). Notably, themuchhigher affinity of Ku
for DNA ends provides a kinetic basis for the backup character of B-
NHEJ [101]. A further contributing factor to this backup character
may derive from the fact that other forms of lesions (SSBs, base
damages, etc.) present in great excess to DSBs compete for PARP1
and a a result also for LigIII (see above).
Ku, in addition to its function in the recruitment of DNA-PKcs
is thought to also help align the DNA ends prior to ligation [84].
There is evidence that histone H1 contributes to B-NHEJ possibly
A B 
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Figure 1.10: Mechanism of homologous recombination repair (HRR). Homologous recombination starts 
with nucleolytic resection of the DSB in the 5′ → 3′ direction by the MRE11–Rad50–NBS1 complex, forming a 
3′ single-stranded DNA fragment to which Rad52 binds. Rad52 interacts with Rad51, provoking a DNA strand 
exchange with the undamaged, homologous DNA molecule. Assembly of the Rad51 nucleoprotein filament is 
facilitated by different Rad51 paralogues (such as Rad51B, Rad51C and Rad51D, XRCC2 and XRCC3). After 
DNA synthesis, ligation and branch migration, the resulting structure is resolved (Christmann et al., 2003). 	  
1.2.2 Epigenetic modification and DNA damage response 
DNA DSBs are the most toxic form of DNA damages that offer a potential risk both 
to genetic and epigenetic integrity. Mutations and perturbed epigenetic regulations both are 
essential characteristics of cancer. Severe disruptions of chromatin configuration in 
heterochromatin, like those caused by radiation-induced DSBs, can lead to incomplete or 
incorrect restoration of chromatin structure, leaving a DSB induced epigenetic memory of 
damage (Lorat et al., 2012). Hence, to understand how cells repair DSB damage in the 
context of the nuclear architecture and condensed chromatin structure is an important aim of 
currently radiology. 
Several studies showed that the chromatin structure has an influence on cell survival 
and the efficiency of DSB repair after irradiation (Falk et al., 2008). In this respect, 
Karagiannis at al., (2007) reposted that cells treated with Trichostatin, an inhibitor of histone 
deacetylases, accumulates γH2AX foci, which then leads to the radiation sensitivity of tumour 
cells. There was also an effect on the spatial distribution of γH2AX foci with significantly 
higher foci number in heterochromatin compared to that in euchromatin. It has been shown 
M. Christmann et al. / Toxicology 193 (2003) 3–34 15
Fig. 5. Mechanism of homologous recombination (HR). Homologous recombination starts with nucleolytic resection of the DSB in the
5′ → 3′ direction by the MRE11–Rad50–NBS1 complex, forming a 3′ single-stranded DNA fragment to which Rad52 binds. Rad52 interacts
with Rad51, provoking a DNA strand exchange with the undamaged, homologous DNA molecule. Assembly of the Rad51 nucleoprotein
filament is facilitated by different Rad51 paralogues (such as Rad51B, Rad51C and Rad51D, XRCC2 and XRCC3). After DNA synthesis,
ligation and branch migration, the resulting structure is resolved.
important protein that interacts with Rad 51 is RPA
(Golub et al., 1998; Park et al., 1996). It is supposed
that RPA stabilizes R d51-mediated DNA pairing by
binding to the displaced DNA strand (Eggler et al.,
2002). After DSB recognition and strand exchange
performed by Rad proteins, the resulting structures
are resolved according to the classical model of Hol-
liday (Holliday, 1964; see also Constantinou et al.,
2001).
7. DNA-damage signaling and checkpoint control:
ATM and ATR
Recognition and signaling of DNA damage is a
prerequisite for the induction of subsequent cellular
responses such as increased repair, cell cycle arrest
and apoptosis. Recognition of DNA breaks is accom-
plished by a group of phosphatidylinositol-3-kinases.
These kinases re ATM (ataxia telangiectasia mutated;
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that a decrease in H3K9 trimethylation in heterochromatin, which results in a relaxation of 
heterochromatin structure, is important for DNA damage response (Wang et al., 2013). In 
addition, perturbation of histone methyltransferase SUV39H1 and demethylase JMJD2b was 
shown to have a significant impact on DSB repair. Depletion of JMJD2b or sustained 
expression of SUV39H1 delay the repair of heterochromatic DNA and reduces clonogenic 
survival after IR, as described by Zheng et al., (2014).  
Falk et al., (2010) reported that artificial chromatin hypercondensation inhibited the 
repair process, but did not decrease chromatin sensitivity as measured by γH2AX induction. 
They also could not find accumulation of the repressive mark H3K9me2 at damage sites.  
Additionally, heterochromatin and euchromatin exert different DNA damage 
sensitivity and repair process (Falk et al., 2014; Jeggo et al., 2011; Murray et al., 2012; Sak et 
al., 2015). The explanation for the heterogeneity in the damage response in eu- and 
heterochromatin may be that the majority of DSBs are caused by indirect effect mediated by 
reactive free radicals, with only about 20% of DSBs generated by direct ionisation effect of 
IR on DNA (Falk et al., 2014). More radicals are produced in decondensed chromatin due to 
its high hydratation. In addition, DNA in dense heterochromatin is better shielded against the 
harmful radicals due to higher fraction of proteins associated with the chromatin (Figure	  1.11). 
According to bodyguard hypothesis, the compacted heterochromatin helps to protect DNA 
from damage and to block the expansion of H2AX phosphorylation (Hsu, 1975; Qiu, 2015). 
However, the molecular mechanism for the higher resistance of heterochromatin to DSB 
induction by sparsely ionizing radiation is still unclear. 
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Figure 1.11: A possible explanation of the higher sensitivity of the decondensed eurochromatin to the DSB 
induction by low-LET γ-rays. (Details see in text, the picture from Falk et al., 2014). 	  
Goodarzi et al., (2010) reported that heterochromatic DSBs compared to that of 
euchromatin are repaired at a later times after DNA DSB induction. DSB repair in 
heterochromatin is mainly dependent on the HR pathway with the formation of foci at sites of 
heterochromatic DSBs proceeding with slower kinetics compared to that of euchromatic 
regions (Chiolo et al., 2011). Furthermore it was shown that the local decondensation of 
heterochromatin at the sites of DSBs leads to the movement of DSBs to the heterochromatin 
periphery where repair may take place (Falk et al., 2014; Falk et al., 2007; Jakob et al., 2011; 
Zhang et al., 2015). These data implicate that the highly compacted chromatin structure could 
be a physical barrier to the detection of DSB and signalling of its repair (Goodarzi and Jeggo 
2012; Lorat et al., 2012). It has been proposed that ATM is essential for repair of the DSBs in 
heterochromatin, because it was shown to be required for DSB repair in heterochromatin, but 
was dispensable for the relocalization within heterochromatin (Figure	   1.12). Thus, ATM 
signalling enhances heterochromatin relaxation in the DSB vicinity and therefore it could be a 
prerequisite for DSB repair in heterochromatin. In other words, the heterochromatin 
superstructure confers a barrier to DSB repair, which can be relieved by loss of the proteins 
that contribute to the heterochromatin structure.  
!
with the previous results on chromosomal territories, gH2AX foci
significantly predominated in the RIDGE territories. Indeed, the
difference between the RIDGE and antiRIDGE domains was even
more pronounced than between the chromosomal territories. This
observation can be easily explained by the structural and func-
tional homogeneity of the RIDGE/antiRIDGE domains (relative to
heterogeneous chromosomal territories) and confirms higher
sensitivity of decondensed active chromatin to the harmful effect
of reactive free radicals (Fig. 1; the reader is referred to Falk et al.
(2008b) and (2010) for the description of experiments explaining
the mechanism of this phenomenon).
3.2. DSB repair in condensed (hetero)chromatin
Upon the irradiation with g-rays, the fraction of gH2AX foci in
decondensed chromatin was growing with the time PI and only a
low fraction of gH2AX foci colocalized with 53BP1 repair protein in
heterochromatin (at the resolving power of confocal microscopy).
The same phenomenon was observed with protons (30 MeV, 4 Gy/
min), where the condensed (hetero)chromatin may reasonably be
expected to contain many DSBs (due to ionizations concentrated
along the particle tracks). Nevertheless, independently of the radia-
tion used, gH2AX foci predominated in low-density chromatin
already 2 min PI and this fraction increased with time (not shown).
This suggests that chromatin must either decondense around
DSB lesions or DSBs must migrate into the repair-competent nuclear
subdomains in order to complete the repair (Falk et al., 2007,
2008a); reviewed in Falk et al (2010)). Alternatively, the repair of
DSBs located in the condensed chromatin (further referred as to
‘‘heterochromatic’’ DSBs for simplicity; hcDSBs) can proceed without
formation of gH2AX foci and participation of 53BP1. The latter
explanation is not probable since it has been shown recently that
gH2AX and 53BP1 are only necessary for the repair of hcDSBs
(Goodarzi et al., 2008; Scherthan et al., 2008; Goodarzi and Jeggo,
2009; Goodarzi et al., 2009; Noon et al., 2010 etc.). Moreover, our
direct real-time observations made in living cells – discussed in the
next chapter – strongly argue for the first hypothesis.
3.3. Accessibility of heterochromatin for repair proteins in living cells
Earlier, we have studied chromatin decondensation at the sites
of DSBs (marked as repair foci) and the mobility of DSB lesions in
g-irradiated cells co-transfected with H2B-GFP and 53BP1-RFP
proteins. These experiments enabled us to follow movements of
DSB lesions in the context of higher-order chromatin structure.
Even though the overall mobility of DSB lesions (visualized as
repair foci) was equivalent to that of the undamaged chromatin,
hcDSBs progressively protruded into the low-density chromatin
subdomains (see also Falk et al., 2007, 2008a).
Therefore, we have further addressed the requirement for
the chromatin decondensation at the sites of DSBs in cells
presentsized with BrdU, where DSBs were introduced separately
in condensed and decondensed chromatin domains with the
UV-laser. We have analyzed the penetration of NBS1-RFP and
53BP1-RFP repair proteins, respectively, into the condensed
chromatin domains labeled either by H2B or HP1b proteins
tagged with GFP. Whereas NBS1 is a small (85–95 kDa) repair
protein potentially acting as one of the DSB sensors, 53BP1 is a
much bigger (!220 kDa) adaptor protein providing an inter-
action platform for the assembly of other downstream players.
Fig. 1. A possible explanation of the higher sensitivity of the decondensed (eu)chromatin to the DSB induction by low-LET g-rays. About 20% of DSBs along the photon path
(red arrow) are introduced by the direct effect of ionizing radiation (orange ellipses). The vast majority of DSBs is however caused by the indirect effect (green ellipses)
mediated by reactive free radicals (red triangles) produced especially by the water radiolysis. More radicals are produced in decondensed chromatin due to its high
hydratation. Since the radicals are only shortly living, they damage DNA close to the sites of their induction. In addition, DNA in dense heterochromatin is better shielded
against the harmful radicals due to heterochromatin protein composition (a larger amount of proteins, that can scavenge the radicals, binds specifically to
heterochromatin). See Falk et al. (2008b) for further details. (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
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along the particle tracks). Nevertheless, independently of the radia-
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proteins. These experiments enabled us to follow movements of
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Figure 1.12: Differential irradiation induced foci (IRIF) formation between euchromatin and 
heterochromatin. (1) DNA double strand breaks (DSBs) form within either heterochromatin (red) or 
euchromatin (blue); (2) γH2AX occurs on chromatin at the DSB site (green) enabling the formation of the larger 
IRIF (yellow star) comprised of proteins such as Mre11, Rad50, NBS1, MDC1, RNF8, RNF168 and 53BP1. In 
heterochromatin IRIF fail to form to a similar extent (or at all) at the same time point. Rather, the 
heterochromatic DSB relocates from the heterochromatic core to the peripheral zone bordering on euchromatin; 
(3) Once relocated to the heterochromatin: euchromatin border, the heterochromatic DSB elicits IRIF formation 
which expands into the surrounding euchromatic space (Goodarzi and Jeggo, 2012). 	  
1.3 Non-small cell lung cancer (NSCLC) 
Lung cancer is a worldwide problem because of its poor prognosis. There are two 
major forms of lung cancer: small cell lung cancer (SCLC), representing approximately 20%, 
and non-small cell lung cancer (NSCLC), which accounts for the remaining 80% of lung 
cancers. Histologically, NSCLC can be classified into adenocarcinoma, which is the most 
prevalent form (40% prevalence), followed by squamous cell carcinoma (25% prevalence), 
and large cell carcinoma, which represents only 10% of the cases (Mehta et al., 2015). Most 
of the clinical studies in lung cancer are focused on NSCLC, because it is the predominant 
histological type of lung cancer and accounts for approximately 75% of lung cancers. In 
Germany patients with lung cancer have a poor prognosis with a 5 years survival of about 
15% (Robert Koch Institute, 2014). 
Initiation and progression of lung carcinoma is the result of the interaction between 
genetic, epigenetic and environmental factors. In lung cancer, accumulation of genetic 
alterations, including point mutations, deletions, translocation, and/or amplifications, is a 
common event (Balgkouranidou et al., 2013). Genome analysis of lung cancer cells shows 
that genetic and also epigenetic events are involved in tumorigenesis (Fontanière et al., 2006; 
Helman et al., 2012). Global DNA hypomethylation is frequent in NSCLC and is associated 
with genomic instability (Daskalos et al., 2011).  
!
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factor, similarly led to enlarged IRIF. Moreover, a number of human disorders with disordered HC 
have been described, including immunodeficiency, centromeric region, facial anomalies syndrome 
type A (ICFa, caused by mutations in the DNA methyltransferase, DNMT3B), Hutchinson-Guildford 
Progeria syndrome (HGPS, caused by mutations in the nuclear envelope protein lamin A) and Rett 
syndrome (caused by mutations in a methyl-(CpG) DNA binding protein, MeCP2). Interestingly, cells 
derived from such patients also show larger γH2AX foci compared to those observed in control cell 
lines [33]. Moreover, the larger foci are predominantly due to enhanced encroachment of γH2AX foci 
into the dense DAPI-staining regions. Collectively, a broad range of studies have provided substantial 
evidence that HC is a barrier to the expansion of γH2AX spreading, although as a separate and 
potentially confusing issue, DSBs also relocate to the interface between HC and EC regions (depicted 
in Figure 1). 
Figure 1. Differential irradiation induced foci (IRIF) formation between Euchromatin and 
Heterochromatin. (1) DNA double strand breaks (DSBs) form within either 
heterochromatin (red) or euchromatin (blue); (2) γH2AX occurs on chromatin at the DSB 
site (green) enabling the formation of the larger IRIF (yellow star) comprised of proteins 
such as Mre11, Rad50, NBS1, MDC1, RNF8, RNF168 and 53BP1. In heterochromatin, 
however, IRIF fail to form to a similar extent (or at all) at the same time point. Rather, the 
heterochromatic DSB relocates from the heterochromatic core to the peripheral zone 
bordering on euchromatin; (3) Once relocated to the heterochromatin:euchromatin border, 
the heterochromatic DSB elicits IRIF formation which expands into the surrounding 
euchromatic space. 
 
3.3. Can IRIF Formation Be Initiated in HC Regions? 
In our own studies with DSBs induced by gamma or X-rays, we have not, even at early times post 
IR, detected γH2AX foci within the core of densely DAPI-staining regions. Indeed, we have observed 
differential kinetics of γH2AX foci formation at EC versus HC regions, consistent with the n tion that 
IRIF predominately form on the periphery of HC [27,33]. However, further studies involving 3D 
imaging at early times post IR are required to verify whether IRIF can be observed in the HC interior 
at a time when they are first visible in EC regions. In contrast to these studies with X-ray induced 
1. DNA double strand 
breaks (DSBs) form in 
heterochromatin (HC) and 
euchromatin (EC). 
2. In EC, the DSB elicits 
rapid IRIF formation. The 
DSB in HC migrates away 
from HC core to periphery 
with E . 
3. Once at the HC:EC 
border, the DSB within HC 
elicits IRIF, which expands 
away from HC core into 
EC. 
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One of the major epigenetic changes is DNA hypermethylation in the promoter region 
of tumour suppressor genes. Silencing of these genes can promote tumorigenesis by several 
mechanisms, including increasing the cell proliferation rate or suppressing DNA repair and 
apoptosis (Liu et al., 2013). Due to the reversibility of epigenetic modifications, chromatin 
modifiers are potential targets for the development of more effective therapeutic strategies 
against cancer. Thus, the epigenetic regulation by methylation plays an important role in 
tumorigenesis. 
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1.4 Aims of this study  
Epigenetic modification plays a critical role in gene regulation during differentiation, 
cellular survival, and apoptosis, as well as in many types of human cancer. In the present 
study, we focused on histone methylation, which is correlated with transcriptional repression. 
Methylation of histones by specific histone methyl transferases (HMT) are key events in the 
regulation of epigenetic modification. However, the exact role of epigenetic chromatin 
modification in cellular processes has not yet been established. The HMT SUV39H1 was 
shown to be implicated in different types of cancers, including lung cancer (Barh et al., 2013; 
Yost, 2011). Cells lacking SUV39H1 show deregulated cell proliferation (Wang et al. 2013), 
mammalian development (Peters et al., 2001) and have increased radiation sensitivity 
(Ayrapetov et al., 2014).  
So far, most of the research groups focused on the role of SUV39H1 in gene 
expression or genomic instability regards it as a potential target for epigenetic cancer therapy 
(Chiba et al., 2014; Sidler et al., 2014). Sidler provided evidences that downregulation of 
SUV39H1 in human fetal lung fibroblasts in response to DNA-damaging agent was 
associated with induction of apoptosis, DNA repair and senescence.  
However, SUV39H1 was also shown to be recruited to DNA double strand breaks and 
thus implicated in the heterochromatic DSB repair mechanisms (Ayrapetov et al., 2014). 
Thus, the aim of the present work was to study several aspects of epigenetic modulations by 
Suv39h1 and its effect on the radiation response. For this purpose several endpoints were 
addressed by studying (i) methylation pattern, (ii) global condensation status of chromatin 
structure, i.e. condensed versus open (iii) DNA DSB repair pathways (NHEJ and HR), (iv) 
apoptosis and (v) clonogenic survival. These questions were addressed using different 
experimental strategies: (a) by genetic model of Suv39h1 knockout mouse fibroblast, (b) by 
siRNA mediated Suv39h1 knockdown in NSCLC cell lines and (iii) by using specific HMT 
inhibitors.
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2 Material and Methods 
2.1 Material 
2.1.1 Technical devices 
Description Supplier 
CO2 Incubator Thermo scientific 
Centrifuge Universal 32R, Hettich zentrifugen 
Rotina 380R, Hettich zentrifugen 
Mikro 200, Hettich zentrifugen 
ChemiDOC, Imaging System Bio RAD 
FluorImager Typhoon 9400, Molecular Dynamics, 
Germany 
Novex Mini-cell Invitrogen 
Light Microscopy LEITZ DM IL, Leica, Germany 
Florescence Microscopy Imager.Z1, Zeizz, Germany 
Confocal Microscopy TCS SP5 Leica Microsystems, Wetzlar, 
Germany 
Flow cytometry system, Galaxy DAKO 
iBlot® Dry Blotting System Introgen, Life Technologies, Germany 
Odyssey®  infrared imaging system LI-COR Biosciences, Germany 
Multiskan Ascent  Thermo Electron Corporation 
2.1.2 Chemical and biological materials 
β-Mercaptoethanol Sigma-Aldrich 
Agarose Bio-Rad 
Amphidicolin Sigma 
Apocynin Sigma 
BSA Sigma 
Crystal violet  Merck 
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DMEM GibcoTM 
DMSO Sigma 
DTT Roth 
FBS GibcoTM 
Ethanol  Sigma-Aldrich 
Formaldehyde 37%  Sigma 
Glycerol Calbiochem 
HCl Roth 
H2O2 Merck 
Leibowitz L-15 GibcoTM 
MEM GibcoTM 
Membrane blocking agent GE Healthcare UK 
Methanol J.T. Beker 
NaCl Sigma 
NaF Merck 
NaN3  Merck 
Phenylmethylsulfonyl fluoride (PMSF) Life Technology 
Phospatase inhibitor Thermo Scientific 
PRMI GibcoTM 
Protease inhibitor cocktail tablets Roche 
RIPA Sigma 
RNAse Roth 
Sheath Fluid for Flow System PARTEC 
Tiron Sigma 
Tris Roth 
Triton X100 Sigma 
Trypan Blue stain 0.4% Biozym 
Trypcin/EDTA GibcoTM 
Trichostatin A TSA Sigma 
TWEEN20 Sigma-Aldrich 
ZeocinTM Invitrogen 
2.1.2.1 Small molecules inhibiting HMTs 
BIX0194 Selleckchem, USA 
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Chaetocin Cayman chemical, USA 
Gliotoxin Cayman chemical, USA 
Triptolide Sigma, USA 
UNC0638 Sigma, USA 
2.1.3 Plasmids and siRNA 
psiRNA-hSUV39H1 #psirna42-hsuv39h1 Invivogen 
EHMT2 ID s21468 Ambion 
SUV39H1 ID s13658 Ambion 
SUV39H1 ID s13659 Ambion 
SUV39H1 ID s13660 Ambion 
2.1.4 Antibodies and dyes 
2.1.4.1 Primary antibodies  
Antibody Company Host species Catalog no. Dilution used 
53BP1 abcam rabbit Ab21083 IF 1:500 
pH2AX Millipore mouse 05-636 IF 1:500 
abcam rabbit ab2893 WB 1:1000 
pH2AX abcam mouse Ab22551 IF 1:500 
pATM abcam rabbit Ab81292 WB/IF 1:500 
pKAP-1 abcam rabbit Ab70369 WB 1:1000 
SUV39H1 abcam rabbit ab155164 WB 1:1000 
G9a abcam rabbit Ab134062 WB 1:500 
Rad51 CALBIOCHEM rabbit PC130 IF 1:500 
H3K9me1 abcam rabbit ab9045 WB 1:1000 
H3K9me2 abcam mouse ab1220-100 WB 1:1000 
H3K9me3 abcam rabbit ab8898 IF 1:500 
WB 1:1000 
H3K27me3 abcam mouse ab6002 IF 1:500 
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H3K4me3 abcam rabitt ab8580 IF 1:500 
HP1alpha abcam rabbit Ab50514-100 IF 1:500 
upstate mouse 05-689 IF 1:500 
CyclinE1 Cell Signaling mouse 4129S IF 1:500 
Cyclin A Santa Cruz rabbit Sc-596 IF 1:500 
Cyclin B1 Upstate mouse 05-373 IF 1:500 
PCNA abcam rabbit ab18197 IF 1:500 
 
2.1.4.2 Secondary antibodies and dyes 
Antibody Company Host species Catalog no. Dilution used 
actin Santa Cruz rabbit sc-1616 WB 1:500 
Alexa488 Molecular 
probes 
mouse A11017 IF 1:500 
Cy3 Immune 
Research 
Jackson 
rabitt 800-367-52 IF 1:500 
GAPDH abcam mouse ab8245 WB 1:3000 
H3 abcam rabbit ab1791 IF 1:500 
WB 1:3000 
Hoechst 33342 Sigma   WB 1:3000 
DAPI Sigma-Aldrich   1mg/ml 
 
2.1.5 Software 
Partec FloMax ver. 2.4.7 Partec, Muenster, Germany 
MultiCycle for windows ver.3.0 University of Washington, USA 
Axiovision ver. 4.8.2. Zeiss 
Image Lab ver, 4.1 BIO RAD 
LAS-AF Leica Microsystems 
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Imaris v.7.7 Bitplane, Zurich, Switzerland 
Image Quant ver. 5.2 GE Healthcare Life Sciences, USA  
2.1.6 Buffer and solutions  
Crystal violet in 500 mL: 
3.75 g Crystal violet 
1.75 g NaCl 
161.5 ml Ethanol 
35.5 ml Formaldehyde 37% 
rest dH2O 
 
Tris-buffered saline (TBS) 
50 mM Tris-Cl, pH 7.5 
150 mM NaCl 
 
Triton Extraction Buffer 
0.5% Triton X 
2 mM phenylmethylsulfonyl fluoride (PMSF) 
0.02% (3 mM) NaN3  
in PBS 
 
Extraction buffer (E-buffer (-)) 
50 mM NaF 
20 mM Hepes pH 7.6 
450 mM NaCl 
25% Glycerol 
0.2 mM EDTA 
in dH2O 
 
E-Buffer (+) 
In 1 mL: 
950 µl E-Buffer (-) 
37.5 µl Protease inhibitor 
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2.5 µl DTT 
10 µl PMSF 
 
P-buffer 
100 mM Tris Cl pH 7.4 
50 nM EDTA 
0.5% Trition100 
 
Blocking Buffer 
3% BSA 
0.1% Tween 20 
 4xSSC 
7.7 mM NaN3 
in dH2O 
 
10 x TBE 
890 mM Tris 
890 mM boric acid 
200 mL EDTA stock solution 0.5 M EDTA pH 8 
 
0.5% Agarose in 0.5 x TBE 
in 250 ml solution add 1.25 g Agarose 
 
Lysis solution 
10 mM Tris 
100 mM EDTA 
50 mM NaCl 
2% w/v NLS 
0.2 mg/ml Protease (only before using), stored in cold room 
 
Washing solution 
10 mM Tris 
100 mM EDTA 
50 mM NaCl 
0.1 mg/ml RNAse (only before using) stored in cold room 
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Low melt Agarose 1% 
For 50 ml 0.5 g Agarose in Serum free HEPE’s bufferes medium 
2 Material and Methods 	  
	   26	  
2.2 Methods 
2.2.1 Cell lines and cell culture 
The human primary fibroblasts (hFbs) from a skin biopsy were grown in Minimum 
essential media medium (MEM) supplemented with 15% fetal bovine serum. Prof. T. 
Jenuwein (Max-Plank Institute, Freiburg) donated us with the SUV39h1/2 knock-out mouse 
fibroblast cells. The murine fibroblasts (mFbs) W8 (wt) and D5 (Suv39h1/2-/-) were grown in 
Dulbecco’s modified eagle medium (DMEM) supplemented with 10% fetal bovine serum, 2 
mM glutaMax, 1x non-essential amino acids, 1 mM Na-pyruvate and 0.1 mM β-
mercaptoethanol. 
H460 (non-small cell lung carcinoma (NSCLC), p53 wild type) and H1299 (NSCLC, 
p53 mutant) were obtained from American Type Culture Collection (ATCC, Rockville, MD, 
USA) and were maintained in Roswell park memorial institute medium (RPMI 1640) with 
10% fetal calf serum (FBS). MEMS, RPMI, DMEM were supplemented with 
penecillin/streptomycin (100 units ml-1, all Gibco-BRL, Paisley, UK). Cells were grown in T-
75 flaks with 15 ml growth medium and maintained in the logarithmic phase of growth 
through routine passaging by dilution with fresh medium. 
2.2.2 Irradiation 
Cells were irradiated using either a 60Co source (Philips) at dose-rate of 0.7 Gy/min. 
For some experiments as indicated in the results section, irradiation was done with different 
doses of X-rays as required by the experimental protocol using a Seifert/Pantak X-ray 
machine (Siemens, USA) operated at 320 keV, 10 mA with a 1.65 mm Al filter (effective 
photon energy approximately 90 keV), at a distance of 750 mm for 100 mm dishes and 500 
mm for 60 mm dishes, and a dose rate of 1.3 – 3 Gy/min. The dosimetry was performed with 
a PTB dosimeter (Physikalisch-Technische Bundesanstalt, Braunschweig, Germany) and 
Frick`s chemical dosimetry, which was used to calibrate an in-field ionization monitor. The 
distribution of dose was ensured by rotating the radiation table. Cells were returned to the 
incubator immediately after exposure to IR.  
2.2.3 Proliferation assay  
To determine the respective half maximal inhibitory concentrations (IC50), plateau-
phase H1299 and H460 cells were harvested and plated into 6-well (9.6 cm2/well) tissue 
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culture plates (Falcon) 0.2x106 cells per well. Drugs were added into the culture plates to a 
final concentrations of 0, 10, 25, 50, 100, 200 nM for Chaetocin; 0, 10, 25, 50, 100, 200 nM 
for Triptolide; 0, 5, 10, 20, 50 100 nM for Gliotoxin; 0, 0.1, 0.5, 1, 2, 5 µM for BIX01294; 0, 
1, 5, 10, 20, 50 µM for UNC0638 24 h after plating. Cells were incubated at 37°C in 5% CO2 
for 72 h. Then the cell number was counted by Neubauer chamber. The IC50 was calculated 
by statistic program R. 
 
Logarithm of calculation for R: 
concentration <- c(X1,X2,…,Xn)  
perc.cells <- c(Y1,Y2,…,Yn) 
z.dat <- cbind(concentration,perc.cells) 
mean.perc.cells=as.vector(by(z.dat[,2],factor(z.dat[,1]),mean,na.rm=T)) 
IC50=approx(y=unique(z.dat[,1]),x=mean.perc.cells,xout=.5)$y  
IC50 
Where Xn is a number of concentrations, 
            Yn is a percentage of cells. 	  
2.2.4 Life cell imaging  
For Life cell imaging, plateau-phase cells H1299 were harvested and plated into 4-
well (1.7 cm2/chamber) chamber on cover glass (SARSTEDT, Nuebrecht) 150.000 cells per 
chamber. After 24 h the cell culture was treated with Chaetocin at 30 nM (IC50) and 
incubated at 37°C in 5% CO2 for 24 h. After 24 h Chaetocin was washed out and Hoechst 
33342 was added to the culture medium after 6 h at final concentration of 120 µg/ml. After 1 
h incubation the medium was changed to Leibowitz L-15. The live cell imaging was made 
during next 17 h at 37°C by confocal microscopy. Immunofluorescence images of live cells 
were captured on a Leica TCS SP5 laser scanning confocal microscope using the LAS-AF 
software and were further processed using the Imaris software.  
2.2.5 Clonogenic survival assay 
The cells were trypsinized and plated into T25 flasks (NunclonTM) or 6-well tissue 
plates (Falcon). Cells were irradiated after 4 h and incubated at 37°C in 5% CO2 for 10 days 
for 6-well tissue or 14 days for T25 flask. D5 cells were plated into T25 flasks with feeder 
cells to form colonies. 
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Chaetocin treatment 
For clonogenic survival assay, plateau-phase H1299 and H460 cells were harvested 
and plated into T25 flasks with a density of 0.5x106 cells/flask. After 4 h Chaetocin was 
added to the culture medium and the cells were incubated at 37°C in 5% CO2 24 h. After 
Chaetocin incubation cell were irradiated with doses at 2, 4, 6, 8 Gy. At 24 h after IR the cells 
were plated into 6-wells plates for 10 days.  
To determine clonogenic survival after fractionated IR, cell lines H1299 and H460 
were plated into T25 flasks with a density of 0.5x106 cells/flask. After 4 h Chaetocin was 
added to the culture medium and the cells were incubated at 37°C in 5% CO2. The cell culture 
was irradiated for 3 times with 2 Gy every 24 h after Chaetocin treatment. 24 h after the last 
IR cells were plated into 6-wells (control (non-irradiated cells) – 200 cells/well; control 
(Chaetocin- untreated cells), ¼ IC50 and ½ IC50 – 400cells/well; IC50 – 600 cells/well) and 
then incubated for 10 days. Cells were fixed and stained with crystal violet, washed with 
water. Colonies (more than 50 cells) were counted manually.  
2.2.6 Aphidicolin treatment 
2.2.6.1 Proliferation with Aphidicolin and Chaetocin treatment 
H1299 cells were harvested and plated into 6-well plates with a density of 0.4x106 
cells/well. After 4 h the cells were treated with Chaetocin and Aphidicolin (2 µM) either in a 
combined or single treatment schedule for 18-20 h and the cells were incubated at 37°C in 5% 
CO2. Chaetocin was washed out and Aphidicolin was continued for 24, 48 and 72 h. The cells 
were incubated at 37°C in 5% CO2. Then the medium was removed; cells were washed once 
with PBS, trypsinized and were counted by Neubauer chamber. 
2.2.6.2 Cell cycle after Aphidicolin treatment 
Cells were harvested and plated into T25 flasks with a density of 0.5x106 cells. After 4 
h incubation the cells were treated with Aphidicolin (2 µM) for 4 and 20 h. The probes were 
trypsinized and collected into tubes, washed with PBS, fixed with 80% of ethanol overnight at 
40C. For the cell cycle analysis the samples were washed with PBS and stained with DAPI (1 
µg/mL) overnight. The samples were measured by Flow Cytometry. The results were 
analysed by software FloMax and MultiCycle ver.3.0. 
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2.2.7 Transfection with siRNA 
One day before transfection, cells were plated into 8-well (0.69 cm2) chamber slides 
(0.015x106 cells/chamber) for immunofluorescence analysis or 6 well culture plates (0.4x106 
cells/well) with the respective growth medium for western blotting assay. Optimal cell density 
was optimized to reach 60-80% at the time of transfection. 
For each transfection sample, Lipofectamine® RNAiMAX reagent was prepared, a 
transfection kit (Invitrogen), complexes as follow: 
Solution A: Depending on the experimental contitions siRNA, negative siRNA control 
and dH2O were separately diluted in Opti-MEM® (Gibco) without serum and antibiotics and 
antimycotics and mixed gently. 
Solution B: 6 µl of RNAiMAX® regent (Invitrogen) was diluted in Opti-MEM®. The 
diluted transfection reagent (solution B) was added directly to the siRNA solution (solution 
A). The tubes with solutions were mixed gently and incubated for 20 minutes at RT. The cells 
were washed once with Hank’s Buffer and Opti-MEM®. The cells were incubated at 370C for 
20 min. For each transfection 250 µl of transfection mix solution was added to each of the 8-
well chambers and 1 ml for 6 well tissue culture plates. Then the cells were incubated at 370C 
for 4 h. After 4 h incubation equal volume of growth medium with 20% FBS was added to 8-
well chamber (250 µl) and 1ml for 6 well tissue culture plates. The cells were incubated for 
48 h at 370C in 5% CO2. 
2.2.8 Transfection with shRNA 
The cells were plated into 24-well tissue culture plates (0.1x106 cells). Optimal cell 
density was optimized to reach 60-80% at the time of transfection. The cells were transfected 
according to supplier’s protocol (Lipofectamine® 3000 (Life Technologies). Two days after 
transfection ZeocinTM (200 µg/ml) was added. The selection was performed for 2 weeks. 
2.2.9 Histone extraction 
The cells were harvested and washed twice with ice-cold PBS. Then the cells were 
centrifuged at 300 g for 5 min. Resuspended cells were transferred into the Triton Extraction 
Buffer (TEB) with 1/25 protease inhibitor cocktail and 1/100 phosphatase inhibitor. The cells 
were lysed on ice for 10 min by gentle stirring and centrifuged at 600 g for 10 min at 40C to 
spin down the nuclei and the supernatant was removed. Nuclei were washed in TBE (100 µl). 
After centrifugation  cells were suspended in 50 µl cold 0.2N HCl and histone proteins were 
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extracted over night at 40C. Next day the samples were centrifuged again at 600 g for 10 min 
at 40C. The supernatant, which contains the histone proteins, was collected and the protein 
concentration was determined by using the Bradford assay and aliquots were stored at -200C. 
2.2.10 Protein extraction 
The cells were harvested and washed twice with ice-cold PBS and centrifuged at 300 g 
for 5 min. Approximately 3-5x106 cells were resuspended with 50 µl E-buffer (+). Cells were 
frozen for 1 min in N2, and then were put into warm bath at 30C0 for 1 min. This procedure 
was repeated four times. Thereafter the cells were centrifuged at 15.000 g for 10 min at 4C0. 
For higher molecular weight proteins extraction method with RIPA buffer was used. 
The cells were harvested, centrifuged twice at 2500 g for 5 min, and then 100 µl of RIPA 
buffer containing with 1/100 phosphatase and 1/25 protease inhibitor cocktail was added. The 
cells were incubated on ice for 15 min by gentle stirring and centrifuged at 15000 g for 15 
min at 4C0. 
2.2.11 Protein quantification 
Protein concentrations were determined using the BioRad Protein Assay according to 
the manufacture`s instruction. Protein concentration was measured by colorimetric Bradford 
method. 
2.2.12 Western blotting 
Protein samples were mixed with 4x sample buffer and boiled at 950C for 5 min, 
centrifuged and loaded onto the gel. Pre-cast acrylamide gels 4-12% NuPAGE® Bis-Tris 
Gels (Invitrogen) for high molecular weight proteins and 12% NuPAGE® Bis-Tris Gels for 
histone proteins were loaded with the respective samples. The proteins were separated by gel 
electrophoresis with running buffer MOPS SDS Running Buffer (Life technologies). 
The gel was running for 15 min at 90 V, and then the voltage was increased up to 180 
V and continued for further 30-60 min, depending on the experimental conditions. Proteins 
were transferred with 1x transfer buffer (Life technologies) containing 10% Methanol onto 
Immun-Blot® LF PDVF membrane (BIO-RAD); 30 min for histones and 45 min for heavy 
proteins at 45 V. For the blotting procedure filter pads was soaked in 1x blotting buffer with 
10% methanol. The PDVF membrane was firstly soaked in methanol for 30 seconds until it 
becomes transparent. The proteins were transferred to PVDF membrane with 40 V for 45 
min. Then the membrane was blocked for 30 min in TBST containing 5% dry milk powder, 
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0.5% Tween20 and then incubated with the respective primary antibodies over night at 40C. 
The antibody was diluted in lowCross-buffer® (Candor bioscience GmbH). The membrane 
was washed 3x 10 min with washing buffer (TBS, 0.5% Tween20). The secondary antibody 
was diluted in block buffer (TBS, 5% dry milk powder, 0.1% Tween20) and the membrane 
incubated for 90 min at RT. Before detection, the membrane was washed for 3x 10 min in 
wash buffer. 
For detection of the signal, LumigenTM TMA-6 (GE Healthcare UK) solution A and B 
were diluted (1:4) with TBS; for detection of strong signal the WesternBrightTM ECL with 
WesternBrightTM Peroxide (1:1) was used. Imaging system with chemiluminiscence and 
fluorescence (Alexa488) filters was used for signal detection. Images were analysed by Image 
Lab (BIO-RAD). After detection the membrane was washed in dH2O. For reblotting, re-blot 
plus mild solution (Millipore) was used and the membrane was incubated for 30 min at RT. 
Afterwards the membrane was blocked again and incubated with the respective antibodies as 
before. 
2.2.13 Immunofluorescence 
Cells were seeded onto the 4- or 8-wells chamber slides. For immunofluorescence, 
cells were fixed in 4% paraformaldehyde (PFA) for 15 min, washed twice with PBS for 10 
min, permeabilised with P-buffer for 15 min at RT and washed twice with PBS for 10 min. 
The slides were put into the blocking solution over night at 40C. For immunostaining, slides 
were washed with PBS + 1% FBS solution for 3x 10 min. Primary antibody was diluted in 
buffer (1% BSA, 0.1% tween20 in PBS) and 300 µl was added onto the slides. The samples 
were incubated in a wet chamber over night at 40C. Slides were washed in PBS 3x 10 min and 
incubated with secondary antibodies and DAPI (1 µg/ml) for 90 min at room temperature. 
Cells were washed in PBS three times and dried on air. For mounting, aqua immu-mount 
(Thermo Scientific) was used. 
EdU assay 
Cells were seed into 4-chamber slides with 0.1x106 cell/well. After 24 h incubation 
cells were treated with Chaetocin for 24 h at 37C0. The cells were stained according to 
supplier’s protocol (Click-iT® EdU Alexa Flour® 488 Imaging kit, Molecular ProbesTM).  
Cells were incubated for 1 h at 37C0. After incubation, the medium was removed and 
the slides were fixed in 4% formaldehyde for 15 min. After fixation the slides were washed 
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twice with 3% BSA in PBS and further incubated with 0.5% Triton-100X in PBS for 20 min 
at RT. The Click-iT solution was added onto the slide and incubated for 30 min at RT in 
darkness. Hoechst 33342 was added onto the slides and incubated for 30 min at RT in 
darkness. The slides was washed twice in PBS and prepared for IF microscopy. 
 
2.2.14 Pulsed-field gel electrophoresis (PFGE) 
PFGE is a technique used for the separation of large DNA molecules by applying to 
an agarose gel an electric field that periodically changes direction. The advantage of this 
method is that fragmentation of chromosomal DNA with radiation leads to a linear dose-
dependent increase in the fraction of DNA that enters the gel, whereas intact mammalian 
chromosomes are unable to migrate into the gel. PFGE resolves DNA fragments ranging in 
size from 0.2 – 6 Mbp, whereas gel electrophoresis with a constant electric field cannot 
resolve DNA fragments above 50 Kbp. This enables the measure of induction and repair of 
DSBs. Cells were seeded into 60 mm petri dishes with 0.5x106 cells per dish one day before 
irradiation. 
2.2.14.1 Dose response of DSB induction 
Cells were trypsinized, centrifuged and washed with PBS and counted. After washing 
agarose plugs containing the cells were prepared as described. After cutting, plugs were 
placed into 3 ml serum free HEPES buffered medium and irradiated on ice. Three plugs for 
each treatment conditions 0, 10, 20, 30 Gy were prepared. 
2.2.14.2 Repair kinetics 
Cells were irradiated in petri dishes on ice at 20 Gy. After irradiation the cells were 
replaced into the incubator for ½ h, 1 h, 2 h, 4 h and 8 h. At about 5 min before collecting the 
cells, the dishes were removed from the incubator, trypsinized and collected in a falcon tube 
and resuspended with 3 ml ice cold medium. Cells were washed twice on a shaking platform 
with 1500 rpm at 40C. Control cells (non-irradiated cells) were typsinized and collected at 4 h 
and 8 h time point after IR. Plugs were prepared (4 plugs for each time point) as described. 
2.2.14.3 Preparation of plugs 
The freshly prepared low melting agarose was warmed up at 300 W in the microwave 
for 2 min and put into the water bath at 500C. Cells at a concentration of about 6x106 cell/ml 
in 1% low melting agarose were mixed. The solution was put into the glass tubes and left on 
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ice for 5 min or longer. Agarose plugs containing the cells mix were removed from the glass 
tube and cut to 0.5 cm pieces. After cutting the plugs they were put in the 3 ml lysis solution 
(3-4 plugs) for 16 h at 500C with about 0.15x106 cells/plug. Then the lysis solution was 
removed and washed with 3 ml wash buffer per 3-4 plugs and incubated at 370C for 1 h. After 
incubation at 370C the washing solution was removed and RNAse solution was added and 
incubated at 370C for 2 h and stored at 40C until used. 
2.2.14.4 Preparing and running of agarose gel electropharesis 
For each gel 250 ml of 0.5% agarose in 0.5xTBE was prepared. The solution was 
warmed up in the microwave for 5 min and put into waterbath at 500C. After preparation the 
chamber for electrophoresis and the respective agarose gel, plugs containing the naked DNA 
were loaded into wells and sealed with 1% Agarose three times. Electrophoresis was 
performed for 40 h at 80C in 0.5x TBE using alternating cycles of 50 V in the direction of the 
DNA migration for 900 s and 200 V for 75 s in the reverse direction. After 40 h the gel was 
stained with 5 mg/ml EtBr in 0.5x TBE solution. The gel was stained for 4 h at RT by shaking 
and distained with water overnight. 
2.2.14.5 Scanning and analysis 
Gels were scanned in the Typhoon and analysed using the Image Quant and Excel 
software. The fluorescence settings were 200 microns, 3 mm focal plane. Setup emission 
filter 610 BP SPYRO RyPy EtBr; PMT470 Green. 
2.2.15 Minimonolayer 
Cells were trypsinized, counted and recovered from trypsin for 2 h in PRMI medium 
with 10% FBS. Cells were seeded as a small plaque of higher density, with 80-95% of the 
cells having cell-cell contacts. Approximately 1500 cells in 5 ml medium were seeded as a 3 
mm spot into each well of 24-well culture plates, resulting in a cell density of approximately 
2x 104 cells/cm2 in the plaque monolayer. The plates were incubated for 20-40 min until the 
cells were attached to the surface. Then 0.5 ml of PRMI medium with 10% of FBS was added 
into the wells and the cells were incubated for 24 h at 370C. The medium was removed, 1 ml 
of medium with drugs was added and the cells were incubated for 4-6 h before irradiation. 
The final concentration of Chaetocin was 0 nM, 10 nM and 15 nM. Thereafter, cells were 
irradiated with the respective single irradiation doses of 0, 2, 4, 8, 12, 16, 18, 20 up to 25 Gy. 
For the fractionated irradiation experiments with 2 Gy/day per fraction mini-
monolayer were irradiated until reaching the respective overall radiation doses. For all 
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treatment conditions, Chaetocin-containing medium was removed at about 6 h after the last 
irradiation (14x 2 Gy). Two 2 ml growth medium was added and the samples were incubated 
at 370C, 5% CO2 for up to 6 weeks. A plaque monolayer was designated as surviving if cells 
reached >50% confluence in the well and cell number increased >10-fold (Sak et al., 2012). 
 
2.2.16 Co-localization DNA repair foci in CICC 
For the detection of colocalised γH2AX foci with CICC phenotype cells, we used the 
ApoTome fluorescence microscope with Plan-APOCHROMAT 63x/1.4 oil DC objective. 
The software Axiovision ver 4.8.2 was used for analysis. We selected the cells manually and 
every cell was separately semiautomaticly analyzed. The region of DAPI, which represented 
the nucleus with the CICC structure, was determined by mask (sky blue) (Figure	  2.1). Then the 
green mask visualized the region of γH2AX foci in nucleus (Figure	  2.2). The colocalization of 
CICC region versus γH2AX was identified by pink mask (Figure	  2.3).  
All foci per nucleus were counted and separated into two groups: “Foci in” group, 
which identified more than 50% of localization region (mask pink); “Foci out” group, which 
indentified less than 50% of localization region. 
 
	  
Figure 2.1: The representative picture of the nucleus. The nucleus was stained with DAPI (deep blue), the 
picture was made by using the Axiovision programm.  	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Figure 2.2: The representative picture of DAPI mask. DAPI mask (deep blue) show chromatin neriched 
regions within the nuclei.  
	  
Figure 2.3: The representative picture of the colocolization of DAPI enriched CICC regions versus 
γH2AX foci. The nucleus was stained with DAPI (deep blue) versus γH2AX foci (green) in H1299 cells and 
analyzed by using the Axiovision program. Colocalization is represented by pink marks.  	  
2.2.17 Statistical analysis 
Data analysis and the graphs were done using Prism software and R environment free 
program (section 2.1).  
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3. Results 
In this study, we focused on histone methylation, which plays an important role in the 
regulation of chromatin structure. We hypothesized that the histone methyltrasferase (HMT) 
suppressor of variegation 3-9 homolog 1 (Suv39h1), which is involved in the spreading of 
heterochromatin into adjacent euchromatin genes, may also regulate the radiation response of 
the cells. To investigate the influence of Suv39h1 on radiation response, i.e. cell proliferation, 
induction and repair of DNA DSBs and cell death in fibroblasts and tumour cell lines, we 
decided to modulate the activity of Suv39h1. To do this, different models were used: (i) 
knockout mouse Fbs (wild type (W8) and knockout Suv39h1 (D5)), (ii) knockdown of 
Suv39h1 by siRNA and shRNA in NSCLC cell lines (H1299, H460) and (iii) small molecule 
inhibitors of SUV39H1. 	  
3.1 Increasing radiation sensitivity in HMT SUV39H1 
deficient cells  
3.1.1 Decreased the cell survival in Suv39h1 knockout mFb 
Several studies demonstrated that overexpression of HMT SUV39H1 induced altered 
proliferation and differentiation of cells (Czvitkovich et al., 2001; Spyropoulou et al., 2014). 
To analyse the cell’s ability to proliferate and to form colonies after IR in HMT SUV39H1 
deficient cells, we used mFbs (Suv39h1-/- D5 and the respective wild type cells, W8). Our 
results demonstrate that D5 cells proliferate slower as compared with W8 cells (Figure	  3.1A). 
Comparable level of cell proliferation was achieved in both cell lines by mixing the medium 
with 0.1 mM β-mercaptoethanol, which reduced reactive oxygen species in cells. Thus, in all 
experimental settings β-mercaptoethanol was in the growth medium of both mouse cell lines. 
In addition, the plating efficiency and the consistency of D5 cells to form colonies in 
comparison to that of W8 cells were also low (Figure	  3.1B). Thus, D5 cells have to be seeded 
out with feeder cells, which increased plating efficiency of D5 cells to that of the wt W8 cells. 
Surviving fractions were measured in both cell lines under these condition after 
irradiation with 0 Gy, 2 Gy, 4 Gy and 6 Gy. The results show, that the surviving fraction after 
2 Gy (SF2) significantly decreased from 0.71 to 0.49 in D5 compared with that of W8. The 
difference in surviving fraction was even higher at higher irradiation doses (Figure	  3.1C).  
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Figure 3.1: Role of HMT SUV39H1 in cell proliferation and cell survival in mFbs. A: The graph shows the 
proliferation with β-mecaptoethanol (+) in mFB (n=1); B: The table of the plating efficiency in mFbs. Results 
represent the mean ± s.d of 4 experiments; C: The graph represents the radiation sensitivity in D5 mFbs 
compared with W8 after exposure to IR. Representative results from at least four independent experiments are 
shown. Bars represent the mean ± SEM. Statistical analyses: 2-way ANOVA with Borferroni posttest for mFbs, 
p < 0.001 (***). 
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3.1.2 Radiation sensitivity in SUV39H1 knockdown tumour cells 
Epigenetic regulation plays an important role for the radiation sensitivity of lung 
cancer cell lines (Kim et al., 2010). To validate this hypothesis, we used two human NSCLC 
cell lines, H460 and H1299, with different responses to IR (Jeong et al., 2009). In order to 
explore the radiation sensitivity of both NSCLC cell lines, cells were irradiated with 0, 2, 4, 6, 
8 Gy and incubated for 14 days. The results show significantly higher radiation sensitivity of 
H460 compared to the H1299 cell line (Figure	  3.2).  
	  
Figure 3.2: The radiation sensitivity of NSCLC cell lines. H460 and H1299 cells were irradiated at 0, 2, 4, 6, 
8 Gy and incubated for 14 days. Representative results from five independent experiments are shown. Bars 
represent the mean ± s.d. 	  
In order to examine the effect of Suv39h1 on the radiation sensitivity of NSCLC cell 
lines, 48 h before the cells were irradiated, we have knocked down the expression of HMT 
SUV39H1 by using shRNA approach. The results show that there is significant difference (p 
< 0.05) in the ability of the cells to form colonies after irradiation with 6 Gy in the transfected 
H1299 as compared with the non-transfected cells (Figure	  3.3). However, over all irradiation 
doses, there was no significant effect of Suv39h1 knockdown on the surviving fraction in both 
cell lines.  
0 Gy 2 Gy 4 Gy 6 Gy 8 Gy
0.001
0.01
0.1
1
H460
H1299
Su
rv
iv
in
g 
fra
ct
io
n
3. Results 	  
	   39	  
	  
Figure 3.3: Effect of Suv39h1 on cell survival in NSCLC. A: The graph represents the cell survival in the 
transfected H1299 and H460 by shRNA targeting Suv39h1; B: The table shows PE in Control and Suv39h1 
siRNA-treated cells. Representative results from at least six independent experiments are shown. Bars represent 
the mean ± SEM. Statistical analyses: trend by t-test, p < 0.05 (*). 	  
To sum it up, lack of SUV39H1 affects the cell proliferation in mFbs and their colony 
formation capacity in mFb as well as in NSCLC. 
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3.2 The role of HMT SUV39H1 in DNA repair 
3.2.1 The enhancement of DNA repair in tumour cells after HMT 
SUV39H1 knockdown 
To evaluate the effect of HMT SUV39H1 on DNA repair mechanisms, we initially 
inhibited the expression of SUV39H1 protein by using siRNA approach. Successful reduction 
of protein expression of SUV39H1 and G9a to about 50% of that of the non-transfected cells 
after transfection with siRNA by western blotting was shown (Figure	  3.4).  
	   	  
Figure 3.4: Reduction of SUV39H1 and G9a protein expression by siRNA. H1299 cells were transfected by 
siRNA targeting Suv39h1 and/or G9a for 48 h. L is the respective lipofectamine control. A: Results from three 
independent experiments are shown. Bars represent the mean ± SEM; B: Representative western blot showing 
G9a and actin as internal control. si(A + B) is defined as si(SUV39H1 + G9a). 	  
The H1299 cells were transfected by siRNA targeting Suv39h1 and/or G9a for 48 h, 
and irradiated with 0.5 Gy and 10 Gy for the measurement of initial and residual damage. The 
respective cells were fixed at 1 h, 4 h and 24 h after IR and stained for γH2AX and 53BP1 as 
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a measure for the activity of the NHEJ pathway. The data showed that there was no difference 
in the initial number of DSBs after IR (0.5 Gy) in cell lines transfected with the specific 
siRNA for Suv39h1 (Figure	  3.5) and G9a (Figure	  3.6). However, downregulation of SUV39H1 
expression significantly reduced the numbers of the residual γH2AX and 53BP1 foci 24 h 
after IR in H1299 cells. 
	   	  
Figure 3.5: Downregulation of HMT SUV39H1 affects NHEJ repair mechanism in H1299. Cells were 
transfected with siRNA targeting Suv39h1 for 48 h, then exposited to IR at 0.5 Gy, 10 Gy and fixed at 1 h, 4 h 
and 24 h post irradiation. The samples were stained with γH2AX and 53BP1. A: The immunofluorescence 
images of γH2AX (green) and 53BP1 foci (red) in 24 h after IR at 10 Gy; B: The quantification of the DNA 
repair kinetics after IR by visible γH2AX and 53BP1 foci. Representative results from four independent 
experiments are shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with 
Bonferroni posttest, p < 0.01 (**), p < 0.001 (***). Scale bar = 10 µm. 	  
Overall, our results show that downregulation of SUV39H1 affected NHEJ repair 
mechanism, i.e. decreased number of residual foci at 24 h after IR in the radioresistant H1299. 
In comparison, downregulation of the HMT G9a showed no significant effect on γH2AX and 
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53BP1 foci and thus seems to be not involved in the signalling of NHEJ.  	  
	  
Figure 3.6: Downregulation of HMT G9a and its effect on NHEJ repair. H1299 cells were transferred for 48 
h by using siRNA G9a, exposited to IR at 0.5 Gy and 10 Gy and fixed in 1 h, 4 h and 24 h post irradiation time. 
The samples were stained with γH2AX and 53BP1, a hallmark of NHEJ repair. Representative results from four 
independent experiments are shown. Control L is a lipofectamine control. Representative results from at least 
three independent experiments are shown. Bars represent the mean ± s.d. 	  
It is possible that siRNA mediated downregulation of SUV39H1 protein level to about 
50% was not sufficient to affect initial repair signalling. Thus, we decided to investigate the 
influence of SUV39H1 on NHEJ and HR repair in H1299 cells by using shRNA, which allow 
more stable downregulation of SUV39H1. The kinetic of DSB repair was evaluated in H1299 
cells transfected with Suv39h1 shRNA and compared this to the non-transfected wild type 
cells. The respective cells were irradiated with 0 Gy, 0.5 Gy, 4 Gy and 10 Gy and fixed at 1 h, 
4 h and 24 h after IR. For the analysis of NHEJ repair, cells were stained with γH2AX and 
53BP1 antibodies as a measure for NHEJ and Rad51 as a measure for HR. To control the 
level of SUV39H1 protein expression for each experiment, nuclear extracts were prepared 
and analysed by Western blotting (Figure	  3.7). The downregulation of SUV39H1 protein level 
was not higher than 50% from that of the control cells and significantly reduced H3K9me2 
and H3K9me3 as well as an increased H3K9me1 level, which was used as a functional read-
out for SUV39H1 activity and a measure for reduced heterochromatic fraction of the 
respective cells (Figure	  3.8). 
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Figure 3.7: SUV39H1 protein expression after transfection with shSuv39h1. A: Reduction of SUV39H1 
protein expression; B: Representative western blot showing SUV39H1 and GAPDH as internal control. Results 
from three independent experiments are shown. Bars represent the mean ± s.d. 	  
  
Figure 3.8: The histone level expression in shSuv39h1 cells. A: The histogram represents the relative histone 
level expression in H1299 cells, which were transferred with shSuv39h1. Protein was isolated from passage 2, 4, 
6. Representative results from at least three independent experiments are shown. Bars represent the mean ± s.d; 
B: Representative western blot shows SUV39H1, H3K9me1, H3K9me2, H3K9me3 and GAPDH, H3 as internal 
control.  	  
The results show that downregulation of SUV39H1 leads to significantly lower initial 
number of γH2AX and Rad51 compared to non-transfected H1299 cells and thus affects 
initial signalling of NHEJ (Figure	  3.9) and HR repair (Figure	  3.10). In addition, residual number 
of γH2AX and 53BP1 foci also significantly decreases in cells lacking SUV39H1 after IR 
with 4 Gy and 10 Gy.	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Figure 3.9: Downregulation of SUV39H1 and its effect on NHEJ in H1299. Non-transfected and shSuv39h1 
transfected cells were irradiated (0, 0.5, 4, 10 Gy), allowed to recover for 1 h, 4 h and 24 h; stained with 
antibodies targeting γH2AX and 53BP1. Representative results from at least three independent experiments are 
shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 
0.01 (**), p < 0.001 (***). 
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Figure 3.10: Role of HMT SUV39H1 downregulation in homologues recombination repair in H1299. Non-
transfected and shSuv39h1 transfected cells were irradiated with 0 Gy and 4 Gy allowed to recover for 4 h and 
24 h and stained with antibody Rad51. A: The immunofluorescence images from experiment (B). Staining for 
Rad51 (red) and DAPI (blue) is as indicated. Scale bar = 10 µm; B: The quantification of the DNA repair 
kinetics after IR by visible Rad51 foci. Representative results from at least three independent experiments are 
shown. Bars represent the mean ± s.d. Statistical analysis: 2way ANOVA analysis with Bonferroni posttes, p < 
0.001 (***). 	  
Overall, by using the shSuv39h1 approach we were able to demonstrate that 
downregulation of SUV39H1 affects both NHEJ and HR signalling by reduced initial foci 
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formation measured at 1 h after 0.5 Gy for the NHEJ and 4 h for the HR as well as residual 
damage for NHEJ.  
3.2.2 The role of HMT SUV39H1 on DNA repair in mFb 
In order to confirm the effect of HMT SUV39H1 for DNA damage signalling by NHEJ 
and HR in NSCLC cells, we also explored the effect of Suv39h1 for repair signalling used the 
Suv39h1 knockout mFbs. The damage induction and repair kinetics of DNA DSBs in mFbs 
(wt W8 and Suv39h1-/- D5) after irradiation was studied. Cells were irradiated with 0 Gy and 
0.5 Gy; the repair foci were counted per nucleus at 1 h, 4 h and 24 h post irradiation. For the 
analysis, cells were stained for 53BP1 and for the analysis of NHEJ and HR repair. 
The results showed that the number of initial number of 53BP1 foci at 1 h after 
irradiation with 0.5 Gy was significantly decreased in the knockout (D5) compared with the 
wild type (W8) cells (Figure	   3.11). In comparison, the number of residual 53BP1 foci was 
significantly higher in cell lacking Suv39h1 compared to wt. These results indicate slower 
repair signalling in D5 as compared to W8. With respect to HR, no significant effect on the 
number of initial and residual number of Rad51 foci in D5 and W8 cells was found (Figure	  3.12). 
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Figure 3.11: Role of HMT SUV39H1 for nonhomologous end joining. Mouse cell lines, wild type (W8) and 
Suv39h1 knockout (D5) cells were irradiated with 0 Gy and 0.5 Gy, allowed to recover for 1 h to measure initial 
damage or 4 h and 24 h for residual damage and stained with 53BP1 antibody. A: Examples of 
immunofluorescence images. Staining for 53BP1 (red) and DAPI is as indicated. Scale bar = 10 µm; B: 
Quantification of the 53BP1 foci kinetics after IR. Representative results from five independent experiments are 
shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 
0.01 (**), p < 0.001 (***).  
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Figure 3.12: Role of HMT SUV39H1 for homologous recombination repair. mFbs W8 and D5 were 
irradiated with 4 Gy, allowed to recover for 4 h (initial damage) and 24 h (residual damage) and stained with 
Rad51 antibody. Representative results from five independent experiments are shown. Bars represent the mean ± 
s.d. 	  
In summary, lack of HMT SUV39H1 influenced NHEJ repair mechanisms in NSCLC 
as well as in mFbs by decreasing the number of initial foci and has an opposite effect on the 
number of residual foci in H1299 cells and in mFbs. It also affects HR in NSCLC, but not in 
mFbs. These data confirm our previous results that the number of initial 53BP1 foci is 
significantly decreased in NSCLC cells with reduced expression of SUV39H1. 
3.2.3 The role of HMT SUV39H1 on DNA DSB induction and 
rejoining 
As was described above, we initially used the number of radiation induced γH2AX 
foci as a measure for DSB. γH2AX foci are commonly used as markers for DSBs and it has 
been reported that the number of γH2AX foci correlates with the number of DSBs present, 
and that it increases linearly with radiation dose (Rothkamm and Löbrich, 2003). However, 
the kinetics of γH2AX foci formation that visualized DSB related signalling and those of the 
removal of physical breaks measured by pulsed-field gel electrophoresis (PFGE) are widely 
different (Kinner et al., 2008). PFGE is a reliable method for determination of the induction 
of DSBs and their physical rejoining. However, due to its insensitivity experiments have to be 
done after irradiation with relatively high radiation doses. Nevertheless, a γH2AX foci scoring 
was thought to represent an acceptable surrogate for physical DSB determination (Kinner et 
al., 2008; Löbrich et al., 2005) 
Thus, in order to analyse the direct induction and rejoining of DNA DSBs after IR, the 
PFGE technique was used. In this technique, the number of DSBs present in the cells is 
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measured by the fraction of DNA released (FDR). To obtain an adequate dose response effect, 
the fraction of DNA released (FDR) was plotted against the applied radiation doses up to 30 
Gy. The dose response curves were used to estimate the dose equivalent (Deq) values from 
each FDR value.  
The mFbs W8 and D5, with wild type and Suv39h1-/- genotypes, were initially used to 
determine DNA DSB dose response curves. The results from PFGE analysis after lysing cells 
at high temperature (50°C) lysis demonstrate that DNA dose response damage is increased in 
Suv39h1-/- cells compared to that of the wt cells (Figure	  3.13).  
	  
Figure 3.13: Role of HMT SUV39H1 DSB yield in mFbs as measured by PFGE. A: The respective dose 
response curves. The lines show linear regressions through the measured points of each data set; B: 
Representative gels from three independent experiments with identical results are shown. Bars represent the 
mean ± SEM from 3 determinations of independent 4 experiments.  	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The results from PFGE demonstrate that Suv39h1-/- cells (D5) repaired damages 
slightly slower with increased residual damage than the respective wt (W8) cells (Figure	  3.14). 
Although these results from PFGE did not reach statistical significance, they share similarity 
with results from immunofluorescence foci assay, indicating slight repair deficiency in D5 
cells. 
	  
Figure 3.14: DNA repair kinetics in HMT SUV39H1 deficient mFbs as measured by PFGE. A: Results 
show the DNA repair kinetics after IR at 20 Gy with or without Chaetocin treatment; B: the representative gels 
from three independent experiments with identical results are shown. Bars represent the mean ± SEM from 3 
determinations in 3 experiments.  	  
The next step was to investigate the role of HMT SUV39H1 in the direct DSB dose 
response damage and DSB rejoining kinetics in knockdown NSCLC cells lines. The results 
demonstrate that there is no difference in the DSB dose response damage between the 
radiosensitive H460 and radioresistant H1299 cell lines. In addition, knockdown of 
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shSuv39h1 by shRNA also have no effect on the initial number of DSB induced after IR 
(Figure	  3.15A). However, slower DNA repair kinetics in H460 compared with that of H1299 
(Figure	  3.15B) is evident. Moreover, DNA repair kinetics was slightly steeper in both Suv39h1 
knockdown cells compared to the wild type H460 and H1299 cells. However, the difference 
does not reach statistical significance in our experiments.  
	   	  
Figure 3.15: The yield of DSBs and DNA repair kinetics in shSuv39h1-treated NSCLC cells. A: The 
respective dose response relation for DSBs in the respective cell lines. The lines shown are linear regressions 
through the measured points of each data set; B: DNA repair kinetics as measured by PFGE. The respective 
(H460 and H1299) cell lines with and without shSuv39h1. Bars represent the mean ± SEM from 3 
determinations of at least in 3 independent experiments.  	  
Overall, the results suggest that HMT SUV39H1 affects DNA repair kinetics more 
efficiently in knockout mFbs compared to that of knockdown NSCLC cell lines.	  	  
3.3 Modulation of chromatin structure by small molecules 
targeting HMTs and its effect on the radiation response 
The results with the HMT SUV39H1 show that radiation response of cells might be 
modulated by decreasing the activity of this enzyme. Thus, we were further interested in how 
modulation of HMT SUV39H1 with small molecules (Chaetocin and Triptolide) and thus of 
the chromatin structure regulates proliferation, activation of cell cycle checkpoints after IR, 
DNA repair mechanisms (NHEJ and HR) and cell survival.  
3.3.1 Effect of modulators of chromatin structure on cell 
proliferation 
Initially, we examined the effect of the modulators on proliferation of the NSCLC cell 
lines H460 and H1299 (Figure	  3.16A). The data show that growth rate of the H460 cell line is 
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higher compared to that of the H1299 cell line, with an increase of the initial number of cells 
by a factor of 16 and 36, respectively. Next, the respective half maximal inhibitory 
concentration (IC50) was determined for each modulator. Cells were treated with different 
concentrations of the HMT inhibitors for 96 h. The IC50 values were calculated by the R 
environment software. The respective IC50 values for cell proliferation were 1.5 nM and 2.9 
nM for Triptolide in H460 and H1299, respectively (Figure	  3.16B). The respective values for 
Chaetocin were 37 nM and 29 nM (Figure	  3.16C). Overall, the present results show that all 
modifiers of chromatin used in the present study inhibit proliferation of the NSCLC cell lines. 
	  
Figure 3.16: Effect of chromatin modulation on the proliferation of NSCLC cell lines. H460 and H1299 
cells were treated for 96 h inhibitors Chaetocin and Triptolide. The relative number of cells at the end of the 
treatment with respect to the untreated cells was calculated. A: Comparison of the proliferation of H460 and 
H1299 without treatment. B and C: Effect of chromatin modulators on proliferation for Triptolide (B), Chaetocin 
(C) treatment. Representative results from at least three independent experiments are shown. Bars represent the 
mean ± SEM. 	  
3.3.2 Effect of Chaetocin on cell cycle progression and apoptosis  
To analyse the effect of Chaetocin, which inhibits the activity of the HMTs SUV39H1 
and G9a on cell cycle progression, H460 and H1299 cells were treated with different 
concentrations of Chaetocin, fixed at 72 h and stained with DAPI for cell cycle analysis. 
Treatment of cells with 75 nM Chaetocin for 72 h significantly decreased the fraction of cells 
in G1 phase from 63.8 ± 1.3% to 53.5 ± 2.6% (p < 0.001) in H460 cells and significantly 
0 1 2 3 4 7
0
2
4
6
8
10
H460
H1299
nu
m
be
r o
f c
el
ls
 (1
0^
6)
days
0 1 2 5 10 20
0.0
0.5
1.0 H460
H1299
concentration of  Triptolide (nM)
re
la
tiv
e 
nu
m
be
r o
f c
el
ls
 
A
B C
0 10 25 50 100 200
0.0
0.5
1.0
H460
H1299
concentration of Chaetocin (nM)
re
la
tiv
e 
nu
m
be
r o
f c
el
ls
 
3. Results 	  
	   53	  
increased the fraction of cells in G2 from 7.42 ± 1.3% to 17.0 ± 1.4% (p < 0.001) (Figure	  3.17A). In H1299 cells, 75 nM had no effect, but higher concentration of Chaetocin (150 nM) 
significantly decreased the fraction of cells in G1 phase from 59.1 ± 11.4% to 40.63 ± 14.2% 
(p < 0.05) and increased the fraction of cells in G2 from 10.6 ± 3.3% to 31.8 ± 13.7% (p < 
0.05) (Figure	  3.17B). 
 
 
	  
Figure 3.17: Influence of Chaetocin on cell cycle progression. H460 and H1299 cells were treated with 
different concentrations of Chaetocin for 72 h. Flow cytometry data showing cell cycle distribution of H460 (A) 
and H1299 cells (B). Representative results of three independent experiments are shown. “BG” is a background 
signal from apoptotic and degraded cells. Bars represent means ± s.d. Statistical analysis: 2-way ANOVA 
analysis with Bonferroni posttest, p < 0.05 (*), p < 0.001 (***). 	  
In conclusion, the results show that Chaetocin reduces the fraction of cells in the G1-
phase and accumulates cells in G2-phase of the cell cycle in a concentration-dependent 
manner in both cell lines.  
To study the effect of Chaetocin on apoptotic cell death, we treated the cells with 
increasing concentrations of Chaetocin and irradiated them with 10 Gy at 4 h after beginning 
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of Chaetocin treatment. Cells were fixed at 48 h thereafter. The fraction of detached cells was 
used as a measure for apoptosis, which was previously shown to be an appropriate measure 
for apoptosis in NSCLC cell lines (Stuschke et al., 2002). Chaetocin increases apoptosis in a 
concentration-dependent manner in both cell lines (Figure	   3.18). We also observed that IR 
slightly increased the percentage of apoptotic cells in combination with Chaetocin in H1299, 
but not in H460. 
	  
Figure 3.18: Effect of Chaetocin on radiation-induced apoptosis in NSCLC cell lines. Cells were treated 
with different concentrations of Chaetocin for 4 h, irradiated with 10 Gy after 24 h Chaetocin treatment and 
continued the treatment for further 48 h. The fraction of detached cells as a measure for apoptotic, cells were 
collected and counted. Representative results from two independent experiments are shown. Bars represent the 
mean ± s.d. 	  
3.3.3 Effect of HMT inhibitors on DNA DSB repair in tumour cell 
lines 
Based on the hypothesis that abnormal histone methylation and chromatin remodelling 
may lead to deficient DNA repair signalling, we previously showed that genetic modulation 
of the HMT SUV39h1 impairs repair signalling in Suv39h1 knockdown NSCLC as well as in 
knockout Suv39h1 mFb cells. Here, we extended these studies and evaluated the effect of 
small molecule HMT inhibitors on DNA repair pathways (NHEJ and HR). For this purpose, 
the NSCLC cell lines H460 and H1299 were treated with Chaetocin and Triptolide for 4 h, 
irradiated thereafter with 0.5 Gy and 4 Gy for NHEJ and HR pathways, respectively and fixed 
at 1 h, 4 h and 24 h after IR. 
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In order to examine the effect of Chaetocin and Triptolide on NHEJ repair pathway 
cell lines were stained with 53BP1. The results show that Triptolide has no significant effect 
on DNA repair signalling in both cell lines (Figure	   3.19). However, the number of residual 
53BP1 foci at 4 h post irradiation time is significantly higher (p < 0.01) in H1299 cell line as 
compared to untreated cells (Figure	  3.19B). 
 
	  
Figure 3.19: Effect of Triptolide on NHEJ repair in NSCLC cell lines after IR. The cells were treated for 4 h 
with and without Triptolide in combination with IR and stained with 53BP1 antibody. Graphs show the DNA 
repair kinetics after IR at 0.5 Gy in H460 (A) and in H1299 (B) cell line. Representative results from three 
independent experiments are shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis 
with Bonferroni posttest, p < 0.01 (**), p < 0.001 (***). 	  
Short time incubation with Chaetocin for 4 h before irradiation increased the initial as 
well as residual number of 53BP1 foci in H1299 (Figure	  3.20B), but only residual number of 
foci in H460 (Figure	  3.20A). Moreover, Chaetocin delays the foci kinetics in H1299 at 4 h after 
combined treatment with IR and Chaetocin at the respective IC50 (29 nM). Interestingly, if 
H1299 cells were treated with higher concentration of Chaetocin (300 nM), corresponding to 
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about 10x IC50, the initial 53BP1 foci were completely diminished as compared to the 
untreated cells.	  
	  
Figure 3.20: Effect of Chaetocin on NHEJ repair in NSCLC cell lines after IR. H460 and H1299 cells were 
treated with and without Chaetocin (with the respective IC50 (29 nM) for H1299 and H460 (37 nM)) for 4 h and 
then irradiated with 0 Gy and 0.5 Gy. The cells were stained with 53BP1 antibody and the number of foci was 
determined in H460 (A) and H1299 (B). Results from three independent experiments are shown. Bars represent 
the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 0.05 (*), p < 0.01 (**), 
p < 0.001 (***). 	  
To examine the effect of Chaetocin and Triptolide on homologous recombination 
repair in NSCLC cell lines, H460 and H1299 cells were pre-treated with the respective drugs 
for 4 h and then irradiated with 4 Gy. The number of Rad51 foci was determined at 4 h and 24 
h after IR, as a measure for initial and residual damage. The results show that Triptolide had 
no effect on HR in H460 (Figure	  3.21A) but it strongly decreased the number of initial and 
increased the number of residual Rad51 foci in H1299 in a concentration-dependent manner 
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(Figure	   3.21B). In comparison, Chaetocin decreases the initial number of Rad51 foci and 
increased the residual number of Rad51 foci in both cell lines (Figure	  3.22). 
 	  
Figure 3.21: Effect of Triptolide on HR repair in NSCLC cell lines after IR. The cells were treated for 4 h 
with and without Chaetocin in combination with IR and stained with Rad51 antibody, a hallmark of HR repair 
pathway. Graphs show the DNA repair kinetics after IR at 0.5 Gy in H460 (A) and in H1299 (B) cell line. 
Representative results from three independent experiments are shown. Bars represent the mean ± s.d. Statistical 
analysis: 2-way ANOVA analysis with Borferroni posttest, p < 0.001 (***). 
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Figure 3.22: Effect of Chaetocin on HR repair in NSCLC cell lines after IR. Cells were treated with and 
without Chaetocin at the respective IC50 (29 nM) for H1299 and H460 (37 nM) for 4 h and then irradiated with 
0 Gy and 4 Gy. Cells were stained with Rad51 antibody and the number of Rad51 foci determined at 4 h and 24 
h after IR in H460 (A) and H1299 (B). Representative results from three independent experiments are shown. 
Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 0.05 
(*), p < 0.001 (***). 	  
In the next step, pre-treatment with Chaetocin was extended from 4 h to 24 h before 
cells were irradiated and its effect on repair signalling was determined by using the 53BP1 
foci assay. Cells were pre-treated for 24 h with Chaetocin at 2x IC50 (60 nM), irradiated with 
0.5 Gy, fixed at 1 h, 4 h and 24 h thereafter and stained with γH2AX antibody. As expected, 
Chaetocin significantly increases the number of initial as well as of residual γH2AX foci 
compared with untreated control group (Figure	  3.23). 
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Figure 3.23: Effect of Chaetocin on NHEJ repair after extended pre-treatment. H1299 cells were pre-
treated with Chaetocin (60 nM) for 24 h, irradiated with 0.5 Gy, allowed to recover for 1 h, 4 h and 24 h and 
stained with γH2AX. Representative results from three independent experiments are shown. Bars represent the 
mean ± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 0.001 (***).  	  
To analyse the effect of Chaetocin on HR repair after extended pre-treatment, cells 
were treated with Chaetocin (30 nM and 60 nM) for 24 h, irradiated with 4 Gy, fixed at 4 h 
and 24 h after IR and stained with Rad51 as well as with cyclin B1, which identifies cells in 
the G2-phase. Positive cells for cyclin B1 were scored for the number of Rad51 foci. In 
comparison with the previous results of shorter pre-treatment of only 4 h, these results from 
extended treatment show significant increase in the number of initial and residual Rad51 foci 
(Figure	  3.24).  
	  
Figure 3.24: Effect of Chaetocin on HR repair after extended pre-treatment. H1299 cells were pre-treated 
with Chaetocin (30 nM and 60 nM) for 24 h, irradiated with 0.5 Gy, allowed to recover for 1 h, 4 h and 24 h and; 
stained with Rad51 and Cyclin B1. Rad51 foci were scored only in Cyclin B1 positive cells. Representative 
results from three independent experiments are shown. Bars represent the mean ± s.d. Statistical analysis: 2-way 
ANOVA analysis with Bonferroni posttest, p < 0.001 (***). 
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Additionally, Chaetocin and Triptolide were reported as potential inhibitors of 
H3K9me3. Unexpectedly, that we could not detect any effect of Chaetocin on H3K9me3 in 
both cell lines at low concentrations (< 300 nM) of Chaetocin (Figure	  3.25).  
	  
Figure 3.25: Chaetocin does not affect H3K9me3 protein expression in H1299 cell line. Graph shows the 
relative H3K9me3 histone expression in H1299 after Chaetocin treatment. Representative results from at least 
three independent experiments are shown. Bars represent mean ± s.d. 	  
Taking together, although Chaetocin regulated NHEJ and HR repair pathway, we did 
not detect significant reduction of H3K9me3 on protein expression level. 
 
3.3.4 Effect of Chaetocin on cell survival 
In order to investigate the effect of Chaetocin on clonogenic survival of H460 and 
H1299, cells were treated with Chaetocin with the respective concentrations of 1x IC50 (29 
nM for H1299 and 37 nM for H460), 2x IC50 and 10x IC50 for 24 h, irradiated thereafter 
with 0, 2, 4, 6 Gy and incubated for further 24 h. Single cell suspensions were plated out for 
colony formation at 24 h after irradiation, after cells completed repair processes and incubated 
for further 10 days for colony formation. 	  
Chaetocin treatment at concentrations of about 1x IC50 and 2x IC50 had no effect on 
the surviving fraction after irradiation up to 6 Gy. Only at higher concentration surviving 
fraction was significantly (p < 0.05) reduced after irradiation with 2 Gy and 6 Gy (Figure	  3.26B). In comparison, no effect of Chaetocin at all was evident in H460.  
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Figure 3.26: Effect of Chaetocin on the radiation sensitivity of NSCLC cell lines. Cells were treated with 
different concentration of Chaetocin with 1x IC50 (37 nM for H460 and 29 nM for H1299), 2x IC50 and 10x 
IC50, irradiated with 0, 2, 4, 6, 8 Gy and incubated for 10 days. A: Cell survival curves of H460; B: Survival 
curves of H1299. Representative results from three independent experiments are shown. Bars represent the mean 
± s.d. Statistical analysis: 2-way ANOVA analysis with Bonferroni posttest, p < 0.05 (*). 	  
Overall, surviving fraction after irradiation was significantly reduced only at high 
concentration of Chaetocin (290 nM) in H1299. 
 
3.3.5 Combined effect of Chaetocin and fractionated irradiation 
on cell survival  
As was described above, there was no significant effect of Chaetocin at low 
concentrations on the surviving fraction after combined single radiation schedules. As shown 
in paragraph 3.3.3, Chaetocin increased residual number of γH2AX at 24 h after irradiation. 
Thus, we hypothesized that the fraction of these sublethal damages may increase during 
protracted radiation exposure. In order to evaluate the impact the residual DSBs on cell 
survival, fractionated radiation with daily fractions of 2 Gy was used. 
For this purpose, H1299 cells were pre-treated with low doses of Chaetocin (0, 7.5, 
15, 30 nM) for 4 h and irradiated thereafter with daily 2 Gy fractions up to a total dose of 6 
Gy. The highest concentration of 30 nM Chaetocin used in this set of experiments correspond 
to 1x IC50 values in H1299. The initial number of γH2AX foci at 1h after irradiation with 2 
Gy as well as residual number at 4 h and 24 h after irradiation were determined. In addition, 
the number of γH2AX after 3x 2 Gy was determined at 24 h after the last fraction. As shown 
in Figure	   3.27 the initial as well as residual number of γH2AX at 1 h and 4 h after IR 
significantly increased with increasing concentrations of Chaetocin. An increase of the 
residual number of foci with increasing Chaetocin concentrations at 24 h after single 
irradiation with 2 Gy was evident, but not significant. However, fractionated irradiation 
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significantly increased the residual number of γH2AX foci with increasing Chaetocin 
concentrations.	   
	  
Figure 3.27: Effect of Chaetocin on radiation induced γH2AX after fractionated irradiation. H1299 cells 
were treated with different concentrations of Chaetocin (0, 7.5, 15, 30 nM) for 4 h and irradiated 3 times with 2 
Gy every 24 h. Cells were fixed and stained with γH2AX at 24 h after the last radiation fraction. For initial foci 
detection, cells were fixed after first irradiation treatment at 1 h, 4 h and 24 h. Results from three independent 
experiments are shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with 
Bonferroni posttest, p < 0.05 (*), p < 0.01(**), p < 0.001(***). 	  
In order to evaluate the effect of fractionated irradiation, i.e. the accumulation of 
residual damage on the surviving fraction cells were plated for colony formation at 24 h after 
the last fraction and continued incubation for further 10 days without Chaetocin. As shown in Figure	  3.28, Chaetocin gradually reduced the surviving fraction after fractionated irradiation. 
However, the effect was significant (p < 0.05) only at the highest concentration of 30 nM, 
corresponding to the respective 1x IC50 value in H1299 cells. We could not detect significant 
reduction of cell survival at lower doses of Chaetocin by clonogenical assay. 
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Figure 3.28: Effect of Chaetocin on cell survival by fractionated irradiation. H1299 cells were treated with 
different concentrations of Chaetocin (0, 7.5, 15, 30 nM) for 4 h and irradiated 3 times with 2 Gy every 24 h. At 
24 h after last radiation treatment the cells were seeded for colony formation without Chaetocin and incubated 
for further 10 days. Results from five independent experiments are shown. Bars represent the mean ± SEM. 
Statistical analysis: Paired t-test (p < 0.05).  	  
In conclusion, Chaetocin gradually increased the fraction of residual number of 
γH2AX foci and decreased surviving fraction after fractionated irradiation schedules.  
 
3.3.6 Effect of Chaetocin on tumour control  
As a long term survival control assay the plaque-monolayer assay was performed. It is 
a sensitive and quantitative procedure for evaluating cell proliferation for extended periods of 
time (Sak et al., 2012).  
The H460 and H1299 cells with a cell number of 1500 cells were seeded into 24 well 
tissue plates and treated 24 h later with Chaetocin concentrations of 0, 10, 15 nM for H1299 
and 0, 7.5, 10, 15, 20 nM for H1460. At about 4 h after treatment, cells were irradiated with 
single doses of 0, 2, 4, 8, 12, 15, 16, 17, 19, 20, 21, 23, 25 Gy. In a parallel assay, cells were 
irradiated with fractionated doses with 2 Gy per fraction every 6 h. After the last fraction 
Chaetocin was washed out and the cells were incubated for 6 weeks at all. The overall time 
for Chaetocin treatment was the same for the single schedule and fractionated irradiation 
group. 
After single irradiation, Chaetocin significantly reduced the dose to control growth of 
50% of the H1299 plague-monolayer (TCD50) from 19.5 Gy to 9.9 Gy and 3.2 Gy for 0 nM, 
10 nM and 15 nM, respectively (Figure 3.29A). In comparison, fractionated irradiation reduced 
TCD50 from 25.0 Gy in the untreated cells to 14.7 Gy and 9.8 Gy after 10 nM and 15 nM 
Chaetocin, respectively (Figure 3.29B).  
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Figure 3.29: Effect of Chaetocin on tumour control dose of H1299 cells in the plague-monolayer assay. 
About 1500 cells in 5 µl were plated into 24 well plates and treated after adhering with Chaetocin (0, 10, 15 nM) 
and irradiated thereafter either with single radiation doses (A) and fractionated irradiation, using 2 Gy per 6 h 
(B). At about 6 h after the fraction the medium with Chaetocin was removed and the cells were incubated for 
further 6 weeks. Results from one experiment are shown. 
In comparison, Chaetocin also reduced the TCD50 in H460 cells from 12 Gy to 10.6, 
10.2, 8.6 and 2.9 Gy after single irradiation for Chaetocin concentrations of 0, 7.5, 10.0, 15.0 
and 20.0 nM, respectively (Figure 3.30A). The respective TCD50 values after fractionated 
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irradiation were 21.0, 14.2, 10.2, 8.6 and 8 Gy, for Chaetocin concentrations of 0, 7.5, 10.0, 
15.0 and 20.0 nM, respectively (Figure 3.30B). 
	  
Figure 3.30: Effect of Chaetocin on tumour control dose of H460 cells in plague-monolayer survival assay. 
About 1500 cells in 5 µl cells were plated into 24 well plates and then were treated after adhering with Chaetocin 
(0, 7.5, 10, 15, 20 nM) and irradiated thereafter either in combination with single irradiation doses (A) and 
fractionated irradiation, using 2 Gy per 6 h (B). At about 6 h after the last fraction the medium with Chaetocin 
was removed and the cells were incubated for further 6 weeks. Results from one experiment are shown. 
Overall, the data show that reduced SUV39H1 deregulates DNA damage signalling 
with increased number of DSB associated foci during fractionated irradiation. This damage 
accumulation also led to an increased radiation sensitivity of the cells, which was apparent in 
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H1299 but not in H460 cells. In addition, preliminary data using the long term plaque-
monolayer survival assay show increased radiation sensitising effect of Chaetocin at very low 
concentrations of  <10 nM, in both cell lines. Notwithstanding, the effect of Chaetocin was 
more pronounced in H1299 compared to H460.  	  
3.4 Characterisation of a Chaetocin-induced chromatin 
clustering phenotype 
To modulate the chromatin structure, small molecules (Chaetocin, Gliotoxin, 
BIX1294 and UNC0638) targeting the histone methyltransferases SUV39H1 and G9a were 
used. Chaetocin and Gliotoxin, which belong to the chemical class of 
Epipolythiodioxopiperazine (ETP), was shown to inhibit both HMTs SU(VAR)3-9 and G9a 
(Greiner et al., 2005), while BIX1294 and UNC0638 inhibit only HMT G9a (Figure	  3.31). 
The data demonstrate global chromatin remodelling after Chaetocin treatment, which 
was clearly visible in fluorescent microscopy (Figure	  3.32A). Illner et al. (2010) described this 
effect of Chaetocin-induced chromatin condensation (CICC) only in primary hFbs but not in 
tumour cells. In contrast to the results of Illner et al. (2010), the present data show CICC also 
in the NSCLC cell line H1299 as well as in primary hFbs and mFbs cells.  
Chaetocin is a class of fungal metabolites knows as EPT, which is characterized by 
having a disulfide-bridged ring. In order to explore if hypercondenced chromatin clustering is 
a result of the unique chemical structure of ETPs, cells were treated with Gliotoxin, which is 
also a member of ETPs. In addition, BIX01294 and UNC0638, with different from ETPs 
chemical structures were also used. The results clearly show that condensed chromatin 
clustering was found only after Chaetocin and UNC0638 treatments, two structurally distinct 
classes of HMT inhibitors. Thus, the chemical structure seems to be not critical for the 
formation of condensed chromatin structure. 
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Figure 3.31: Effect of different small-molecule HMT inhibitors on proliferation of NSCLC cell lines. A: 
Structure of small-molecular HMT inhibitors (modified pictures from Decarlo and Hadden, 2012); B: 
Comparison of IC50 and HMT status in NSCLC lines (H460, H1299) for the different inhibitors as measured by 
proliferation assay. IC50 was calculated by R program from three independent experiments are shown. 
	  
Figure 3.32: Chromatin remodelling after Chaetocin treatment in H1299. The fluorescence pictures 
represent nucleus after Chaetocin treatment (A) and non-treated cell nucleus (B) (blue, DAPI). Images are taken 
by confocal microscopy. 
!
dependent BIX-01294-mediated reduction in cancer growth after
48 hr incubation (2e6 mM) in a panel of human cancers (urothelium
carcinoma, lung, and bladder) [90].
Informedmodifications from the structural data on the GLP/BIX-
01294 complex led to the synthesis and characterization of E72 (8)
[91]. While BIX-01294 binds the GLP H3 peptide region, it lacks the
depth necessary to serve as a structural mimic of the K9 residue.
Replacing the C-7 methoxy of BIX-01294 wit a 5-aminopentyloxy
moiety provided an extended aliphatic chainwith a terminal amine
that could reach within the K9 binding region of GLP. A further
modification included replacing the 3-diazepine ring with a dime-
thylaminopropyl group designed to improve electrostatic interac-
tions between the inhibitor and Asp1131 within the binding site of
GLP. Co-crystallization of the E72/GLP complex demonstrated that
it binds in a similar fashion to BIX-01294, includingmaintaining key
hydrogen bonds between the core quinazoline and piperidine rings
and aspartate residues within the binding site. In addition, the
dimethylamino functionality formed a salt bridge with Asp1131 as
predicted. A minimal SAR study on aliphatic chain-length for this
moiety determined that the three-carbon linkage was optimal for
activity [91]. Finally, the 5-aminopentyl substituent replacing the
benzyl moiety of BIX-01294 fits in an acidic surface groove of the
GLP binding site and the amine may improve electrostatic inter-
action with the carbonyl of adjacent Val1136 [91]. Isothermal
titration calorimetry demonstrated that E72 was a high affinity
binder to both G9a and GLP (Kd values ¼ 164 and 136 nM,
respectively) and a mass spectrometry-based inhibitory assay
generated an IC50 of 1.3 mM for GLP, a 7-fold increase in potency
compared with BIX-01294 [91]. It also was shown that treatment
with 2.5 mM rescues the pro-apoptosis gene for fatty acid synthase
(Fas) from epigenetic silencing in NIH 3T3 cells, a functional
observation of G9a inhibition. At present, no published reports of
in vitro or in vivo tumor-specific activity have surfaced, however at
equal 10 mM doses E72 exhibits significantly reduced cytotoxicity
compared to BIX-01294 in three mouse embryonic stem cell
models [91].
A second series of quinazoline-based inhibitors (designated
UNC0) designed to improve on the limitations of BIX-01294
through structure-based drug design has also be n reported.
Initially, thirteen analogs were synthesized and evaluated in two
separate assays as potential G9a inhibitors [92]. SAR from these
studies confirmed that removing or replacing the benzyl moiety
fails to affect potency; however, the methyl piperidine is essential
for G9a inhibition and remains present on all UNC compounds to
date [92e94]. Chlorination at the 2-amino region resulted in severe
potency reduction in both assays, whilst tolerable potency loss was
achieved with various heterocyclic and alkylamino substitutions at
this region. Side-chain functionalization at the C-7 methoxy was
predicted to incorporate activity at the GLP lysine binding pocket
similarly to the E72 study [92]. The results from these initial SAR
studies yielded UNC0224 (9) as a high affinity binder (Ki ¼ 2.6 nM)
and inhibitor of G9a (IC50 ¼ 15 nM) [92].
Building upon the success of UNC0224, an updated report on the
previously mentioned SAR studies was published with a more
extensive focus on the 7-aminoalkoxy moiety [93]. Extension of the
alkyl chain identified that the G9a lysine binding pocket was able to
accommodate up to a 5-carbon aminoalkoxy tether. Capping the
chain with various methylamino or cyclicamino functional groups
maintained or slightly improved G9a inhibition. Similar to the
piperidine substituent, replacing the terminal nitrogen resulted in
drastic loss of potency. The most potent analog, UNC0321 (10) was
generated upon replacing the 5 carbon alkylamino with an ethox-
yethyl moiety. Subsequent SAR on a constrained ring system and
increased amino capping groups produced potency loss, verifying
that the dimethylaminoethoxyethyl moiety was optimal for inter-
actions at the lysine binding pocket. Binding studies indicate that in
contrast to the equipotent inhibition of G9a and GLP by UNC0224,
UNC0321 is more selective for G9a (Ki¼ 63 pM). Both UNC0224 and
UNC0321 demonstrated >1000-fold selectivity for G9a over SET7/
9, SET8 and PRMT3 and the histone demethylase JMJDE2 (IC50
values > 40 mM) [93].
Despite the superior potency of UNC0321 in biochemical assays,
BIX-01294 maintains enhanced activity in cellular assays,
presumably due to poor membrane permeability. UNC0638 was
designed to increase lipophilicity while maintaining potent in vitro
activity against G9a and this discovery effort was successful [94].
UNC0638 (11) inhibited both G9a and GLP (IC50s < 15 nM and
19 nM, respectively) and was identified as a competitive inhibitor
with respect to the peptide substrate, but non-competitive with
respect to SAM. UNC0638 exhibited >500-fold selectivity for G9a/
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dependent BIX-01294-mediated reduction in cancer growth after
48 hr incubation (2e6 mM) in a panel of human cancers (urothelium
carcinoma, lung, and bladder) [90].
Informedmodifications from the structural data on the GLP/BIX-
01294 complex led to the synthesis and characterization of E72 (8)
[91]. While BIX-01294 binds the GLP H3 peptide region, it lacks the
depth necessary to serve as a structural mimic of the K9 residue.
Replacing the C-7 methoxy of BIX-01294 with a 5-aminopentyloxy
moiety provided an extended aliphatic chainwith a terminal amine
that could reach within the K9 binding region of GLP. A further
modification included replacing the 3-diazepine ring with a dime-
thylaminopropyl group designed to improve electrostatic interac-
tions between the inhibitor and Asp1131 within the binding site of
GLP. Co-crystallization of the E72/GLP complex demonstrated that
it binds in a similar fashion to BIX-01294, includingmaintaining key
hydrogen bonds between the core quinazoline and piperidine rings
and aspartate residues within the binding site. In addition, the
dimethylamino functionality formed a salt bridge with Asp1131 as
predicted. A minimal SAR study on aliphatic chain-length for this
moiety determined that the three-carbon linkage was optimal for
activity [91]. Finally, the 5-aminopentyl substituent replacing the
benzyl moiety of BIX-01294 fits in an acidic surface groove of the
GLP binding site and the amine may improve electrostatic inter-
action with the carbonyl of adjacent Val1136 [91]. Isothermal
titration calorimetry demonstrated that E72 was a high affinity
binder to both G9a and GLP (Kd values ¼ 164 and 136 nM,
respectively) and a mass spectrometry-based inhibitory assay
generated an IC50 of 1.3 mM for GLP, a 7-fold increase in potency
compared with BIX-01294 [91]. It also was shown that treatment
with 2.5 mM rescues the pro-apoptosis gene for fatty acid synthase
(Fas) from epigenetic silencing in NIH 3T3 cells, a functional
observation of G9a inhibition. At present, no published reports of
in vitro or in vivo tumor-specific activity have surfaced, however at
equal 10 mM doses E72 exhibits significantly reduced cytotoxicity
compared to BIX-01294 in three mouse embryonic stem cell
models [91].
A second series of quinazoline-based inhibitors (designated
UNC0) designed to improve on the limitations of BIX-01294
through structure-based drug design has also been reported.
Initially, thirteen analogs were synthesized and evaluated in two
separate assays as potential G9a inhibitors [92]. SAR from these
studies confirmed that removing or replacing the benzyl moiety
fails to affect potency; however, the methyl piperidine is essential
for G9a inhibition and remains present on all UNC compounds to
date [92e94]. Chlorination at the 2-amino region resulted in severe
potency reduction in both assays, whilst tolerable potency loss was
achieved with various heterocyclic and alkylamino substitutions at
this region. Side-chain functionalization at the C-7 methoxy was
predicted to incorporate activity at the GLP lysine binding pocket
similarly to the E72 study [92]. The results from these initial SAR
studies yielded UNC0224 (9) as a high affinity binder (Ki ¼ 2.6 nM)
and inhibitor of G9a (IC50 ¼ 15 nM) [92].
Building upon the success of UNC0224, an updated report on the
previously mentioned SAR studies was published with a more
extensive focus on the 7-aminoalkoxy moiety [93]. Extension of the
alkyl chain identified that the G9a lysine binding pocket was able to
accommodate up to a 5-carbon aminoalkoxy tether. Capping the
chain with various methylamino or cyclicamino functional groups
maintained or slightly improved G9a inhibition. Similar to the
piperidine substituent, replacing the terminal nitrogen resulted in
drastic loss of potency. The most otent analog, UNC0321 (10) was
generated upon replacing the 5 carbon alkylamino with an ethox-
yethyl moiety. Subsequent SAR on a const ained ring sys em and
increased amino capping groups produced potency loss, verifying
that the dimethylaminoethoxyethyl oiety was optimal for int r-
actions at the lysine binding pocket. Binding studies indicate that in
contrast to the equipotent inhibition of G9a and GLP by UNC0224,
UNC0321 is more selective for G9a (Ki¼ 63 pM). Both UNC0224 and
UNC0321 demonstrated >1000-fold selectivity for G9a over SET7/
9, SET8 and PRMT3 and the histone demethylase JMJDE2 (IC50
values > 40 mM) [93].
Despite the superior potency of UNC0321 in biochemical assays,
BIX-01294 maintains enhanced activity in cellular assays,
presumably due to poor membrane permeability. UNC0638 was
designed to increase lipophilicity while maintaining potent in vitro
activity against G9a and this discovery effort was successful [94].
UNC0638 (11) inhibited both G9a and GLP (IC50s < 15 nM and
19 nM, respectively) and was identified as a competitive inhibitor
with respect to the peptide substrate, but non-competitive with
respect to SAM. UNC0638 exhi ite >500-fold selectivity for G9a/
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[82]. It has been hypothesized that 1 competes with SAM for
binding to three C-terminal cystein residues esse tial for activity
on H3K9-specific KMTs and although structural analysis has not
verified this hypothesis, it is thought that the lack of the cysteine
residues on E(z), PRSET7 or SET7/9 is resp sible for its limited
activity against these targets [83]. Development of a fully synthetic
pathway and subsequent ex loratory SAR for 1 identified key
structural motifs requisite for G9a inhibitory activity [84]. There
was no difference i G9a inhibition between the natural produc 1
and its antipode (IC50 values ¼ 2.4 mM vs. 1.7 mM, respectively) [84].
The sulfur moieties of 1 and other fungal epidithiodiketopiper-
azines (ETPs) are critical for activity against other targets as it
imparts torsional strain that locks the molecule into a rigid
configuration [85,86]. An S-deficient (þ)-chaetocin (2) analog was
inactive against G9a, demonstrating that tetra-sulfation was
essential for anti-KMT activity as well [84]. Tr atment with 1
(0.5 mM) reduced H3K9me3 levels in U937 h man lymphoma cells
and induced apoptosis in a dose-dependent manner (0.05e1 mM)
[83]. In vivo studies for 1 have been reported; however, these
results have not demons rated in vivo inhibition of KMTs [83].
Other (ETP) have rece tly been shown to exhibit anti-KMT-ase
activity in vitro; particularly against G9a and SUV39H1 [87].
These results confirmed that the disulfide moiety is essential for
KMT inhibition (Fig. 2). Gliotoxin (3), chetomin (4), and 11,110-
dideoxyverticillin A (5) contain at least one disulfide bridge and
demonstrated potent inhibition of KMT activity; by contrast, the
loss of the disulfide bridge in the structurally related
bisdethiobis(methylthio)-acetylgliotoxin (6) significantly reduces
potency of the ETP scaffold as evidenced by a nearly 20 fold loss in
activity at G9a and SUV39H1. It has been postulated that the
disulfide moiety present in 4 of the 5 ETP compounds may grant
selectivity through interaction with the pre- and post-SET cysteine
containing domains of G9a and SUV39H1 [87]. In vitro results for
these ETPs have not been reported.
2.2.2. Small molecule inhibitors
2.2.2.1. Quinazoline-based hibitors. Chaetocin and other epige-
netic inhibitors are known to compete for the conserved SAM
binding region on several HMT families. This explains the observed
cross-reac ivity of GLP and G9a with Cha tocin and other struc-
turally cons rved SAM-dependent-enzymes. With this in mind,
discovery efforts have begun to includ competitive SAM bi ding of
hits as exclusion criteria for lead selection, as is the case in the
discovery of BIX-01294 (7, Fig. 3) [88]. Results from a virtual screen
identified a 125K compound subs t with probabilistic activity
against KMTs that was subsequently screened for anti-KMT activity
against G9a. It is important to note that the screening assay was
conducted in the presence of excess SA to limit the number of
non-specific false positives [88].
While BIX-01294 was no the ost ctive inhibitor dentified in
the screen, it was the sole compound to exhibit significantly greater
electivity toward G9a/GLP (IC50s ¼ 1.9 and 0.7 mM, respectively)
compared to SUV39H1 and PRMT1 (an arginine methyltransferase).
BIX-01294 reduced H3K9me2 levels at multiple G9a target genes in
mous embryonic stem cells and fibroblas s i a ransient fashion,
suggesting its potential as a valuable probe f r reversible modula-
tion of H3K9me2 [88]. Co-crystallographic data identified BIX-
01294 as a non-competitive inhibitor of GLP that binds a region
separate from the SAM binding domain [89]. The dimethoxy of the
quinazoline and the diazepane ring are responsible for the majority
of interaction with GLP. The benzyl moiety does not appear
essential for high affinity GLP binding; however, it may enhance cell
permeability. The selectivity for GLP and G9a is due to the favorable
interactions and structura arrangement adopted by BIX-01294
upon binding; specifically, the inhibitor occupi s the region
reserved for the histone (H3) peptide, Lys4 to Arg8. While, overlay
analysis revealed striking structural overlap with the histone
peptide and the inhibitor, BIX-01294 does not occupy the Lys9
binding channel [89]. A singular report demonstrates dose-
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[82]. I has been hypo h sized that 1 competes with SAM for
binding to three C-terminal cysteine residues essential for activity
on H3K9-specific KMTs and although structural analysis has not
verified this hypothesis, it is thought that the lack of the cysteine
residues on E(z), PRSET7 or SET7/9 is responsible for its limited
activity against these targets [83]. Development of a fully synthetic
pathway and subsequent exploratory SAR for 1 identified key
structural motifs requisite for G9a inhibitory ctivity [84]. There
was no diff rence in G9a inhibit on between th natural product 1
a its antipode (IC50 values ¼ 2.4 mM vs. 1.7 mM, respectiv ly) [84].
The sulfur moieti s of 1 and other fungal epidithiodiketopiper-
azines (ETPs) are critical for activity agains o her targ ts as it
imparts torsional strain that locks the molecule into a rigid
configuration [85,86]. An S-deficient (þ)-chaetocin (2) analog was
inactive against G9a, demonstrating that tetra-sulfation was
ess ntial fo anti-KMT ac ivity as well [84]. Treatment with 1
(0.5 mM) reduced H3K9me3 levels in U937 human lymphoma cells
and induced apoptosis in a dose-dependent manner (0.05e1 mM)
[83]. In vivo studies for 1 have been reported; however, these
results have not demonstrated in vivo inhibition of KMTs [83].
Oth r (ETP) have recently been show to exhibit anti-KMT-ase
activity in vitro; particularly against G9a and SUV39H1 [87].
T ese results confirmed hat the disulfide moiety is essential for
KMT inhibition (Fig. 2). Gliotoxin (3), c etomin (4), and 11,110-
dideoxyverticillin A (5) contain at least one disulfide bridge and
demonstrated potent inhibition of KMT activity; by contrast, the
loss of the disulfide bridge in the structurally related
bisdethiobis(methylthio)-acetylgliotoxin (6) significantly reduces
potency of the ETP scaffold as evidenc d by a nearly 20 fold loss in
activity at G9a and SUV39H1. It has been postulated that the
disulfide moiety present in 4 of the 5 ETP compounds may grant
selectivity through interaction with the pre- and post-SET cysteine
containing domains of G9a and SUV39H1 [87]. In vitro results for
these ETPs have not been reported.
.2.2. Small molecule inhibitors
2.2.2.1. Quinazoline-based inhibitors. Chaetocin and other epige-
netic inhibitors are known to compete for the conserved SAM
binding region on several HMT families. This explains the observed
cross-reactivity of GLP and G9a with Chaetocin and other struc-
turally conserved SAM-dependent-enzymes. With t is in mi ,
discovery efforts hav begun t include compe itive SAM binding of
hi s as exclusion criteria for lead sel ction, as is th case in the
discovery of BIX-01294 (7, Fig. 3) [88]. Results from a virtual screen
identified a 125K compound subset with probabilistic activ ty
against KMTs that was subsequently screened for anti-KMT activity
agai st G9a. It is imp rtant to note that the screening assay was
conduct d in th pr se ce of excess SAM to limit the number of
non-specific false positives [88].
While BIX-01294 was not the most active inhibitor identified in
the screen, it was the sole compound to exhibit significantly greater
selectivity toward G9a/GLP (IC50s ¼ 1.9 and 0.7 mM, respectively)
compared to SUV39H1 and PRMT1 (an arginine methyltransferase).
BIX-01294 reduced H3K9me2 levels at multiple G9a target genes in
mouse embryonic stem cells and fibroblasts in a transient fashion,
sugge ting its potential as a valuable probe for reversible modula-
tion of H3K9me2 [88]. Co-crystallographic data identified BIX-
01294 as a non- ompetitive inhibitor of GLP that binds a region
separate from the SAM binding domain [89]. The dimethoxy of the
quinazoline and the diazepane ring are responsible for the majority
of interaction with GLP. The benzyl moiety does not appear
essential for high affinity GLP binding; however, it may enhance cell
permeability. The selectivity for GLP and G9a is due to the favorable
interactions and structural arrangement adopted by BIX-01294
upon binding; sp cifically, the inhibitor occupies the region
reserved for the histone (H3) peptide, Lys4 to Arg8. While, overlay
analysis revealed striking structural overlap with the histone
peptide and the inhibitor, BIX-01294 does not occupy the Lys9
binding channel [89]. A singular report demonstrates dose-
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3.4.1 Characteristics of Chaetocin induced chromatin clustering  
In order to understand the mechanism and principles of Chaetocin-induced chromatin 
clustering, time kinetics, effect of radiation, reversibility and its association with chromatin 
markers were evaluated. To investigate the time course of chromatin clustering in H1299 and 
in hFbs, cells were treated with Chaetocin and observed up to 40 h. The data show that the 
percentage of cells with Chaetocin-induced chromatin clustering (CICC) increases in a 
concentration- and time-dependent manner. The first chromatin clustering was detected at 
about 8 h after treatment with the maximum achieved at about 24 h (Figure	  3.33A). Moreover, 
the percentage of CICC cells did not depend on IR exposure (Figure	  3.33B). 
	  
Figure 3.33: Time course of CICC phenotype in H1299 cells. A: Concentration- and time-dependent 
formation of CICC in H1299. The results from at least 500 scored cells per point (n=1) are shown; B: Effect of 
IR on CICC formation at 24 h after combined treatment with Chaetocin and 4 Gy. Bars represent the mean ± s.d 
(n = 2). 	  
Unexpectedly, in H1299 cells transfected with siRNA targeting Suv39h1 and G9a, the 
percentage of CICC cells is significantly reduced after Chaetocin treatment (30 nM) (Figure	  3.34). Thus, it seems that the HMTs SUV39H1 and G9a have an impact on CICC formation. 
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Figure 3.34: Effect of downregulation of SUV39H1 and G9a on CICC formation. Knockdown of siRNA 
mediated Suv39h1 and G9a decreased CICC at 48 h after Chaetocin (30 nM). The cells were fixed at 24, 28 and 
48 h after Chaetocin treatment and analysed for CICC cells. Bars represent the mean ± s.d from three 
independent experiments. 	  
3.4.2 Reversibility of Chaetocin-induced chromatin condensation  
In order to investigate the reversibility of the chromatin effect on chromatin 
reorganization, Chaetocin was washed out at 24 h after treatment at that time when the 
maximum of CICC formation was seen. The data show that the percentage of CICC cells 
strongly decreases within 24 h after washout. However, in order to exclude that proliferation 
of non-affected cells or preferential death of CICC cells falsify the results, several control 
experiments were performed.  
At first, to exclude that the fraction of CICC cells can be overgrown by proliferation 
of normal cells, i.e. non-affected cells, which do not have a visible chromatin clustering after 
the Chaetocin treatment, proliferation of the cells was stopped. Aphidicolin (Apc), which is a 
reversible inhibitor of eukaryotic DNA replication and arrests cell cycle transition of the cells 
at early S phase, was used for this purpose. Treatment of G1 enriched cells for 20 h with 2 
µM of Apc arrested more than 80% of cells in the G1/S phase, while untreated cells went 
through the cell cycle (Figure	  3.35A). Proliferation kinetics showed that Apc treated cells did 
not proliferate within 72 h of in comparison to the control groups (with and without Chaetocin 
treatment) (Figure	  3.35B). There was no effect of Chaetocin on the cell number of Apc-treated 
cells, while Chaetocin significantly reduced proliferation of non-Apc treated cells. The data 
clearly show that the percentage of CICC cells significantly even in Apc-treated cells reduced 
(Figure	  3.35C). In addition, hFbs, which naturally have a low proliferation capacity, were also 
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used to eliminate the possibility that proliferation may thin out the fraction of CICC cells 
(Figure	  3.35D).  
	  
Figure 3.35: The reversibility of CICC after Aphidicolin (Apc) treatment in H1299 and HFbs. A: the cell 
cycle progression after 20 h Apc treatment; B: H1299 cells proliferation after Apc treatment with and without 
Apc; the reduction of CICC cells with Apc after Chaetocin washout in H1299 (C) and in hFbs (D). 
Representative results from three independent experiments are shown. Bars represent the mean ± s.d. 	  
Second, to exclude that preferential death of cells with the CICC phenotype may 
reduce the percentage of CICC cells live cell imaging was used. For this purpose, cells were 
treated with Chaetocin for 24 h and then washed out from the cell culture. Afterwards cells 
were stained with Hoechst 33342 and were monitored in real time up to 16 h after washout 
(Figure	   3.36). About 33.5% ± 9.9% of the cells with CICC phenotype were reversible. For 
more detailed quantification (Figure	  3.37), Chaetocin-treated “normal” cells without CICC as 
well as cells with CICC phenotype either reversible or non-reversible were divided into three 
groups (A, B, C): A1: “normal” cells, which survived; A2: “normal” cells, which underwent 
apoptotic or necrotic cell death; B1: CICC reversible cells, which survived within the 
observation period; B2: reversible cells, which underwent apoptotic or necrotic cell death; C1: 
irreversible cells, which survived; C2: irreversible cells which underwent apoptotic or 
necrotic cell death within the observation period. The results showed that 68.5 ± 22.5% of 
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“normal” cells survived (A1), while 31.5 ± 22.5% died (A2). In comparison, 82% ± 6% of 
CICC cells survived (B1), while 18% ± 6% were dead (B2). In contrast, 48% ± 11.6% of 
irreversible CICC irreversible cells survived (C1), while nearly the same fraction of 
irreversible cells died (C2). The Chaetocin-untreated cells during observation time did not 
have an apoptotic features. 
	  
Figure 3.36: The reversibility of CICC phenotype after Chaetocin washout. The sequence of pictures shows 
the reversibility of CICC structure (light blue, Hoechst 33342) in H1299. Cells were observed in real time from 
9 h until 20 h after Chaetocin washout. Images are taken by confocal microscopy. Scale bar = 10 µm. 
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Figure 3.37: The reversibility of CICC in H1299 cell line. The cells were treated with Chaetocin (30 nM) for 
24 h, thereafter the drug was washed out and the cells were observed for further 20 h. For quantification, cells 
were classified into 3 groups. A: “Normal” cell: Chaetocin-treated cells without chromatin condensation, which 
survived and dead cells; B: Cells with CICC structures, which were reversible; C: The observation of cells with 
CICC structures, which were irreversible. Data from four independent experiments with n(CICC) = 155, 
n(Control) = 194. The live cells imaging was performed by confocal microscopy. Representative results from 
four independent experiments are shown. Bars represent the mean ± s.d.  	  
Overall, the observation shows that most of the cells with chromatin 
hypercondensation after Chaetocin treatment are of reversible phenotype. CICC phenotype 
increased with concentration and time of Chaetocin exposure reaching its maximum level at 
about 24 h after treatment.  
3.4.3 Cell cycle dependence of CICC phenotype  
Chromatin condensation is a common phenotype of cells during mitosis, when cells go 
to from G2 to prophase (Alberts et al., 2008). In order to evaluate whether Chaetocin induced 
chromatin condensation is related to mitotic condensation and to identify the cell cycle phase 
the CICC phenotype is associated with, cells were treated with Chaetocin and stained with 
markers for the different cell cycle phases. The cell cycle phases were analyzed by 
immunodetection of cyclin E, which detects cells in G1 phase. For S-phase cells, cyclin A, 
PCNA and EdU were used. In addition, Cyclin B1 and H3pS10, were used for G2/M phases.  
The results show that CICC cells are not associated with (pre)mitotic phases (Figure	  3.38) and mostly are associated with G1 cells. To confirm that CICC phenotype is associated 
with G1 cells, late passage (35-39) primary hFbs with low proliferative activity, i.e. with high 
G0/G1-fraction, were treated with Chaetocin. The results clearly show that primary hFbs in 
late passages can clearly adopt CICC phenotype. 
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Figure 3.38: Cell cycle dependence of CICC phenotype. H1299 cells were treatment with Chaetocin for 24 h 
and stained for the various markers for cell cycle phases. A: Cyclin E (G1-phase, green), DAPI (DNA, blue); B: 
Cyclin A (S-phase, red), DAPI (DNA, blue); C: Cyclin B1 (G2-phase, green), DAPI (DNA, blue); D: PCNA (S-
phase, red), DAPI (DNA, blue); E: H3pS10 (Mitosis, green) DAPI (DNA, blue); F: EdU (S-phase, green). 
Images are taken by fluorescent microscopy. 	  
Overall, because CICC was not associated with cyclin A, EdU and H3S10ph, it is 
concluded that the CICC phenotype is mostly associated with G1-phase cells. 
3.4.4 Association of CICC phenotype with heterochromatin 
markers 
Chromatin condensation strongly correlates with domains of heterochromatin and is 
associated with specific histone markers, e.g. H3K9me3 and H3K27me3. In order to confirm 
that the CICC phenotype is enriched in heterochromatin markers cells were treated with 
Chaetocin, stained and analysed by immunodetection of heterochromatin associated markers 
H3K9me3, HP1α and H3K27me3. In addition, the euchromatin associated histone markers 
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H3H4me3 and H3K9ac were also used. As shown in Figure	   3.40, CICC phenotype was 
positive for each of the heterochromatin markers, confirming that the condensed chromatin 
structures found after Chaetocin treatment are enriched in heterochromatic regions. Staining 
for euchromatin markers shows that euchromatin is less associated with CICC structures but 
instead the whole nucleus is evenly stained for the euchromatin marks indicating no 
preferential association of these markers with CICC structures (Figure	  3.39). 
 
Figure 3.39: Association of euchromatin markers with CICC phenotype. H1299 cells were treated with 
Chaetocin for 24 h and stained for the euchromatin marker H3K4me3 (red) and H3K9ac (green). DAPI (blue) 
was used to stain the overall DNA. The respective overlaps are shown.  	  
Overall, the present data show that the Chaetocin-induced chromatin clusters are 
enriched for heterochromatin.	  
!
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Figure 3.40: Association of heterochromatin markers and CICC. The H1299 cells were treated with 
Chaetocin for 24 h. A: H3K9me3 (DAPI, H3K9me3, overlap) stained CICC nucleus; B: H3K27me3 (DAPI, 
H3K27m3, overlap) stained CICC cell; C: HP1α (red rabbit, green mouse) (overlap and DAPI vs HP1α) and 
stained CICC nucleus. Images are taken by confocal microscopy. Scale bar = 10 µm. 
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3.4.5 Influence of CICC formation on IR induced 53BP1 
signalling 
The p53-binding protein 1 (53BP1) is an important regulator of DSB signalling and 
specifically localizes to damaged chromatin and protects genomic stability by signalling DSB 
repair (Panier and Boulton, 2014). As shown in paragraph 3.3.3, Chaetocin significantly 
reduced radiation-induced 53BP1 foci formation. In order to quantify this effect, radiation-
induced 53BP1 and γH2AX foci were analysed separately in Chaetocin-treated cells with 
"normal" and CICC phenotype, respectively (Figure	   3.41B, C). The data show that the 
reduction of 53BP1 foci in Chaetocin-treated cells mostly occurs in CICC cells, which 
completely lost their ability to form 53BP1 foci. In contrast, 53BP1 foci were not affected in 
Chaetocin-treated cells that had the "normal" phenotype. In comparison, radiation-induced 
γH2AX foci formation is not affected in CICC cells as well as in "normal" cells.  
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Figure 3.41: Effect of Chaetocin on 53BP1 and γH2AX foci formation in H1299 and hFbs. A: Selective 
inhibition of 53BP1 foci formation in H1299 cells with the CICC phenotype after Chaetocin pre-treatment (30 
nM) for 24 h and fixed at 1 h after IR at 0.5 Gy (DAPI, blue; 53BP1 foci, red; γH2AX foci, green). B: Kinetics 
of γH2AX foci repair in H1299 (left) and in hFb (right) after IR at 0.5 Gy and Chaetocin treatment. “Normal” – 
cells without chromatin changings after Chaetocin treatment and CICC – Chaetocin induced chromatin 
clustering. C: Kinetics of 53BP1 foci repair in H1299 (left) and in hFb (right) after IR of 0.5 Gy and Chaetocin 
treatment. Representative results of at least two independent experiments are shown. Bars represent the mean ± 
s.d. Scale bar = 20 µm. 
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   The	   present	   results show that the formation of 53BP1 foci in CICC cells is 
significantly abrogated. In order to investigate if this effect mainly relies on the formation of 
foci or if protein expression is also affected, H1299 cells were treated with Chaetocin for 24 
h, irradiated with 0 Gy and 30 Gy proteins were isolated at 1 h after IR. The results from 
Western blotting analysis show that Chaetocin reduces not only foci formation, but also 
reduced 53BP1 on the protein level. For comparison, Chaetocin has no effect on the 
expression of other DNA repair proteins, such as Rad51 and γH2AX (Figure	  3.42).  
	  
Figure 3.42: Effect of Chaetocin on DNA repair proteins expression after IR in H1299. A: The reduction of 
53BP1 protein expression after Chaetocin and IR treatments by WB; B: a representative blot with identical 
results are shown; C: Increasing of γH2AX phosphorylation after IR; D: Increasing of Rad51 protein expression 
only with combination IR and Chaetocin treatment. Representative results from three independent experiments 
are shown. Bars represent the mean ± s.d. 	  
Overall, the present results demonstrate that formation of the 53BP1 foci is strictly 
dependent on the chromatin phenotype of the cells, and is mostly diminished in CICC cells. 
The same effect was also found after UNC0638 treatment, which shows the same phenotype 
of CICC cells in H1299 as Chaetocin did (Figure	   3.43). The effect seems to be specific to 
53BP1 protein expression and foci formation because other repair signalling proteins, such as 
γH2AX and Rad51 were not affected. 
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Figure 3.43: Effect of UNC0638 on 53BP1 foci formation in H1299 cells. Selective inhibition of initial 53BP1 
foci formation after IR at 0.5 Gy and UNC0638 treatment. Representative results of one experiment are shown.  	  
3.4.6 Effect of Chaetocin on pATM foci formation in CICC cells 
after IR 
ATM is initially phosphorylated and recruited to DSBs and it retains and appears at 
DSBs as visible pATM foci, which however require the 53BP1 protein for foci formation 
(Noon and Goodarzi, 2011). Based on the results in paragraphs 3.3.3 and 3.4.5, which show 
that the formation of radiation-induced 53BP1 foci in CICC cells is abrogated, it was thus of 
interest to investigate if Chaetocin also has an influence on pATM foci formation in CICC 
cells. For this purpose, H1299 cells were treated with Chaetocin (30 nM) for 24 h, irradiated 
with 0.5 Gy and fixed at 1 h, 4 h and 24 h thereafter. The pATM foci were scored separately 
in “normal” and in CICC cells. The results show that Chaetocin reduces radiation-induced 
pATM foci in both phenotypes, CICC and "normal" cells, the effect however is more 
pronounced in CICC cells (Figure	   3.44C). After showing the reduction in pATM foci 
formation we were also interested on Chaetocin effects on the expression of phosphorylated 
ATM (pATM) and KAP1 (pKAP1). The pKAP1 protein is of interest because ATM 
phosphorylates KAP1 at serine 824 during DSB repair and the reduction of pKAP1 leads to 
global chromatin relaxation, which is essential especially for DSB repair within 
heterochromatic regions (Ziv et al., 2006). To investigate the protein expression of pATM 
and pKAP1, the cells were treated with and without Chaetocin (60 nM and 300 nM) for 24 h, 
irradiated with 10 Gy and then cells were harvested in 1 h after IR. The results show that 
Chaetocin have no effect on pATM and pKAP1 protein expression (Figure	  3.44B). 
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In summary, the results show that Chaetocin reduces radiation-induced pATM foci 
formation in H1299 cells, which however does not rely on reduced expression pATM and 
KAP1 at the protein level.  
	  
Figure 3.44: Effect   Chaetocin on pATM and pKAP1 in H1299 cells. A: The immunofluorescence images of 
pATM foci (red) after with or without Chaetocin treatment (30 nM) in combination with radiation (0.5 Gy) in 1 
h after IR; B: a representative blot showed the protein level of pATM and pKAP1 with and without Chaetocin 
treatment (0, 60, 300 nM) after IR (10 Gy) in 1 h; C: The quantification of the DNA repair kinetics after 
Chaetocin and IR treatment by visible pATM foci. “Normal” is the cell, which does not have visible 
morphological changes in nucleus after Chaetocin treatment. Cells were pre-treated with Chaetocin (30 nM) for 
24 h, irradiated with 0.5 Gy and fixed at 1 h, 4 h, 24 h thereafter. Representative results from three independent 
experiments are shown. Bars represent the mean ± s.d. Statistical analysis: 2-way ANOVA analysis with 
Bonferroni posttest, p < 0.01 (**), p < 0.001 (***). Scale bar = 10 µm. 
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3.4.7 The distribution of radiation-induced DSBs in CICC  
Our previously data showed that CICC structures were associated with 
heterochtomatin marks. Thus, we wished to investigate how radiation induced γH2AX foci 
were distributed in these chromatic regions. For this purpose, H1299 cells were treated with 
Chaetocin (60 nM) for 24 h to form the CICC structures, irradiated at 0.5, 1 Gy and then fixed 
in 15 min, 30 min, 1 h and 24 h post irradiation time. Our results demonstrated that after IR at 
15 min the number of γH2AX foci in DAPI dense CICC region was slightly higher as 
compared to less intense DAPI regions (Figure	  3.45). The proportion of γH2AX foci in DAPI 
dense CCC regions (“FOCI in”) and γH2AX foci in less DAPI dense regions (“FOCI out”) 
changed slightly during post irradiation time. However, the difference did not reach statistical 
significance in experiments. 
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Figure 3.45: Distribution of γH2AX foci in chromatic regions after Chaetocin and IR treatment. The cells 
(H1299) were treated with Chaetocin (60 nM) for 24 h, then irradiated at 0.5, 1 Gy, fixed in 0.25, 0.5, 1 h, 24 h 
and were stained with γH2AX and DAPI. A: (left) the representative immunofluorescence picture of 
colocalization γH2AX foci (green) and DAPI (blue) and (right) the picture of colocalization (pink) γH2AX foci 
(green) and DAPI (blue) after Axiovision analysis. B: The quantification of γH2AX foci and CICC domains 
after IR. “FOCI in” is defined as γH2AX foci are localized with DAPI, “FOCI out” – γH2AX foci located in 
DAPI free region. Representative results from at least three independent experiments are shown. Bars represent 
the mean ± s.d. 
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3.4.8 Influence of ROS on cellular effects of Chaetocin 
3.4.8.1 Effect of reactive oxygen species (ROS) on cell cycle, proliferation and 
cell death 
Chaetocin is a member of ETP class, which can induce oxidative stress by activating 
reactive oxygen species (ROS) and thus can lead to cell death (Isham et al., 2007). In order to 
show if Chaetocin induces chromatin condensation also rely on ROS production we used 
various antioxidants. The superoxide dismutase Tiron, a cell-permeable superoxide scavenger 
(100 µM) or the antioxidant apocynin (100 µM) did not inhibit CICC induction. In contrast, 
N-acetyl-cysteine (NAC) an antioxidant, which is quite popular for its ability to reduce 
oxidative stress, fully inhibited the induction of CICC phenotype at concentration of 1 mM. 
However, we did not detect CCC formation after H2O2 (0.1%) treatment. 
In order to explore the effect of NAC on downstream negative effects of Chaetocin, 
proliferation and activation of radiation-induced apoptosis were studied. To understand how 
NAC affects the cell cycle progression, cell death and cell proliferation and to determine the 
effective concentration to do this, cells were treated with increasing concentration of NAC 
(0.5, 1, 2, 5, 10 mM) for 2 h, treated with Chaetocin at 150 nM for 2 h, irradiated at 10 Gy 
and then incubated for 24 h. NAC treatment shows no effect on cell cycle progression with or 
without irradiation with 10 Gy (Figure 3.46). However, NAC reversed the cell cycle effects of 
Chaetocin in a concentration-dependent manner, reaching its optimum effect level at about 2 
mM.  
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Figure 3.46: Effect of NAC on the cell cycle progression after Chaetocin treatment and IR in H1299 cell 
line. The cells were treated with increasing concentrations NAC (0.5, 1, 2, 5, 10 mM), after 2 h Chaetocin (150 
nM) was added, in 2 h the half of the cells was irradiated at 10 Gy and incubated for 24 h. Representative results 
from three independent experiments are shown. Bars represent the mean ± s.d. 	  
Additionally, we found that NAC normalized cell proliferation after Chaetocin 
treatment (150 nM) in a concentration-dependent manner (Figure	   3.47A). Indeed, the NAC 
strongly reduced the percentage of dead cells after Chaetocin alone and in combination with 
IR (Figure	  3.47B). NAC had no effect on cell death and the cell proliferation after IR only. 
	  
Figure 3.47: Effect of NAC on cell proliferation and cell death after Chaetocin treatment and IR in H1299. 
Cells were treated with increasing concentrations of NAC (0.5, 1, 2, 5, 10 mM) for 2 h, then Chaetocin “Ch” 
(150 nM) was added to the cell culture medium and 2 h later cells were irradiated with 0 Gy and 10 Gy and 
further incubated for 48 h. A: Cell proliferation after Chaetocin treatment; B: Cell death. Results from three 
independent experiments are shown. Bars represent mean ± SEM. 	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In addition, the order of treatment with Chaetocin and NAC on cell cycle progression 
was tested by adopting two different treatment schedules. In schedule A, cells were pre-
treated for 2 h with Chaetocin (75 nM and 150 nM), then NAC (5 mM) was added to the cell 
culture, and after further 2 h cells were irradiated with 10 Gy and incubated for further 48 h. 
In schedule B, cells were pre-treated for 2 h with NAC (5 mM), then Chaetocin was added 
into cell culture (75 nM and 150 nM) and after further 2 h the cells were irradiated with 10 Gy 
and incubated for 48 h. Proliferation, cell cycle and apoptosis were determined. 
The results show that in both treatment options Chaetocin resulted in cell cycle arrest 
in the G2 phase which increases with the concentration of Chaetocin used from 10.6 ± 3.3% 
to 31.8 ± 13.7% (Figure 3.48A) and from 10.5 ± 4.3% to 21.3 ± 13.1% (Figure 3.48B). In parallel 
to G2-phase arrest, the percentage of cells in G1 phase decreased from 59.1 ± 11.4% to 40.6 ± 
14.2% for schedule A and from 58.4 ± 9.8% to 49.4 ± 14.3% for schedule B after treatment 
with 150 nM of Chaetocin. The same results were observed in combination with IR (10 Gy) 
in both treatments. In addition, an increase in the percentage of background (BG) cells, which 
represents fragmented dead cells, i.e. apoptotic and necrotic ones. Interestingly, that NAC 
normalized the cell cycle progression of Chaetocin induced deregulations in cell cycle 
distribution. The effect of NAC was even stronger if the cells were pre-treated with NAC 
before Chaetocin was added to the cell culture (treatment B). 
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Figure 3.48: Effect of NAC on Chaetocin induced cell cycle deregulations. Treatment schedule A: Cells were 
treated with Chaetocin “Ch” (75 nM, 150 nM), after 2 h NAC (5 mM) was added, then 2 h later irradiated with 
10 Gy and incubated for 48 h. Treatment schedule B: Cells were treated with NAC (5 mM) for 2 h, after 2 h 
Chaetocin (75 nM, 150 nM) was added, then in 2 h later irradiated with 10 Gy. Results from three independent 
experiments are shown. Bars represent mean ± s.d. 	  
By using the different treatment schedules, the combined effect of NAC, Chaetocin 
and IR was tested also on the proliferation capacity of treated cells. The data show that IR and 
Chaetocin induce apoptotic cell death and reduce cell proliferation of H1299 (Figure 3.49) and 
H460 cells (Figure 3.50) in a concentration-dependent manner. Interestingly, that pre-treatment 
of the cells with NAC (5 mM) before IR and Chaetocin treatment significantly reduced 
apoptotic cell death and normalized the proliferation of cells. These results demonstrate that 
the ROS inhibitor NAC have a protection effect with respect to cell cycle deregulation, 
proliferation and apoptotic cell death induced by Chaetocin and IR. 
 
A H1299
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
0
20
40
60
80 G1
S
G2
BG
concentration of drugs
%
 o
f c
el
l
B H1299
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
0
20
40
60
80 G1S
G2
BG
concentration of drugs
%
 o
f c
el
l
A H1299 10 Gy
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
0
20
40
60
80
G1
S
G2
BG
concentration of drugs
%
 o
f c
el
l
B H1299 10 Gy
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
D
M
SO
C
h 
75
 n
M
C
h 
15
0 
nM
D
M
SO
+N
A
C
C
h 
75
 n
M
+N
A
C
C
h 
15
0 
nM
+N
A
C
0
20
40
60
80
G1
S
G2
BG
concentration of drugs
%
 o
f c
el
ls
3. Results 	  
	   87	  
	  
Figure 3.49: Effect of NAC on proliferation and apoptosis after combined treatment with Chaetocin and 
IR in H1299. Schedule A: (A, B) H1299 cells were treated with Chaetocin (75 nM, 150 nM) for 2 h, after 2 h 
NAC (5 mM) was added, then in 2 h the half of cells were irradiated at 10 Gy and incubated for 48 h. Method B: 
(C, D) H1299 cells were pre-treated with NAC (5 mM), after 2 h Chaetocin (75 nM, 150 nM) was added, then 2 
h late cells were irradiated with 10 Gy. Effect on cell proliferation (A, C) and apoptosis (B, D) were measured. 
Results from three independent experiments are shown. Bars represent the mean ± SEM. 	  
	  
Figure 3.50: Effect of NAC on proliferation and apoptosis after combined treatment with Chaetocin and 
IR in H460. Schedule A: (A, B) H460 cells were treated with Chaetocin (75 nM, 150 nM) for 2 h, after 2 h NAC 
(5 mM) was added, then in 2 h the half of cells were irradiated at 10 Gy and incubated for 48 h. Method B: (C, 
D) H1299 cells were pre-treated with NAC (5 mM), after 2 h Chaetocin (75 nM, 150 nM) was added, then 2 h 
late cells were irradiated with 10 Gy. Effect on cell proliferation (A, C) and apoptosis (B, D) were measured. 
Results from three independent experiments are shown. Bars represent the mean ± SEM. 
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In summary, our data show that NAC, an antioxidant, fully inhibits CICC formation, 
reduces the number of dead cells and normalizes cell cycle progression after Chaetocin 
treatment alone and in combination with IR. 
3.4.8.2 Effect of NAC on DNA DSBs repair after Chaetocin and IR treatments 
To examine the effect of NAC on DNA repair after Chaetocin and IR treatment, 
H1299 cells were treated with NAC (0, 1, 2, 5 mM) and 2 h later the half of cells were treated 
with Chaetocin (60 nM) for 24 h, irradiated with 0.5 Gy, 4 Gy and 10 Gy and then fixed at 1 
h, 4 h and 24 h thereafter. The cells were stained with γH2AX and 53BP1 antibodies and foci 
formation was determined. As shown in previous section of this study, Chaetocin increased 
the numbers of initial and residual number of foci after IR. Interestingly, that NAC 
significantly decreases the number of initial as well as of the residual number of foci alone 
and in combination with Chaetocin after IR (Figure	  3.51).  
	  
Figure 3.51: Effect of NAC on NHEJ in H1299 cell line. The cells were treated with NAC (0, 1, 2, 5mM) for 
2h (A, B), then in figures C and D with Chaetocin (60 nM) for 24 nM. All cells were irradiated at 0, 0.5, 4, 10 
Gy and fixed in 1 h, 4 h 24 h after IR. Number of γH2AX (A, C) and 53BP1 foci (B, D) was scored manually. 
Representative results from three independent experiments are shown. Bars represent the mean ± s.d. Statistical 
analysis: 2-way ANOVA analysis with Borferroni posttest, p < 0.05 (*), p < 0.01 (**), p < 0.001 (***). 	  
From these results, we concluded that NAC is able to significantly reduce the number 
of initial and residual radiation γH2AX and 53BP1 foci in both Chaetocin treated and non-
treated DSBs. 
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4. Discussion 
The dynamic nature of chromatin and its modifications play a critical role in 
transcriptional gene regulation and thus can affect several cellular functions such as 
differentiation, replication, DNA damage response, activation of cell death (Deb et al., 2014; 
Dinant et al., 2008; Falk et al., 2014; Kouzarides, 2007; Misteli and Soutoglou, 2009; 
Mungamuri et al., 2012). The chromatin is divided into two distinct domains, 
heterochromatin and euchromatin, which are associated with silent and active gene regions, 
respectively. Gene expression is mostly regulated by epigenetic mechanisms, e.g. 
methylation, acetylation and phosphorylation of histones, as well as methylation of the DNA 
itself. Histone methylation regulates not only gene expression, but has also an impact on 
genomic instability (Putiri and Robertson, 2011).  
In this respect, Pandey et al. (2014) considered the important role of the histone lysine 
methyltransfrase SUV39H1 as one of the key early events in urethane induced mouse lung 
tumour initiation and progression. The level of HMT SUV39H1 expression was shown to be 
enriched in heterochromatic regions regulating the higher-order chromatin structure (Rea et 
al., 2000). The level of SUV39H1 expression correlates with di- or tri- methylation at lysine 9 
of histone H3, which is a hallmark of silent chromatin (Noma et al., 2001). Both HMTs, G9a 
and SUV39H1, are implicated in different types of cancers, including lung cancer (Yost, 
2011). Alterations in cellular epigenetic and genetic structure, for example after IR, can lead 
to long term effects such as survival and genomic instability. However, the molecular 
mechanisms of modified chromatin structure on the DNA damage response are still unclear. 
In order to evaluate the effect of epigenetic modification, especially of histone methylation, 
we modulated the activity of the histone methyltransferase SUV39H1. Short and long term 
effects of SUV39H1 modulation on radiation induced DNA damage response were studied in 
two NSCLC cell lines (H460, H1299) and mice fibroblast cell lines (mFbs). To do this, we 
apply different experimental strategies: (i) genetics model of knockout of Suv39h1 in mFbs, 
(ii) knockdown of Suv39h1 in human NSCLC cell lines, and (iii) specific small molecule 
inhibitors of SUV39H1. 
4.1 Genetic modulation of Suv39h1 
HMT SUV39H1 has been reported as a first SET domain-containing histone lysine 
methyltransferase (HKMT), which generates di- and trimethylation of H3K9 (Rea et al., 
2000). Furthermore, the HKMT G9 also generates dimethylation of H3K9 (Tachibana et al., 
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2001). In the present study, reduced expression of H3K9me2 and H3K9me3 as well as 
increased expression of H3K9me1 was evident in shSuv39h1 transfected H1299 cells.  
Previous studies showed that Suv39h genes regulate viability as well as pre-and 
postnatal development of mice (Peters et al., 2001). It is involved in cell migration in breast 
and colorectal cancer cells (Yokoyama et al., 2013) with reduced cell proliferation after 
downregulation of SUV39H1 (Wang et al., 2013). An increase in the number of hepacellular 
carcinoma cells in G0/G1 phase after Suv39h1 knockdown can explain this reduced 
proliferation (Chiba et al., 2014). Moreover, the human embryonic kidney cells (293T) 
lacking Suv39h1 show increased radiation sensitivity (Ayrapetov et al., 2014). In addition, 
deficiency of HMT G9a (G9a-/-) in mice leads to embryonic lethality, with a significant 
increase in apoptosis (Tachibana et al., 2002). 
In the present work, we focused on the role of HMT SUV39H1 in radiation resistance 
of NSCLC and mice fibroblasts. On the hypothesis that the radiation sensitivity can be 
modulated by an altered methylation status of histones, we wanted to investigate the role of 
HMT SUV39H1 in cellular response to DNA damage induced by IR. The results confirm the 
findings from a previous study (Jeong et al., 2009), which showed that the human H1299 cell 
line is significantly more resistant to ionizing radiation compared to H460. In this respect, it 
has been shown that the number of hypermethylated genes in radioresistant H1299 cells was 
by a factor of two higher compared to that of the radiosensitive H460 cells (Kim et al., 2010; 
Shames et al., 2006).  
Indeed, deregulation of epigenetic control through histone methylations as well as 
DNA and histone modification is an important issue for the radiation resistance of cancer 
cells (Kim et al., 2002). We also found that Suv39h1 influences radiation sensitivity of mFbs, 
because knockout Suv39h1 significantly decreased clonogenic survival. However, no 
significant effect of Suv39h1 knockdown on the radiation sensitivity was observed in human 
NSCLC cell lines, although a trend to more radiation sensitivity at higher doses was evident 
in H1299 cells. The most likely explanation for the different effect of HMT SUV39H1 on 
radiation sensitivity in knockout and knockdown cells may be that the level of 
downregulation by about 50% is not sufficient to reduce the radiosensitization in H460 and 
H1299 cells. 
In order to explore the molecular mechanism of increased radiation sensitivity after 
downregulation of Suv39h1, activation of DNA response mechanisms were focused on. 
Studies suggest that epigenetic abnormalities indeed can influence the DNA damage response 
of the cells (Putiri and Robertson, 2011). A number of histone modifications are known to be 
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involved in DNA damage response (Friedl et al., 2012; Karagiannis et al., 2007; Kinner et al., 
2008; Maroschik et al., 2014; Masumoto et al., 2005). However, the role of these 
modifications in DNA repair is not fully understood.  
DSB repair initiates dynamic changes in histone modifications, including the 
phosphorylation of H2AX on serine 139 and thus the formation of γH2AX foci, which is a 
hallmark of NHEJ. In mammalian cells nonhomologous end joining (NHEJ) repair is the 
predominant DNA repair pathway, which is active in all phases of the cell cycle (Rothkamm 
et al., 2003). In addition, dynamic changes in H3K9 modification in euchromatin is one of the 
earliest events within 5 min required for processing and remodelling of the damaged 
chromatin template. It was shown that HMT SUV39H1 rapidly recruits to DSBs, where it 
directs H3K9 methylation on large chromatin domains adjacent to the DSB (Ayrapetov et al., 
2014). Zheng et al. (2014) reported about the importance of SUV39H1 in DNA repair, with 
sustained expression of SUV39H1 being shown to delay the repair of heterochromatic DNA 
after IR. The induction of γH2AX in heterochromatin was also shown to be significantly 
lower compared to euchromatin (Cowell et al., 2007; Karagiannis et al., 2007; Sak et al., 
2015). In addition, depletion of SUV39H1 was shown to reduce H3K9me3 level and restored 
DNA repair capacity (Liu et al., 2013). Furthermore, SUV39H1 is involved in 
heterochromatin relaxation and genome instability in response to DNA damage in cancer cells 
(Wang et al., 2013). Our results from immunofluorescence analysis show that loss of HMT 
SUV39H1 regulates DNA damage repair mostly by NHEJ repair mechanism. The number of 
initial 53BP1 foci was significantly reduced in mFbs with knockout Suv39h1 as well as in 
knockdown H1299 compared with the respective wild type cells. In addition, the number of 
residual foci was significantly decreased in SUV39H1-reduced H1299 cells. However, the 
number of residual foci was significantly increased and DNA repair was slower in mFbs with 
knockout of Suv39h1 compared to the wt cells.  
Unrepaired DNA damage after IR can lead to cell death, which was the case in D5 
mFb with reduction of clonogenic survival after IR. Interestingly, we observed that 
clonogenic survival after IR is slightly lower in SUV39H1 knockdown H1299 cells. These 
findings correlate with results from pulsed–field gel electrophoresis (PFGE). The data from 
PFGE show that Suv39h1-knockout increases DNA DSBs in D5 mFbs compared with wild 
type (W8) cells. In addition, difference in DNA repair kinetics was also observed with slower 
DNA repair in D5 compared with W8. Furthermore, residual damage was also higher in D5 
compared to W8. Overall, these results are supported by the findings of Goodarzi et al. 
(2008), who found that DNA repair was mildly slower in the Suv39H1/2-/- MEFs compared 
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with wt cells. Downregulation of HMT SUV39H1 in response to IR results in loss of 
heterochromatin, which may result in altered gene expression or genomic instability in 
primary hFbs (Sidler et al., 2014).  
Homologous recombination (HR) was also discussed to depend on chromatin 
structure. In addition, the findings of Ayrapetov et al. (2014) suggest that although NHEJ 
activity was not significantly altered by loss of Suv39h1 in U2OS cells, the HR-mediated 
repair was significantly reduced. This led us to investigate the function of HR pathway repair 
in Suv39h1 deficient cells or after treatment with chemical inhibitors. Our results showed that 
the number of initial Rad51 foci was significantly reduced in SUV39H1 downregulated 
H1299 cells compared with wt cells and also slightly reduced in knockout D5 mFbs.  
Taking together, our results confirm that SUV39H1 plays an important role in cell 
survival after IR through modulation of DNA damage response and the in mFbs, but with a 
mirror effect on survival of NSCLC tumour cell lines. 
4.2 Chromatin modulation by small molecule inhibitors 
We were also interested in the modification of chromatin structure modulated by 
different small molecule inhibitors and how this affects NHEJ and HR repair mechanisms and 
other cellular responses. It is known that the HMTs SUV39H1 and G9a are methylation 
writers on lysine and are altered in many types of human cancers, including lung cancer 
(Pandey et al., 2014). We used Chaetocin as a SUV39H1 and G9a inhibitor and Triptolide as 
a SUV39H1 inhibitor (Zhao et al., 2010) to modify chromatin structure and to investigate the 
effect of HMTs on DNA repair pathways in NSCLC H460 and H1299 cells. We obtained a 
significant effect on cell proliferation with an IC50 of 29 nM and 37 nM for Chaetocin and of 
2.9 nM and 1.5 nM for Triptolide in H1299 and H460, respectively. However, at these low 
concentrations, Chaetocin (<300 nM) and Triptolide (<30 nM) do not induce any changes in 
methylation status of H3K9me3, H3K9me2 or H3K9me1.  
In addition, the effect of small molecules on DNA repair mechanisms was evaluated in 
NSCLC cells. Here we could show that Triptolide influences NHEJ and HR repair pathways 
in H1299 with significantly higher 53BP1 foci, as a measure for NHEJ and significantly 
decreases the number of initial Rad51 foci, as a measure for HR. In comparison, Chueh et al. 
(2013) showed that Thiptolide induced higher levels of DNA damage in human malignant 
melanoma cells which is thought to be mediated by reduction of DNA repair genes (BRCA1, 
DNA-PKcs, ATM, ATR and MGMT). From these data it is concluded, that most of the DSBs 
induced in H1299 were rejoined by slow kinetics. 
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Chaetocin, which inhibits both HMTs SUV39H1 and G9a, increased the number of 
initial radiation induced 53BP1 foci at low doses (<60 nM) after short drug pre-treatment in 
H1299. Chaetocin impaired DNA DSB repair resulting in increased number of residual 
53BP1 foci in both H460 and H1299 cell lines. Additionally, the effect of Chaetocin on DNA 
DSB repair in H1299 after a long Chaetocin pre-treatment (24 h) and combined with IR was 
similar to short drug pre-treatment (4 h), as measured by γH2AX foci. Longer pre-treatment 
with Chaetocin also resulted in significantly higher number of initial and residual Rad51 foci 
in H1299. Most plausible explanation for this effect could be rapid Chaetocin uptake in cells. 
It has been reported by Isham et al. (2007) that Chaetocin is rapidly accumulated in cancer 
cells, i.e. intracellular concentration of Chaetocin reached 10-fold higher level within 1 to 2 
min and up to 1000-fold after 24 h. Overall, the present data show that Chaetocin modifies 
DNA repair with slower kinetics and increased residual damage. Also, it can affect chromatin 
structure and thereby impair DNA damage signalling of tumour cell lines.  
4.3 The cellular effects of Chaetocin 
Since Hauser et al. (1970) elucidated the unique chemical structure of Chaetocin, 
therapeutic cancer research focused on the biological functions of Chaetocin as a potential 
therapeutic agent. It is a natural product produced by Chaetomium fungal species, which 
belongs to the epipolythiodioxopiperazine (ETP) class of fungal toxin (Gardiner et al., 2005) 
and is characterized by the presence of an internal disulphide bridge. Cherblanc et al. (2013a) 
reported that Chaetocin is a non-specific inhibitor of histone lysine methyltransferases. 
However, several recent studies considered that Chaetocin specifically inhibits the HMTs G9a 
and SUV39H1 (Cherblan et al., 2013; Greiner et al., 2005; Maleszewska et al., 2014). If 
Chaetocin specifically inhibit the HMT SUV39H1, then knockdown Suv39h1 and Chaetocin 
treatment should have similar effects. Here we show that knockdown of Suv39h1 can reduce 
H3K9me3 methylation, but Chaetocin treatment at low concentrations used in the present 
study (<300 nM) did not result in significant changes of H3K9me3. However, Chaetocin 
inhibits cell proliferation in H1299 and H460 with IC50 values of 29 nM and 37 nM, 
respectively. On the other hand, Chaetocin induces CICC changes, which was not detected 
after SUV39H1 knockdown. Therefore, it seems that Chaetocin exerts other effects compared 
to that of suppressing SUV39H1 expression. It was shown that Chaetocin has an antimyeloma 
effect via induction of oxidative stress (Isham et al., 2007) and decreases cell migration in 
breast cancer possibly by inhibition of trimethylation of lysine 9 (H3K9me3) (Yokoyama et 
al., 2013). Chaetocin also inhibits HMTs through protein – ETP adduct formation, that 
4. Discussion 	  
	   94	  
involves chromatin remodelling (Illner et al., 2010) and selective gene expression. Chiba et 
al. (2014) clearly demonstrated that Chaetocin treatment (>50 nM) reduced SUV39H1 and 
H3K9me3 levels in hepatocellular carcinoma cells. The same effect was observed after 
treatment with a high (>500 nM) concentration of Chaetocin in human leukaemia cell lines 
(Chaib et al., 2012).  
With respect to cell inactivation, the present data show that low concentrations of 
Chaetocin (<40 nM) do not induce apoptotic cell death within 72 h after drug treatment in the 
NSCLC cell lines used in this study. However, it seems that the toxicity of Chaetocin depends 
on cell type. Isham et al. (2007) reported that Chaetocin at concentration of 200 nM induces a 
higher level of apoptosis (90%) in 24 h in myeloma cells (OCI-MY5). Teng et al. (2010) 
reported that Chaetocin at higher concentrations of 0.3 µM and 30 µM induces apoptosis in 
human leukaemia HL-60 cells through the caspase-8/caspase-3 activation pathway. Another 
study has shown that Chaetocin treatment (100 nM) of U937 human leukaemia cells induced 
more than 60% apoptotic cells after 24 h (Tran et al., 2013).  
Activation of cell cycle checkpoints can be the mechanism for reduced proliferation 
after Chaetocin treatment. Our findings demonstrate that Chaetocin increases the fraction of 
the cells in G2 phase and decreases the fraction of cells in G1 in H460 and H1299 cell lines. 
Chaetocin at high concentration of about 500 nM was shown to induce cell cycle arrest in S 
phase after 24 h (Chaib et al., 2012).  
Recently it was reported (Sepsa et al., 2015) that Chaetocin treatment reduces the 
ability of T98G glioblastoma cells to form colonies. However, our results demonstrate no 
significant radiosensitizing effect of Chaetocin at these low concentrations as measured by 
clonogenic assay. However, in long term mini-monolayer growth assay, which enable to 
follow the proliferation of the cells for several weeks, Chaetocin at low concentration of 10 
nM was shown to reduce the radiation dose, which is necessary to control 50% of the plague-
monolayer culture (TCD50), from 20 Gy to 10 Gy. In addition, we also found a significant 
radiosensitizing effect of Chaetocin at low concentration of Chaetocin (30 nM) after 
fractionated IR (3x 2 Gy in 24 h) in NSCLC H1299 (p < 0.05). This finding correlates with 
significant increase in the number of γH2AX foci after fractionated IR as compared to cells 
without Chaetocin treatment (p < 0.001). Overall, the data show that Chaetocin can 
radiosensitize tumour cells depending on the treatment and experimental conditions and 
influences DNA repair, cell cycle, and apoptotic response of the cells. 
Previous studies showed that Chaetocin induces the production of ROS, resulting in 
oxidative damage of cells (Chaib et al., 2012; Isham et al., 2012; Teng et al., 2010). It was 
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also shown that N-acetyl-L-cysteine (NAC), a well-known inhibitor of radical oxygen species 
(ROS), co-treatment abrogates Chaetocin-induced toxicity (Isham et al., 2007). According to 
these findings, we hypothesized that NAC treatment may also abrogate the Chaetocin effects 
seen in the NSCLC cells. Thus, the NSCLC cell lines were treated with NAC before and after 
Chaetocin treatment to reduce the effect of oxidative stress. Here we showed that NAC 
significantly reduced (i) the initial as well as the residual number of DSBs, (ii) normalized the 
reduction of cell proliferation after Chaetocin treatment, (iii) decreased Chaetocin modulated 
cell cycle delay in G2/M and (iv) reduced Chatocin-induced apoptosis with and without IR. 
The effect of NAC was higher if NAC was added to the cell culture before Chaetocin 
treatment.  
4.3.1 Chaetocin as a potential chromatin remodelling agent 
Previous studies reported that chromatin changes play an important role during 
transcription (Li et al., 2007), replication (Groth et al., 2007) and DNA repair (Misteli and 
Soutoglou, 2009). In the present study we focused on chromatin remodelling processes with 
respect to the cellular response to DNA damage. Chromatin remodelling is necessary for main 
features of the DNA damage repair mechanisms. Moreover, chromatin structure influences 
the response to DNA damage. Chromatin undergoes rapid local and global decondensation 
after ionizing irradiation (Unal et al., 2004; Ziv et al. 2006), thus enhancing the access of 
repair proteins to sites of DNA damage. Local perturbation in chromatin structure and DNA 
damage-induced histone modifications after IR provide docking sites for DNA damage-
associated proteins in the vicinity of DNA DSBs. DSBs in heterochromatic regions are 
characterized by lower initial induction (Sak et al., 2015) and slower repair kinetics than those 
in euchromatic regions (Goodarzi et al., 2008).  
In the present work, we were able to modulate the global nuclear chromatin assembly 
by Chaetocin. For the first time we showed that Chaetocin induces visible reorganisation not 
only in human fibroblast nuclei (Illner et al., 2010) and mouse fibroblasts, but also in human 
tumour cells. Up to now, the formation of senescence associated heterochromatic foci was 
described only in fibroblasts (Narita et al., 2003). Our data from the time course experiments 
demonstrated that the induction of CICC phenotype became visible as early as 4 h after 
treatment with Chaetocin and reached its maximum in 24 h. The percentage of CICC 
increased in a concentration-dependent manner with an asymptotic level at about 80% at the 
highest concentration of 300 nM Chaetocin. IR has no effect on CICC formation. We suggest 
that Chaetocin modulates chromatin structures by concentrating heterochromatic regions or 
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the whole chromosomal domains (Illner et al., 2010). 
We analysed the nature of the chromatin remodelling process and demonstrated that 
CICC is associated with heterochromatin marks (H3K9me3, HP1α) and is negative for 
euchromatin marks (H3K4me3, H3K9as). Remarkably, that the CICC nuclei are 
phenotypically similar to condensing chromosomes in late prophase or in mitotic phase. 
However, CICC was not found to be associated with an intensive expression of Cyclin A and 
the phosphorylation of H3S10, which characterizes cells in S phase and mitotic phases, 
respectively. CICC cells were negative for EdU staining, as a measurement for replication. To 
confirm that CICC phenotype mostly originates from G1 phase, we used late passages of 
primary hFbs with low S phase and mitotic activity. CICC were clearly visible and detectable 
with the same kinetics as shown in tumour cells with a maximum at about 24 h.  
We demonstrated that the induction of CICC formation by low doses (29 nM) of 
Chaetocin is a reversible process in human H1299 cells. Same results were observed in 
tumour cells with Aphidicolin cotreatment as well as in late passage primary hFbs, which 
having low proliferative capacity. However, Illner et al. (2010) reported that the induction of 
CICC phenotypes became an irreversible process in primary hFbs.  
Chaetocin was shown to inactivate proteins via reaction with thiol groups and generate 
ROS by redox cycling (Chaib et al., 2012; Gardiner et al., 2005; Isham et al., 2007). Illner et 
al. (2010) suggested that the formation of CICC phenotype could be protected in a thiol-
dependent manner. However the effect of thiols on CICC formation was not related to ROS 
scavenging. These studies imposed us to investigate the formation of CICC structure trough 
oxidation stress. There is no CCC formation 24 h after treatment with 0.1% H2O2. As 
expected, treatment with NAC, as an ROS scavenger, fully inhibited the induction of CICC 
phenotype in H1299 cells. However NAC is not a specific ROS inhibitor (Halasi et al., 2013). 
Thus, we used other more specific ROS inhibitors such as Tiron (100 µM) and Apocynin (100 
µM), which were reported to be the specific for NADPH oxidases (An et al., 2007). They do 
not have an effect on CICC induction. 
Chaetocin belongs to ETPs class of fungal metabolites and was shown to inhibit 
HMTs SUV39H1 and G9a. Thus, it was of interesting to know whether the chemical structure 
of Chaetocin has an impact on CICC induction or if it has an inhibition effect on HMTs. In 
order to test this possibility, various small molecules were tested to investigate the effect of 
Chaetocin on the CICC formation. Gliotoxin, as the structurally simplest member of ETPs 
and also an inhibitor of the HMTs SUV39h1 and G9a (Takahashi et al., 2012), does not 
induce chromatin condensation. In contrast, UNC0638, which belongs to a different chemical 
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class, selectively inhibits HMT G9a (Vedadi et al., 2012) and induces CICC. However 
BIX0194, another selective inhibitor of HMT G9a (Kubicek et al., 2007), does not induce 
chromatin condensation. Interestingly, transfection of H1299 cells with specific siRNA 
targeting both Suv39h1 and/or G9a decreased the formation of CICC. 
Thus, the effect of Chaetocin on chromatin condensation seems to be partly related to 
functional HMTs SUV39H1 or G9a. 
4.3.2 Chaetocin inhibits radiation-induced 53BP1 and ATM foci 
in CICC cells 
 Nonhomologous end joining (NHEJ) and homologous recombination (HR) are now 
well-characterized repair pathways. However, it is still unclear how exactly DNA DSBs in 
different chromatin regions – heterochtomain (HC) and euchromatin (EC) – are repaired. It 
was already reported that heterochromatic regions are highly compacted and this might be a 
barrier for DNA repair (Goodarzi et al., 2010). The repair of DSB in HC needs relaxation of 
chromatin to increase the accessibility of repair proteins to the site of damage. In addition, a 
local decondensation of HC at the sites of damage promotes the movement of DSBs to the 
HC periphery where repair may proceed (Goodarzi and Jeggo, 2012; Jakob et al., 2011). 
To investigate the repair kinetics of DSBs in different chromatin regions we used 
CICC cells as a model system for heterochromatin. This allowed us to study DSBs repair 
signalling in condensed chromatin clusters after Chaetocin treatment. For this endpoint, we 
explore the formation of γH2AX and 53BP1 foci as a measured for NHEJ. Surprisingly, the 
formation of 53BP1 foci was dramatically reduced in CICC cells. In addition, 53BP1 foci 
reduction is correlated with protein reduction at the protein level after Chaetocin treatment. 
Interestingly, that γH2AX foci formation was not significantly affected after Chaetocin 
treatment. Also, the distribution of γH2AX foci in CICC cells after IR showed that 
colocalization of initial and residual γH2AX foci in DAPI free regions and in condensed 
chromatin domains was the same. 
 It is shown that 53BP1 promotes repair by NHEJ (Bunting et al., 2010). A current 
model of 53BP1 action in HC involves its ability to promote the phosphorylation of KAP1 
(KRAB-assosiated protein 1) by ATM kinase, which is needed for repair in HC (Goodarzi et 
al., 2008; Jakob et al., 2011). Indeed, 53BP1 concentrates pATM at DSBs (Noon and 
Goodarzi, 2011). As expected, we observed that lack of 53BP1 also leads to disappearance of 
pATM foci in CICC cells. We did not, however, detect any alterations on the pATM and 
pKAP1 at the protein level after IR in CICC cells. Frohns et al. (2014) has recently reported 
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that adult retina cells, which generally have a high chromatin density, fail to form 53BP1 and 
pATM foci after IR. These data suggest that heterochtomatic structure negatively affects 
53BP1 and pATM foci formation. The level of other proteins involved in DNA repair, such as 
pATP, pKAP1, Rad51 were not compromised after Chaetocin treatment. This finding may 
imply a preferential effect of CICC on 53BP1. In support of this model, supercondensed 
chromatin is an interesting model to study repair of DSBs in HC regions. 
The most likely explanation of 53PB1 foci reduction in CICC cells was practically 
reported by Gonzalez-Suarez and Gonzalo (2010). They indicated that loss of lamin A, a 
member of the type V intermediate filament family and part of nucleoplasmic network, 
associates tightly with chromatin (Goldman, 1992) and leads to destabilization of 53BP1 in 
mFbs, thus providing inappropriate signalling or repair of DNA damage. As we demonstrated 
here, Chaetocin remodelled the chromatin structure by induction of CICC, which could 
destroy or affect the function of lamin A and C and thereby reduce the level of 53BP1. Thus, 
dysfunction of lamin A can also lead to decreased 53BP1 protein level.   
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5. Summary 
In this study we investigated the influence of histone methylation on chromatin 
structure and its effect on radiation response. In this respect the different DNA repair (NHEJ, 
HR), cell cycle checkpoints, proliferation, apoptosis and clonogenic survival in different 
experimental models were evaluated. Initially, the influence of histone methyltransferase 
SUV39H1 on radiation response has been studied using genetic model systems. Mouse 
fibroblasts with genetically knockout Suv39h1 show significant lower clonogenic survival, 
which can be attributed to reduced DSB repair capacity of these cells. The results from repair 
foci analyses show an increase in the fraction of non-repaired damage, i.e. residual 53BP1 
foci as a measure for NHEJ in the mouse model. In addition, decreased number of initial 
Rad51 foci as a measure for HR was evident. Furthermore, experiments with pulsed-field gel 
electrophoresis (PFGE) confirmed the reduced repair capacity, i.e. with higher initial fraction 
of DNA DSB and slower DNA repair kinetics in mFbs with knockout Suv39h1.  
In a second approach we used genetically downregulated Suv39h1 model, using 
siRNA or shRNA in human lung cancer cells. In these experiments SUV39H1 expression 
could be downregulated up to about 50% of the initial level. The results show that the effect 
of HMT SUV39H1 downregulation on clonogenical survival was less marked as compared to 
the mouse knockout model. In addition, there was an obvious difference in the repair 
signalling in both systems with a significant reduced number of residual γH2AX in 
knockdown Suv39h1 NSCLC in contrast to an increased number of residual repair foci in 
knockout mFbs. In addition, results from PFGE experiments show no difference in the initial 
DSBs, but slightly faster repair kinetics in knockdown NSCLC cells in comparison to an 
increase of initial DSB induction and slower repair in knockout mFbs. 
In a third approach, the chromatin structure was modulated in the NSCLC cell lines, 
H460 and H1299 by the small-molecule Chaetocin, which targets the HMT SUV39H1. The 
respective half maximal inhibitory concentration (IC50) for each cell lines was determined by 
using proliferation assays. In the clonogenic assay Chaetocin did not significantly 
radiosensitize the cells. Only an addictive effect could be shown. However, we also 
performed tumour control experiments in the plaque-monolayer assay. The radiation dose 
necessary to control 50% of a plague-monolayer culture after treatment with low Chaetocin 
concentrations significantly reduced from about 20 Gy to 10 Gy. 
In addition, the effect of Chaetocin on the NHEJ and HR repair mechanism and other 
cellular responses was evaluated. The effect of Chaetocin on NHEJ and HRR was 
investigated by 53BP1 and Rad51 foci assay, respectively. Our results show that Chaetocin 
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significantly increases the number of initial and residual 53BP1 foci in NSCLC after short 
Chaetocin pre-treatment. The same effect was observed for γH2AX foci and Rad51 after long 
Chaetocin pre-treatment.  
Most interestingly, Chaetocin was found to remodel the nuclear chromatin structure by 
forming Chaetocin-induced chromatin condensation/clustering (CICC) in primary hFbs, 
transformed mFbs and in the tumour cell line H1299, but not in H460. The CICC structure 
was shown to be reversible after drug washout. IR does not influence the formation of CICC. 
In addition, we confirmed that CICC are mainly associated with heterochromatin marks 
(H3K9me3 and HP1α). Interestingly, if cells were treated with N-acetyl-L-cysteine (NAC), a 
well-known inhibitor of radical oxygen species (ROS), before Chaetocin addition, CICC 
formation was completely abolished. NAC also decreased Chaetocin-induced cell cycle delay 
in G2/M as well as Chaetocin-induced apoptosis. The results further show that formation of 
CICC and radiation induced 53BP1 foci and pATM foci formation are mutually exclusive. 
This was not the case for γH2AX or Rad51 foci. Reduction of 53BP1 foci in CICC forming 
cells mainly relies on reduction of 53BP1 protein expression, as measured by western blot 
analysis.  
Overall, the present study provided data on the effect of downregulation the 
expression of the HMT SUV39H1 for the activation of DNA repair signalling, cell cycle 
checkpoints and cell death mechanisms in mouse and human fibroblast and human cancer cell 
lines after IR. However, additional questions with respect to the molecular interaction of 
HMTs, DNA repair signalling and radiation sensitivity remain open, which have to be 
addressed in further studies. Notwithstanding, because chromatin modifying genes are 
frequently mutated in human tumours, in especially in lung tumours (Govindan et al., 2012; 
Imielinski et al., 2012), it is an innovative field for understanding the role of chromatin 
structure for radio- and chemotherapy. Therefore, research is ongoing in this lab to find 
targets for selective sensitization of tumour cells by additional chromatin modifications. 
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